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c 3  A 3 -Deaza-adenosine 
c 7  A 7-Deaza-adenosine 
c 7  G 7-Deaza-guanosine 
CE Capillary electrophoresis 
CPG Controlled pore glass 
CT Oligonucleotide concentration (total) 





DBU 1 ,8-Diazabicyclo[5.4.0]undec-7-ene 
dC 2'-Deoxycytidine 




dD 2'-Deoxy-2,6-diaminopurine (diaminopurine) 






DMF NN-Dimethylformamide (solvent) 
DMSO Dimethyl suiphoxide 
DMTr 4,4'-Dimethoxytrityl 
DMTrC1 4,4'-Dimethoxytrityl chloride 
DNA Deoxyribonucleic acid 
dU 2'-Deoxyuridine 
EA Ethanolamine 
E Extinction coefficient 
E A Etheno-2'-deoxyadenosine 
EDTA Ethylenediamine tetraacetic acid 
Endproc. End procedure of oligonucleotide synthesis 
Et.0 5-Ethyl-uridine 
F Hyperchromicity factor 
FAB Fast atom bombardment 
G Guanosine 
iGO Stability (free energy) of duplex formation 
HPLC High performance liquid chromatography 




LCAA Long chain alkylamine 
Mac Methoxyacetyl 
Me.0 5-Methyl-cytidine 
mRNA Messenger RNA 
MSC1 Mesitylene sulphonyl chloride 
N Nebularine 
NMR Nuclear magnetic resonance 
NPE 2-(2-nitrophenyl)ethyl 
NTP Nucleotide triphosphate 
Pac Phenoxyacetyl 
PAO-TMG Pyridine aldoximate-tetramethyl guanidine 
Phac Phenylacetyl 





R Gas constant 
RNA Ribonucleic acid 
RNase H Enzyme that hydrolyses RNA when part of a DNA-RNA hybrid 
Entropy of duplex formation 
T Thymidine 
TBAZ Tetrabutyl ammonium azide 




TFAAn Trifluoroacetic anhydride 
THF Tetrahydrofuran 
TIPS Tetraisopropyl-disiloxane 
TIPSC12 1 ,3-Dichloro- 1,1,3 ,3-tetraisopropyl-disiloxane 
TLC Thin-layer chromatography 
TM  Melting temperature 
TPSC1 2,4,6-Tris-isopropyl suiphonyl chloride 





2-Aminoadenine or 2,6-diaminopurine (D), is an adenine analogue where three 
hydrogen bonds are formed in a base pair with thymine, instead of only two 
hydrogen bonds in the A.T base pair. Hence the thermodynamic stability of duplexes 
containing D.T base pairs should be increased relative to those containing A.T. More 
subtle interactions affect the structural transitions of duplexes containing 
diaminopurine. 
Previous attempts at incorporating diaminopurine into DNA during routine 
oligonucleotide synthesis were hindered due to acid catalysed depurination 
(dependent on N6-amino protection) and very poor lability of the N 2-amino 
protecting group during ammonia deprotection. 
An improved N2-amino and N6-amino protection strategy was developed for the 
synthesis of the diaminopurine monomer. This monomer was used successfully 
during routine machine synthesis to make diaminopurine-containing 
oligonucleotides. Derivatised solid support was synthesised to allow 3'-incorporation 
of diaminopurine. A novel synthetic route to the free diaminopurine nucleoside was 
also developed. 
The ability of nucleic acids to form very stable duplexes has many important 
applications in diagnostic and therapeutic molecular biology. The hybridisation of 
DNA probes or PCR primers to their targets may be increased, and hence the 
specificity; or allow shorter probes/primers to be employed. The same strategy may 
be applied to antisense therapy, or DNA sequencing primers. 
In order to predict the physical properties of such duplexes, the thermodynamic 
stability (UV melting) of duplexes containing diaminopurine was determined, using 
oligonucleotides with all combinations of nearest neighbours. This data revealed that 
when diaminopurine replaced adenine, stability of the duplex was increased, with the 
exception of the ID/AT nearest neighbour interaction. This showed that the 
additional hydrogen bond does not always increase stability—more complex 
interactions are responsible for overall duplex stability. 
The cleavage, after synthesis, of an oligonucleotide bound to its solid support, is a 
time-consuming process. Investigations were carried out on a phthaloyl linker, and 
preliminary results showed substantial reductions in the cleavage times, compared to 
the standard succinyl linker. This may give rise to a family of fast-cleaving linkers 
based on the phthaloyl group. 
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INTRODUCTION 
1.1 GENERAL ]INTRODUCTION 
1.1.1 INTRODUCTION TO DNA 
Since the discovery of the nucleic acids in the latter part of the last century, 
several decades elapsed before the structures of the constituent purines and the 
corresponding nucleosides, and the nature of the internucleotide bonds in the 
polynucleotides were clarified. By 1952, the chemical structures of both classes of 
nucleic acids, RNA and DNA, had been established. Soon followed the Watson-
Crick proposal for the DNA structure' and this heralded a new era in chemical, 
biochemical, and molecular biological studies. 
Nucleic acids are biopolymers built from monomeric units known as nucleotides. 
These nucleotides are composed of a sugar-phosphate backbone, and a heterocyclic 
base which is one of four specific "letters" which makes up the genetic code. These 
bases- adenine (A), guanine (G), cytosine(C), and thymine(T)- are shown below. 
NH2 	 0 
N 7 e6 N : 
8(/ 	
2 
N 3 	 N NH2 
adenine (A) 	 guanine (G) 
NH2 	 0 	 0 
4 1 H3C 	
)NH N 	 NH 
NO 	LNO 
6i Ni 0 
H 	 H 	 H 
cytosine (C) 	thymine (T) 	uracil (U) 
Figure 1.1. The five bases found in nucleic acids. 
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The bases are joined to the D-2'-deoxyribose sugar via a -glycosyl linkage, and 
the phosphodiester junction links the sugar groups at the 3' and 5' ends, to give the 
oligonucleotide a directional nature. 
5'-end 






Figure 1.2. The Repeating Nucleotide Unit. 
B= A, C, G or T. 
The double-helical model for DNA proposed by Watson and Crick was 
instrumental in helping understand the role of DNA in biology.' The idea of two 
complementary strands was developed from the recognition that only two kinds of 
base pair can occur involving the major tautomeric forms of G with C, and A with T. 
This idea supported earlier work 2 that identified the ratios of guanine to cytosine, and 
adenine to thymine to always be very close to 1:1. 
H 
rN 	"N-H" 0 	C113 
/D \1 	11 \ R 
A.T 
Figure 1.3. Watson-Crick base pairing between A. T and G. C. 
(R denotes the D-2'-deoxyribose sugar). 
The Watson-Crick model also required that the two strands should run in opposite 
directions (antiparallel), with the strands held together with hydrogen bonding. 
3 
DNA: The Central Dogma of Molecular Biology 
DNA is the repository of genetic information for the vast majority of organisms 
on Earth. DNA is copied by the process of replication, using each complementary 
parent strand as a template for the daughter strands. DNA also serves as a template 
on which transcription of RNA occurs, this messenger RNA (mRNA) is then 
translated into a peptide chain in the ribosome, via transfer RNA (tRNA), which 
carries the individual amino acids to the ribosome. 
1.1.2 CHEMICAL SYNTHESIS OF OLIGONUCLEOTIDES. 
As with other classes of biological macromolecules, interest in the synthesis of 
oligo- and polynucleotides increased very rapidly and systematic studies on the 
synthesis of polynucleotides were undertaken in the mid-1950's. Synthesis of 
oligonucleotides of defined sequences, in conjunction with enzymatic approaches 
enabled the synthesis of high molecular weight polymers that were successfully used 
in the elucidation of the genetic code and later in the total synthesis of genes fully 
functional in vivo. 
Nucleic acids are highly sensitive to a wide range of chemical reactions. The 
heterocyclic bases are prone to alkylation, oxidation, and reduction. DNA is 
vulnerable to acidic hydrolysis, as opposed to RNA where alkaline hydrolysis is 
likely. Such considerations limit the synthesis of oligodeoxyribonucleotides to only 
the mildest of chemical reactions. 
An oligonucleotide is synthesised by assembling monomeric blocks. Each block 
features at least a nucleophilic and an electrophilic function, ie. the 5'-OH and the 3'-
function (phosphate, phosphoramidite, or phosphonate), for nucleotides. The 
nucleophilic and electrophilic sites are linked together in the coupling step. 
Protection is a necessity. It guarantees the chemoselectivity of coupling and the 
solubility of the synthons in organic solvents. 
1.1.2.1 Protecting Groups 
There are two classes of protecting groups: persistent and transient. 3 
4 
The persistent protections remain on the oligonucleotide throughout the synthesis, 
and are cleaved at the very end. They cap the functional groups of the heterocyclic 
base and the phosphate oxygen. The transient protections block the functional groups 
to be coupled (5'-OH) and can be specifically cleaved before each coupling reaction. 
The most convenient way to assemble an oligonucleotide is to utilise preformed 
deoxynucleoside phosphates as basic building units and to couple these sequentially 
to a terminal nucleoside attached to a solid support. Since the primary (5')-hydroxyl 
is a more effective nucleophile than the secondary (3')-hydroxyl, the phosphate is 
best placed on the 3'-position. To achieve selectivity, it is necessary to protect both 
the heterocyclic amino groups and the 5'-hydroxyl group. 
Heterocyclic bases 
Since the initial work of Khorana, 4 ' 5 most studies on the synthesis of 
oligonucleotides have used N-acyl protecting groups for adenine, cytosine, and 
guanine residues. The purine and pyrimidine amino groups are normally protected as 
N6-benzoyl-2'-deoxyadenosine, N 2-isobutyryl-2'-deoxyguanosine, and N 4-benzoyl-2'-
deoxycytosine. 6 These acyl groups are removed by alkaline hydrolysis during the 
ammonia treatment. Therefore there is orthogonality in the protection strategy: the 
permanent protection being base labile, while the sugar protection, which needs to be 
removed for each coupling cycle, is acid labile. 
0 fl Qr 
0 	 HN 	
HN 
	
NH o 	 NN 
NrN' N N I 	k 	' 
N2 Isobutyryl-dG 	 N6-benzoyl-dA 	 N4-benzoyl-dC 
Figure 1.4. The acyl groups commonly used in persistent exocyclic amino protection. 
(R denotes the D-2'-deoxyribose sugar). 
The 5'-hydroxyl group 
The 5'-hydroxyl functions are usually protected with the acid labile trityl ether 
(again introduced by Khorana 7). Most often the 4,4'-dimethoxytrityl group (DMTr) is 
employed, due to its high acid lability which reduces the problem of acid-catalyzed 
depurination during deprotection of the 5'-hydroxyl at the start of each coupling 
cycle. 
' P 
B" denotes a protected base. 
Figure 1.5. Standard 4,4 '-dimethoxytrityl protection. 
1.1.2.2 Phosphoramidite Solid Phase Synthesis 
The phosphoramidite method is an improved version of the phosphite triester 
method pioneered by Letsinger in the 1970's. 8 Letsinger showed that 2-chiorophenyl 
phosphorodichioridate would phosphitylate a 5'-O-protected thymidine at low 
temperatures. 9 Such phosphorodichloridates were exceptionally reactive—too much so 
for common use. 
DMTO1 
NC... 
Figure 1.6 A typical phosphoramidite monomer, showing the cyanoethyl and 
diisopropyl groups. 
6 
However, very shortly afterward, Beaucage and Caruthers found that nucleoside-
3'-O-phosphoramidites could be synthesised, stored, and activated for coupling by 
acid catalysis.' ° Oxidation then led to the phosphate diester. This technique has been 
developed into the most widely used method for automated oligonucleotide 
assembly,6 with the phosphitylating agent: 2-cyanoethyl-N,N-diisopropylamino 
phosphorochloridate, first developed by McBride and Caruthers, emerging as one 
of the most widely used. Figure 1.6 shows the persistent cyanoethyl function, and the 
N,N-diisopropyl function which is protonated by the addition of tetrazole during the 
coupling stage of phosphoramidite synthesis. 
Solid Phase Synthesis 
The pioneering work carried out by Merrifield 12  on the synthesis of peptides on a 
solid support, led to a similar breakthrough in oligonucleotide synthesis, following 
work by Letsinger. 13 
Solid phase synthesis lends itself to automation of the repetitive steps required for 
oligonucleotide assembly, and has the added advantages of speed, high yields, and 
ease of separation of products from impurities. All the required reagents are delivered 
to the growing oligonucleotide which is fixed to an inert support, usually controlled 
pore glass (CPU) beads, 14 via a succinyl linker 15 . Hence all the chemistry takes place 
within the reaction vessel (column), and work up between steps consists of flushing 
away excess reagents and by-products, then introducing reagents for the next step. 
The first step in solid phase phosphoramidite synthesis is the detritylation of the 
solid support-bound nucleoside, using TCA. Step 2 involves activating the next 
monomer with tetrazole, and coupling this to the support-bound nucleoside, in step 3. 
In step 4, any unreacted 5'-OH are capped with acetic anhydride. In step 5, the labile 
phosphorus linkage is converted into a stable phosphate triester using 1 2/H20. Steps 
1-5 are repeated until the desired oligonucleotide chain is assembled, after which the 
oligonucleotide is cleaved from its support using cone. ammonia, and deprotected. 
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Figure 1.7. Solid phase oligonucleotide synthesis, by the phosphoramidite approach. 
Future Developments 
Synthetic oligonucleotides are used as primers in the polymerase chain reaction 
(PCR), in DNA sequencing, and in diagnostic probes (with or without labels), and 
these are applications which have now become routine. 
Academic interest is currently in the development of modified DNA/RNA 
molecules, and in the improvement of RNA synthesis. As functions and types of 
heterocyclic residues used in oligonucleotide synthesis diversify, protection 
strategies have to be adapted. 
Future developments include the application of large- and very large-scale 
synthesis to DNA therapeutics, (the antisense strategy). At the other end of the 
8 
spectrum, a much smaller scale synthesis is of great interest in developing arrays of 
oligonucleotides in hybridisation-based DNA "chips" for use in rapid sequencing 
techniques or diagnosis. 16 
9 
1.2 DUPLEX NUCLEIC AC!]) STRUCTURE 
DNA and RNA duplexes can assume several distinct structures that vary with 
such factors as the nature of the cations present, the humidity, and the base 
sequence.' 7 Double-stranded DNA is conformationally variable; the major 
conformational states are discussed below. 
1.2.1 CONFORMATIONS OF DNA 
B-DNA, also known as the "Watson-Crick" structure, is regarded as the native 
form because its X-ray diffraction pattern resembles that found for the DNA in intact 
sperm heads. B-DNA consists of a right-handed double helix of antiparallel sugar-
phosphate chains with 10 base pairs per turn and with the bases perpendicular to the 
helix axis. The aromatic bases have van der Waals thicknesses of 3.4A, and are 
partially stacked on each other, therefore the helix has a pitch (rise per turn) of 34k 
Bases on opposite strands hydrogen bond in a geometrically complementary manner 
to form exclusively A-T and G-C Watson-Crick base pairs. B-DNA has two deep 
exterior grooves, of unequal size, that wind between its sugar-phosphate chains. The 
minor groove is that in which the Cl'-helix axis-Cl' angle is <1800,  whereas the 
major groove opens towards the opposite edge of each base pair. 17  (See Figure 
1.8(b)). 
A-DNA. When the relative humidity is reduced to 75%, B-DNA undergoes a 
reversible transformation to a wider, flatter right-handed double helix known as A-
DNA. A-DNA has 11 base pairs per turn and a pitch of 28A, leaving an axial hole. A-
DNA's most striking feature, however, is that the planes of its base pairs are tilted 
into the helix axis. A-DNA has a deep major groove and a very shallow minor 
groove. Although B-DNA is the most common form found in nature, most self-
complementary oligonucleotides of <10 base pairs crystallise in the A-DNA 
conformation. 
10 
Z-DNA. Complementary oligonucleotides, with alternating purine-pyrimidine 
base sequences, can take up the Z-DNA conformation at high salt concentrations. 
This helix has 12 Watson-Crick base pairs per turn, a pitch of 45A, a deep minor 
groove and no discernible major groove. Z-DNA is unusual in that it adopts a left-
handed double-helix, and the purines are in the syn conformation. The base pairs in 
Z-DNA are flipped 1800  relative to those in B-DNA. As a consequence, the repeating 
• unit of Z-DNA is a dinucleotide, and the phosphate groups follow a zigzag path 
around the helix. A high salt concentration stabilises Z-DNA by reducing the 
otherwise increased electrostatic repulsions between closest approaching phosphate 
groups on opposite strands (8A in Z-DNA, 12A in B-DNA). ' 8 The methylation of 
cytosine at the C5-residue also promotes Z-DNA formation since the hydrophobic 
methyl group in this position is less exposed to solvent in Z-DNA than it is in B-  
DNA. ' 9 It is thought that the reversible conversion of specific segments of B-DNA to 
Z-DNA may act as a switch in regulating genetic expression, 20  but the in vivo 
existence of Z-DNA has been difficult to prove. 
1.2.1.1 Idealised Models of DNA 
Table 1.1 below summarises the average structural features of ideal A-, B-, and Z-
DNA. However, real DNA is not ideal. Individual residues depart significantly from 
the average conformation in a sequence-specific manner. For example, the self-
complementary "Dickerson" dodecamer d(CGC GAA TTC GCG) crystallises in the 
B-conformation. 2 ' Overall, this molecule shows average helical parameters per 
residue nearly equal to that of ideal DNA. However, the helical twist per base pair in 
this dodecamer ranges from 28-42°, and other deviations include distortions due to 
propeller twisting. Indeed, X-ray and NMR studies of many other double helical 
DNA oligomers catalogue these sequence-specific irregularities. 22,23 
Figure 1.8. Ideal A-, B-, and Z-DNA. (Overleaf). 
The striking difference between the three major types of DNA (apart from the left-handedness of Z-
DNA), is that the A helix appears to be broader and more compressed along its axis relative to B and 
Z. In B-DNA, the base pairs sit almost directly on the axis so that the major and minor grooves are of 
equal depth. In A-DNA the pairs are displaced off-axis, making the major groove very deep, and the 
minor groove extremely shallow. In Z-DNA the base pairs are displaced in the opposite direction, 
















Table 1. 1. Comparing Ideal A-, B-, and Z-DNA. 
7E 	B 	 Z 
Helical sense 	I Right handed 	Right handed 	Left handed 






Narrow and deep 
Wide and shallow 
C3'-endo 
Anti 
10 	 12 (6 dimers) 
Wide and deep 	Flat 
Narrow and deep 	Narrow and deep 
C2'-endo 	C2'-endo (py); C3'-endo (pu) 
Anti 	 Anti (py); syn (pu) 
1.2.1.2 Other Double Helical Structures 
A-RNA. Double helical RNA cannot assume a B-DNA-like conformation because 
its 2'-OH groups would cause steric clash. Instead, RNA adopts a conformation 
resembling A-DNA, known as A-RNA, which has 11 base pairs per turn, a pitch of 
30A, and a base pair inclination of —14". 17  Many RNA structures, for example, 
transfer and ribosomal RNAs, contain complementary sequences that form double 
helical stems. 25 
DNA-RNA Hybrids. These double helices, which consist of one strand each of 
DNA and RNA, possess both "A-like" and "B-like" characteristics. 26 
Segments of DNA-RNA hybrid helices must occur in the transcription of RNA on 
DNA templates; 27  in the initiation of DNA replication by short primers of RNA ;28 
and in the use of heteroduplex molecules for antisense regulation of gene 
expression. 29  RNA may not only serve as the primer in DNA replication, but also, by 
inducing and stabilising an A conformation may play a role in longer-range 
interactions. 30 
1.2.2 THE INFLUENCE OF SEQUENCE ON DUPLEX STRUCTURE 
Different structures may be obtained in duplexes of similar overall base 
composition, but different base sequence. For example poly(dA).(dT) possesses an 
unusual B-DNA conformation which does not undergo a B-A. transition. 31 
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Poly(dA.dT), on the other hand, is thought to exist as two conformers which more 
readily adopt a metastable A-form. 32 (See Section 1.5.3 for further discussion). 
Another example of changing sequence, and consequently the structure, is seen in 
DNA-RNA hybrids. Melting studies of synthetic homopolynucleotides have shown 
that the hybrid: poly(dA-rU) is much less stable than the poly(rA-dT). 33 This work 
was followed up with studies on heptamer duplexes containing a central (A) 5-(TIU)5 
tract. 27 This work supports the idea that instability of the DNA-RNA hybrid plays a 
role in the termination of transcription. Other work with heteroduplexes 34 '35 shows an 
order of stability which differs to that found for homoduplexes, where GC content 
influences the magnitude of relative stabilities. The structural conformations of 
double helical DNA-DNA and DNA-RNA, will be discussed in more detail, later, 
along with the transitions they may undergo. The examples given will be relevant to 
the structure and stability of duplexes containing diaminopurine. (See Sections 1.5.2, 
1.5.3, 3.1 and 3.3). 
1.2.2.1 The Effect of Base Composition 
The most stable duplexes contain A.T/U and G.0 Watson-Crick base pairs. Each 
possible duplex varies in intermolecular interactions, particularly hydrogen bonding. 
Along a helical chain, base-stacking interactions also depend on the exact sequence 
because of the asymmetry of the heterocyclic bases. The ordering of duplexes leads 
to the partition of thermodynamic stability between specific base pair hydrogen 
bonding and base-stacking, often called horizontal and vertical ordering, 
respectively. Sequence-dependent properties of double stranded nucleic acids are 
frequently discussed in terms of base stacking. 36 
1.2.2.2 Environmental Effects 
There is a myriad of environmental parameters that can affect duplex stability. 
These parameters include: the pH of the solution, temperature, ionic strength, 
counter-ion type, and hydration patterns. 36 
The environmental and compositional effects are discussed along with other 
parameters, in Section 1.3 overleaf. 
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1.3 FACTORS AFFECTING DUPLEX STABILITY 
Now that the structural families adopted by double helical nucleic acids have been 
discussed, I will describe the forces acting on these structures that contribute to the 
overall stability of the duplex. These forces, which may affect the structure, 
invariably affect the stability of the duplex. 
1.3.1 THE SUGAR-PHOSPHATE CHAIN 
The rotation of a base about its glycosidic bond is greatly hindered. Purines. have 
two sterically allowed orientations relative to the sugar: syn and anti. Only 
pyrimidines readily form the anti conformation. In most double helical nucleic acids, 
all bases are in the anti conformation, with the exception of Z-DNA. 
To relieve the crowding of the substituents in the eclipsed ribose ring, the ring 
puckers into a half-chair conformation, where the out-of-plane atom is endo-
displaced. There are two main orientations of the ring, depending on which atom (CT 
or C3') is out-of-plane. In DNA, C2'-endo pucker of the deoxyribose leads to the 
formation of mostly B-type helices. Steric hindrance, due to the 02' oxygen in RNA, 
alters the ribose conformation, resulting in a C3'-endo pucker. There are several 
possible interactions of the 02' oxygen which then stabilise the resulting A-type 
conformation of RNA. In Z-DNA, the purine nucleotides are all C3'-endo and the 
pyrimidine nucleotides are C2'-endo. 
P... \ 
0 	
2' / 5.9 C 	,'Base 	7.0  C 
P 
Base 
4 OH 	 0  
P 
C3'-endo 	 C2'-endo 
Figure 1.9. Sugar puckers, showing the two main families of sugar conformations in 
A-RNA (left), and B-DNA (right). Phosphate-phosphate distances are indicated in A. 
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The various torsion angles in the sugar-phosphate chain are also sterically 
constrained. If the angles were completely free to rotate, there would be no stable 
nucleic acid structure. Nevertheless, the sugar-phosphate backbone is by no means 
rigid, so following denaturation, it assumes a random coil conformation. This relative 
flexibility also means that the backbone plays only a minor role in determining 
sequence-dependent structure. 37 
1.3.1.1 Modifications to the Sugar-Phosphate Backbone 
There have been many studies earned out on the modification of the sugar and the 
phosphate groups, particularly for applications in antisense therapeutics. 38,39 
Electronegative substituents on the C2' moiety stabilise the C3'-endo configuration. 
Therefore, DNA with certain C2'-substituents mimics RNA and can form more stable 
duplexes with target RNA, 39  since the favoured A-form duplex is adopted. 
An example of backbone modification is the incorporation of amide groups, 
giving an achiral linkage which increases the propensity for duplex formation. 39  This 
is in contrast to the first generation of backbone-modified DNA where the 
phosphorothioate group destroyed the local centre of symmetry, and created an 
additional centre of chirality, leading to a reduction in binding affinity to the target 
RNA. Geometrical factors are predominant in influencing the affinity of a modified 
oligonucleotide for its target. Adjusting the distance between the sugar moieties and 
choosing the right degree of rigidity (pre-organisation) for the backbone are 
important parameters which influence the binding behaviour. 39 
1.3.2 BASE PAIRING 
Base pairing is responsible for bringing together double-stranded nucleic acids. 
Hydrogen bonding between bases makes Watson-Crick geometry the preferred mode 
of base pairing in double helices—only the bases of Watson-Crick pairs (ie. G.0 and 
A.T, shown in Figure 1.3) have a high mutual affinity. (Non-Watson-Crick base pairs 
are generally of low thermal stability). Hence, Watson-Crick base pairing is both 
geometrically and electronically favoured. 
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1.3.2.1 Non-Watson-Crick base pairs. 
In biological systems, non-Watson-Crick base pairing may be split into two types: 
mispairing involving standard bases, and mispairing involving damaged or modified 
bases. Both types may lead to a mutagenic lesion; and both may have a profound 
effect on duplex stability. 
Mispairing Involving Natural Bases 
In addition to the standard G-C and A-T base pairs, there are eight possible 
mispairs of varying thermodynamic stability. 40 Examples of these wobble base pairs 
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Figure 1.10. Examples of wobble base pairs. 
In higher eukaryotes, there are highly efficient enzymatic defense mechanisms 
against such mismatches. The error rate is kept down to a level of 1 in 10 9, during 
replication in humans. 40 
Some of these non Watson-Crick base pairs may prevail and represent a 
mutagenic event which may be deleterious, beneficial or neutral to the host organism. 
Other non Watson-Crick base pairs may be present to fulfil a structural or other 
functional role within the host cell, e.g. the G-U and G-A "mismatches" play 
important roles in the secondary structure of RNA, such as internal and hairpin loops. 
Examples of other specialist base pairs include those involved in DNA triple-


















Figure 1.11. Unusual base pairs involved in nucleic acid structure. 
Only one example for a G.A mismatch is given—there are four known conformations 
of this unusually stable base pair. 43 
Mutagenic Lesions 
The proof-reading and repair enzymes mentioned above, along with other related 
enzymes have evolved to deal with another kind of non-Watson-Crick base pair. 
These may involve bases modified by chemical damage caused by endogenous 
mutagens, or by environmental mutagens such as UV light and ionising radiation. 44 
These mutagenic lesions include: 0 6-methyl-G, EA, and 8-oxo-purines such as 8-OH-
G. 06-Methyl-G and cA are shown below along with examples of non-Watson-Crick 
base pairs in which they may be involved. 
H3C 
N 	0 	0 	CH3 
R'i 	
H_N> 
N—H ui 0 	R 
/ H 
06-MeG.T 
Figure 1.12. Examples of mispairing involving mutagenic lesions. 
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1.3.2.2 Modified Bases 
Modified bases may be present naturally or be the result of some chemical or 
physical insult (as mentioned above). In addition to the "natural" or "unnatural" 
bases, the development of nucleic acid chemistry and the advent of automated 
oligonucleotide synthesis has facilitated the incorporation of an increasing number of 
novel modified bases (and sugar-phosphate backbones) into oligonucleotides. 
Changing the moieties involved in Watson-Crick base pairing directly affects the 
duplex stability; changing other moieties of the heterocyclic base may affect the 
structure and stability of the duplex in a more subtle manner. 
The modifications made to the heterocyclic bases, and the consequent changes to 
the base pairing, is the subject of Section 1.4. The effects of such changes on the 
duplex structure and stability, are also discussed. 
1.3.3 BASE STACKING AND HYDROPHOBIC INTERACTIONS 
Purines and pyrimidines tend to form extended stacks of planar parallel molecules. 
The bases in these structures are usually partially overlapped, and can occur between 
individual bases, or intra-strand between bases in single- or double-stranded nucleic 
acids. 
It is the stacking interactions between successive base pairs that provide the 
crucial link between sequence, structure and hence properties in double helical 
nucleic acids. Stacking interactions between aromatic molecules have been described 
as "it-it interactions". The total interaction involves dipole-dipole interactions, van 
der Waal's and atom-atom electrostatic interactions. 37 
The surfaces of the aromatic bases are poorly solvated by water and the resulting 
hydrophobic effect forces minimisation of surface area exposed. Environmental 
factors such as solvation and metal counterions also play an important role in nucleic 
acid structure and stability. 
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1.3.4 ENVIRONMENTAL INTERACTIONS 
1.3.4.1 The Role of the Solvent 
Sequence-specific hydration patterns and cross-strand water bridges which may be 
associated with the Watson-Crick moieties, have been proposed as important in 
determining the conformational preferences of base pair steps. For example, A-form 
DNA in fibres undergo a transition to B-form DNA by increasing the degree of 
hydration. 45 
The hydrophobic effect also becomes more important as water and salt content 
increases. This means that the base pair steps are forced into conformations which 
minimise surface area exposed to water. The fact that B-DNA is better solvated than 
A-DNA may also contribute to A-B transitions at high water content in fibres. 37 
1.3.4.2 Ionic Interactions 
The melting temperature of nucleic acid duplexes increases with the cation 
concentration because these ions electrostatically shield the anionic phosphate groups 
from each other. 17  The presence of counterions, such as Na, changes the effects of 
hydration—for example, at high salt concentration, water activity is reduced, and B-
A transitions occur. Salt concentration is also very important in other transitions, 
such as B-Z. Divalent cations, such as Mg 2+'  specifically bind to phosphate groups—
an Mg 
2+  ion has an influence on the DNA double helix comparable to that of 100 to 
1000 Na + ions. 17 
Sequence-specific ionic interactions occur with the heterocyclic base, for example, 
metal ions can form cross-strand bridges by coordinating to carbonyl groups in the 
grooves. 46 
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1.4 MODIFICATION OF THE HETEROCYCLIC BASES 
Chemical modifications of heterocyclic bases are made in order to achieve one or 
more of the following objectives: to enhance their duplex stability (hybridisation 
efficiency), to maintain or increase their target specificity, to provide stability against 
nucleases, and to facilitate cellular uptake. 47 During the last decade, much of the 
work in oligonucleotide synthesis has been directed to investigating the suitability of 
various bases (such as mimics of natural bases, universal bases, and inert or 
ambiguous bases) for the incorporation into antisense oligonucleotides. 39 '48 
The same general principles apply to modification of both pyrimidines and 
purines, and similar effects are observed when modified bases are found in nature 
(Section 1.4.3). Indeed many studies based on modified bases began after such bases 
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Figure 1.13. Sites of modification inpyrimidines and purines. 
1.4.1 PYRIMIDINE MODIFICATIONS 
There are four principal sites of modification in pyrimidines, as shown in Figure 
1.13. 
C2-Modification. There are few reported cases of modification at the C2, as this 
would interfere with hydrogen bonding, and could change steric requirements in the 
minor groove. 
C4-Modification. The susceptibility of the 4-keto group to nucleophilic reagents, 
and the ease of its conversion into a leaving group, has led to several modifications at 
this position. 47 
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C5-Modification. Modifications at this position lie in the major groove of the 
duplex, hence hybridisation will be relatively unaffected. Electrophilic reactions at 
this position are facile, and many 5-substituted pyrimidines have been incorporated 
into oligonucleotides, and their properties studied. The substitution of cytosines 
using 5-methyl- or 5-bromocytosines increased the stability of the duplex. 49 A 
similar behaviour was found for thymine replacing uracil, indicating beneficial 
hydrophobic interactions of the C5-methyl groups in duplex structures. 19 The 
introduction of triple bonds at CS of pyrimidine bases dramatically influences the 
binding behaviour—oligonucleotides containing 5-(1-propynyl)-2'-dU and -dC 
significantly enhance the RNA binding affinity. 5 ' These substitutions are thought to 
increase it-it stacking in the duplex between the additional C5-substituent and the 
adjacent base on the 5'-side. 
C6-Modification. Most substitutions at this position decrease the stability of 
duplexes, as the base, due to steric clashes, is forced to adopt the syn conformation, 
precluding Watson-Crick base pairing. 
1.4.2 PURINE MODIFICATIONS 
Certain substitutions in the heterocyclic base increase, or decrease the 
thermodynamic stability of duplexes, and usually provide a valuable insight into the 
properties affecting stability. Figure 1.14 shows examples of the purines described 
below. 
N' Substituted Bases 
Any modification of the N'-position of purines would be expected to decrease the 
stability of resulting duplexes, due to disruption of a Watson-Crick site. 
C-2 Substituted Bases 
Two examples of C-2 substituted purines that increase duplex stability, are: 2-aza-
inosine (z21), and 2,6-diaminopurine (D). The z 
2  1 is expected to have an acceptor-
donor-acceptor configuration, similar to xanthine (see Figure 1.16), but its pk a is 
22 
higher, and so it could stabilise base pairing (xanthosine carries a negative charge at 
neutral pH). Diaminopurine would be expected to increase the stability of the duplex, 
as it possesses a donor-acceptor-donor configuration, which is a strong Watson-Crick 
base pair complement to thymine (see Section 1.4.4). 
The base analogue diaminopurine, and its effect on structure and stability when 
incorporated into oligonucleotides, is studied in this thesis. 








2-Aza-inosine 	2,6-Diaminopurine 	3 -Dea.za-A 
0 
H)5CN> 
N 	N 	 N 	N 	H2N 	N 
Inosine 	 Nebularine 	 2-Aminopurine 
o 	 0 	 NH2 R 
H2N 	N 	 H2N 	N 	 N 
7-Deaza-G 	 7-Deaza-8-aza-G 	7-Sub-7-deaza-A 
R=Me, Br 
Figure 1.14. Examples ofpurine modifications. 
N3 Substituted Bases 
3-Deaza-adenosine (c 3A) has been incorporated into DNA. It lacks an essential 
hydrogen bond acceptor (N 3 of A) from the minor groove, and hence was used to 
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probe protein-nucleic acid interactions. Study on duplexes containing a single c 
3  A 
residue in the middle of the sequence, showed no destabilising effect, compared with 
A. 50 The higher than expected T m  is explained in terms of the high basicity of c 
3  A 
(PiCa 6.80) versus A (pka 3.62). 
C-6 Substituted Bases 
The order of thermodynamic stability of base pairs containing inosine (I), is: G.0 
> A.T> C.G > I.C> I.A> T.A> G.A> I.G> G.G. This supports the idea that 
inosine might be an ambiguous base, because it pairs and stacks with any of the four 
normal bases, without substantially stabilising or destabilising the duplex. 
52  DNA 
duplexes containing nebularine (N), where the 6-amino group of A is replaced by a 
hydrogen, show a large decrease in T m 'S for both matched and mismatched 
duplexes. 53  The single hydrogen bond formed with thymine is thought to be crucial 
in fixing the base in a position optimal for base stacking. This "pairing" is less 
destabilising than expected, considering only one hydrogen bond is involed. 
2-Aminopurine (AP), another candidate for base ambiguity, also prefers pairing to 
thymine, but destabilises any duplex formed. 
54  Inosine still remains the best "multi-
purpose" base ambiguity, although the development of improved bases continues. 
47 
N7 Substituted Bases 
Seela and coworkers have focused on synthesising a whole series of 7-deaza- and 
8-aza-7-deazapurines and studied the properties of the duplexes formed. Studies 
indicated that oligodeoxynucleotides containing 7-deaza-guanosine (c 7G) have a 
lower TM  value than those of the parent oligonucleotides. In contrast, T m  values were 
increased with oligonucleotides containing 7-deaza-8-aza-guanosine (c 7z8G). 55 
Work was also carried out on oligonucleotides containing 7-substituted c 7A, 
(these are deoxy-derivatives of naturally-occurring tubercidin). These 7-substituted 
purines have a similar effect on the duplex as 5-substituted pyrimidines, and they 
similarly increase the thermodynamic stability, with Br- or Me-substitution. These 
moieties, which have steric freedom within the major groove, also increase its 
hydrophobicity. 56 
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More recent work on 7-substituted-c 7A was carried out in order to investigate its 
effect on the homooligomer duplex: d(A l2).d(T 12), and the alternating oligomer 
duplex: d(AT) 6.d(AT)6, as well as mixed-base duplexes. In the latter case the 
stabilising effect was less dramatic. 
57  This work gives valuable insight into 
modifications carried out at non-base pairing moieties, and their effect on the 
structure and stability of duplex DNA. 
C-8 Substituted Bases 
8-Substituted purines decrease duplex stability because the substituents sterically 
disrupt the major groove. Analogous to 6-substituted pyrimidines, they probably 
force the base into an unfavourable syn conformation. 
1.4.3 MODIFIED BASES FOUND IN NATURE 
Modified DNA bases can be found naturally in eukaryotes, prokaryotes, and 
bacteriophages. 58  They may completely replace the standard base or replace only a 
small fraction. Their substituents vary from simple methyl or hydroxy groups to large 
moieties like amino acids. The majority of hypermodified bases identified thus far 
are present in bacteriophages where they can replace largely or completely one of the 
four common bases. 




N 	N 	1-12N 	N 	 0 
N6-Methyladenine 	2,6-Diaminopurine 	5-Methyl-C 
Figure 1.15. Examples of hypermodfled bases found in natural DNA. 
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The presence of these bases would seem to imply a purpose. It is thought that the 
changes in DNA-protein interactions play an important role in increasing phage 
resistance to host restriction endonucleases, or perhaps the modified bases act as 
transcription signals. 
Bacteria themselves use modified bases: 5-methyl-cytidine is thought to be 
present due to the action of specific restriction-modification systems involved in 
combating phage infection. 58  6-Methyl-adenosine may be used in the regulation of 
DNA repair, the timing of DNA replication, gene expression, and of DNA 
transposition. 58 
It is interesting to note the purpose of 5-methyl-C in mammalian genomic DNA: 
after enzymatic proof-reading, the parent strand is methylated at the 5-position of 
some of the cytosine residues. Repair enzymes recognise this methyl group "marker" 
and make changes only to the daughter strand after DNA replication. 40 
Other examples documented include the adoption of 5-methyl-C, 6-methyl-A and 5-
OH-methyl-U in simple eukaryotes and trypanosomes. 58  It is also worth mentioning 
that in tRNA25 and other RNA molecules, modified bases are present to fulfill 
specialist roles (see Figure 1.11 ) . 59 
1.4.4 SYNTHETIC WATSON-CRICK BASE PAIRS 
In order to find out why nucleic acids are composed from just four bases, and in 
preliminary attempts to extend the genetic alphabet, Piccirilli and coworkers 
synthesised a nucleoside analogue (K). This base hydrogen bonds with xanthosine 
(X), as shown below, to give a novel base pair whose structure is compatible with the 
double helix. 60 This X.K base pair is, along with the familiar G.C, among the 
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Figure 1.16. Four mutually exclusive strong base pairs. 
Diagram shows hydrogen-bonding patterns: a- acceptor; d=donor. 
The geometry of the Watson-Crick base pair can accommodate at least six, of 
eight, mutually exclusive hydrogen-bonding schemes. Four such examples are given 
in Figure 1.16. 
The eight distributions of hydrogen donors and acceptors are defined as follows. 
The middle hydrogen always joins two heterocyclic nitrogen atoms, one of which 
carries a hydrogen atom. Each of the upper and lower hydrogen bonds joins an 
exocyclic donor amino group on one base to an exocyclic acceptor oxygen atom on 
the other.  61  This scheme is shown below. 
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/ C(~ 0) 0~ 
~=< Y 
-------- 
Y ~~ \ R 
Figure 1. 17. An idealised strong base pair. 
If X is a donor NH2 group, X is an acceptor 0 atom, and vice versa. The same rule 
applies to Y and Y'.6 ' 
Piccirilli and coworkers also studied isoC.isoG but this did not form a satisfactory 
base pair (isoG can tautomerise to pair with U/T). 60 
To obtain the desired hydrogen bonding, several of the unnatural base pairs 
require a carbon-carbon bond joining the ribose ring with the heterocyclic base. Such 
structures are undoubtedly more difficult to prepare under prebiotic conditions than 
N-glycosides: perhaps explaining their absence from the repertoire of natural 
nucleotides. In the case of purines, this selection leaves only G, X, and D which are 
products of hydrocyanic reactions. 62 
Natural oligonucleotides use only two of the eight postulated strong base pairs—
one of these incompletely, as adenine, (instead of diaminopurine, shown in Figure 
1.16) as the complement to thymine. 
Diaminopurine, and the strong base pair it forms with thymine, will be discussed 
in Section 1.5, along with the effects this change has on duplex structure and 
stability. 
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1.5 THE BASE ANALOGUE 2,6-DI4,MINOPURINE 
It was once thought that adenine (A), guanine (G), cytosine (C), and thymine (1)! 
uracil (U) were the only bases found in nature. Studies have shown that although 



















adenine (A) 	guanine (G) 
	
diaminopurine (D) 
Figure 1.18. Comparing D with the common bases. 
2,6-Diaminopurine (D) or 2-aminoadenine was first synthesised and incorporated 
into RNA, in 1966 by Howard and coworkers. 63  They found that diaminopurine 
substantially stabilised the duplex compared to the native poly(rA)-(rU), and 
postulated the formation of three hydrogen bonds in a base pair involving rD and rU. 
The initial finding of diaminopurine in naturally-occurring nucleic acids was 
detailed over a decade later. In 1977, Kimos and coworkers reported the isolation and 
identification of diaminopurine, and its deoxyribonucleoside, from S-21, cyanophage 
DNA, where dA is ftilly replaced by dD . M 65  The function of this total substitution 
was not investigated by the authors, although it may serve some structural or 
biochemical defense against the host bacteria. 
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1.5.1 BASE PAIRING INVOLVING DIAMINOPURINE 
The introduction of the amino function at the purine 2-position inserts an NH 2 
group into the minor groove of the base pair it forms. This allows the formation of 
three hydrogen bonds with thymine in DNA, or uracil in RNA, with normal Watson-
Crick geometry. (The base pair formed between D and T, was mentioned in Section 
1.4 as a member of the eight possible strong base pairs). The subsequent base pairs 
are A.T-like in the major groove, and G.C-like in the minor groove. 
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Figure 1.19. Comparing the standard A. T and G. C base pairs with D. T 
1.5.2 THE EFFECT OF dD ON DUPLEX STABILITY 
The ability of nucleic acids to form very stable duplexes has many important 
applications in biology: these applications will be discussed in Section 1.7. 
1.5.2.1 Initial Studies on Oligonucleotides Containing dD 
Three hydrogen bonds (as found in G.0 and D.T) would be expected to be 
thermodynamically more stable than two (found in A.T)—see Figure 1.19. The first 
studies into the stability of duplexes containing diaminopurine were carried out by 
Howard and coworkers. 63  They found that the poly(rD).(rU) duplex to be 
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approximately 25°C more stable than the "native" poly(rA).(rU) duplex. They 
rationalised that the entropy change for dissociation of the two complexes should be 
nearly the same, suggesting that the higher stability of the rD-containing duplex to be 
attributed to a larger enthalpy of base-base interaction, conferred by the additional 
hydrogen bond. 
Soon after this, Cerami et a1 66 prepared an alternating DNA copolymer 
poly(dD.dT), and compared the melting temperature to the similarly-made 
poly(dA.dT). The native sequence was again found to have a much lower melting 
temperature (4Tm=20°C). This data was in agreement with that found for the RNA 
duplexes, and both studies showed duplex behaviour consistent with the "three 
hydrogen bond" proposal. 
The identification of naturally-occurring dD in S2-L cyanophage DNA 64,65 
prompted further study, and enzymatic and chemical methods were employed to 
allow the preparation of polynucleotides or oligonucleotides incorporating 
diaminopurine. For example, Scheit and coworkers 67  made poly dD and poly rD, and 
compared the duplexes formed with dA and rA respectively. In common with other 
workers, these enzymatically-made duplexes showed a large elevating effect where D 
replaced A. 
The study of short synthetic oligonucleotides containing dD were first carried out 
in 1982 by Gaffney and coworkers on the self-complementary hexamer d(TD) 3 . 68 
The hexamer formed a stable duplex at temperatures where the native hexamer did 
not. This work led to the preparation of other hexamers, with regards to their duplex 
stability, classifying the dD.dT base pair as being more stable than the dA.dT base 
pair, but less stable than the dG.dC base pair. 69 
1.5.2.2 The Spine of Hydration and (dA).(dT) Tracts 
Building on their earlier work, Howard and coworkers noted that the stabilising 
effect of D was much greater in RNA than in DNA. 70  They suggested that the lower 
increase in stability for DNA might be due to a change in the hydration pattern of 
DNA which was disrupted by the minor groove amino group. 70,71  For DNA, the 
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overall gain in stability was equal to the beneficial gain from forming three hydrogen 
bonds less the loss in stability due to changes in hydration patterns. These changes 
are particularly detrimental in the case of A.T tracts where Drew and Dickerson had 
previously reported finding a spine of hydration. 72 
Whilst examining the use of diaminopurine in synthetic probes, in particular the 
stability of duplexes formed, Chollet and coworkers reported that in most cases the 
dD-containing probes were more stable than the native probes. 73-75  However, they 
noted that the substitution of dD in A.T tracts, namely in d(CAA ADA AAG), the 
duplex formed was destabilised with respect to d(CAA AAA AAG). 74 In this case, 
the dD is thought to disrupt the network of hydrogen bonds (spine of hydration) 
formed between the N 6 of dA and the 04 of dl on opposite strands. 
76 
While the use of dD adjacent to dA is unlikely, it is important to investigate the 
effect of substitution of dD for dA will have on the duplex structure and hence, 
causally, on the stability, where dD replaces dA. 
This is one example of the complex relationship between the stability of duplex 
nucleic acids and the structure they adopt, which is in turn dependent on other factors 
such as counter ion and the degree of hydration. 
1.5.3 THE EFFECT OF dD ON DUPLEX STRUCTURE 
Diaminopurine has both adenine-like and guanine-like features, (in the major and 
minor grooves, respectively) and would therefore be expected to behave like either 
base, or a mixture of both. The presence, or absence, of the 2-amino group in 
particular, may have a profound effect on the structure adopted, and on subsequent 
structural transitions. 
In order to build up a picture of the conformations and structural transitions that 
diaminopurine may influence, it will be compared with: adenine in homopolymer, 
and copolymer double-helices; and with guanine-containing double-helices. The 
structure adopted by mixed-base duplexes containing diaminopurine will also be 
discussed. 
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1.5.3.1 Comparing (A).(T), and (D).(T) Tracts 
Tracts containing oligo(dA).(dT) have a B-form conformation of DNA that is 
significantly different from that of other deoxypolymers. 77 This B-form duplex bends 
in the helix axis, and has a certain stiffness in the A tract. It owes its particular 
stability to a propeller twist and buckle in the dA.dT base pair which helps maximise 
purine-purine stacking and creates a potential system of non-Watson-Crick hydrogen 
bonding. These bonds may form diagonally across the major groove inter-strand 
between N6 of A and towards the 04 of T, 76 and form the spine of hydration 
mentioned in Section 1.5.2.2, above. 
A striking consequence of this altered structure is its refusal to undergo a 
transition from B-form to the A-form of DNA, even at very low water content. 45  This 
can also be explained in terms of the AA/TT step, which has a strong calculated 
preference for the B-form. 37 
When diaminopurine replaces adenine to give dD.dT tracts, the conformational 
rigidity displayed in dA.dT is not observed. This is partly a consequence of the lack 
of spine of hydration. Howard and Miles 70  compared a variety of homopolymers 
containing (A).(T) and (D).(T) tracts. Of particular interest were: poly(dA).(dT), 
poly(dD).(dT), poly(dA).(rT), and poly(dD).(rT). DNA/RNA hybrids (duplexes of 
importance in antisense therapy—see Section 1.7) were also investigated more 
recently in oligonucleotides by Gryaznov and Schultz. 78  Both groups reached the 
same conclusion, that: 
dD-dT tracts show similar 78  or greater 70  stability to dA.dT, and 
dD tracts bind strongly to rT, whereas dA tracts bind poorly to rT. 
(In the latter case the dA's are reluctant to adopt the A-form helical structure, which 
is favoured by RNA-RNA duplexes and DNA-RNA hybrids). 
27,30,35  In addition, 
Gryaznov and Schultz found that substitution with dD enhanced binding to RNA the 
most where the original relative destabilisation by dA residues was the greatest. 
1.5.3.2 Comparing (A.T) and (D.T) Tracts 
The alternating duplex, poly(dA.dT). is much more conformationally flexible than 
poly(dA).(dT), and has an alternating structure with a small helical twist of the AT 
steps and a larger twist at the TA steps. 57  This results in a polymorphic structure 
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which can adopt more than one conformation {compared to the "stiff' 
poly(dA).(dT)}, depending on the environment/ modifications present. Poly(dA.dT) 
may also undergo the transition to A-DNA more readily than poly(dA).(dT), due to 
the conformational flexibility of the former. 
X-ray diffraction patterns on fibres of the copolymer poly(dA.dT) were first 
obtained by Davies and Baldwin . 79 This suggested a D-DNA structure. Anomalies 
involving poly(dA-dT) include the observation that the strands are cut into 
dinucleotides of pTpA instead of mononucleotides when exposed to DNasel 80 
Existence of regular alternation in the local helical parameters of d(A.T) tracts led to 
the proposal of an alternating B-DNA helix for poly(dA.dT). 8 ' In such a model the 
helical twist angle is smaller at the AT step than at the TA step. Yoon and 
coworkers 82  reported similar alternation in the central AT region of d(CGC ATA 
TAT GCG) to support the alternating B-DNA conformation. 
These observations point to a structure maximising the dApdT overlap at the 
expense of the weaker dlpdA base stacking. 
A 2D-nmr NOE study carried out on poly(dA.dT) showed both bases to adopt the 
anti conformation, 83  and the helix most likely to be right-handed. The authors 
proposed a right-handed B-DNA, and found evidence to exclude alternation. More 
recently, Kypr and coworkers have found poly(dA.dT) to coexist in two 
conformers. 32 
Less study has been carried out on (dD.dT) tracts, but like (dA.dT) tracts, the 
models developed for duplex structure have evolved over the years. This is especially 
true of the conformational transitions oligo and poly(dD.dT) may undergo, which 
differ to that for oligo and poly(dA.dT). 
1.5.3.3 Structural Transitions of Poly(dD.dT) 
Initial studies on CD spectra collected for oligo and poly(dD.dT) concluded that 
the high salt form was most likely Z-DNA. 68 '69' 84 This was deduced from the general 
inversion of the CD spectrum (going from low to high concentrations of NaC1), in a 
manner analogous to that seen for poly(dG.dC). 
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nmr seemed to support a high-salt Z-DNA hypothesis. In low salt poly(dD.dT) 31 P 
has two clearly resolved signals, whose separation increases as the salt concentration 
increases. This is indicative of two different phosphorus environments, and was 
likened to that seen for poly(dA.dT), although it was felt that the downfield signal 
was closer to that found for poly(dG.dC). This was taken to indicate a Z-DNA 
structure for poly(dD.dT).' 85 
These initial conclusions seemed to agree with the premise that alternating purine-
pyrimidine, and the presence of the 2-amino group in dD (like dG), would give a salt 
induced B-Z transition. However, the picture is not quite as simple as this for Z-DNA 
promotion. This matter will be mentioned in more detail, and with reference to dD, in 
Section 1.5.3.4. 
Borah and coworkers reached a different conclusion in later 2D nmr and 31 P nmr 
experiments. 86 '87 From the 2D NOE spectroscopy structural information is obtained 
on the basis of spatial connectivities between nuclei coupled by dipolar interaction. 
In the archetypal B-Z transition, where poly(dG.dMeC) undergoes a transition in 
high salt, intense H8-H' intra-base cross peaks are observed from the resultant syn-
dG. No such cross peaks are found in the high-salt form of poly(dD.dT) suggesting 
anti-dD and dT. A C2'-endo sugar pucker was proposed, possibly due to (H 6)T-
(H2")D interactions, which is typically shown in A-form DNA. This high-salt form of 
poly(dD-dT) was concluded to be a member of the A-family of DNA as it did not 
possess the B or Z conformation. Later studies showed similar results for 
poly(dD.dxU), where x=Br or 1.87 
Several years after the nmr studies, Vorlickova and coworkers recorded the CD 
spectra of poly(dD.dT) under the same conditions previously found to induce a B-A 
transition in poly(dA.dT). 88 They found that the CD spectra of the high salt and 
ethanol forms of poly(dD.dT) were the same. It was concluded this form was not A-
DNA but X-DNA (previously reported for poly(dA.dT)). Poly(dA.dT) was not 
affected by, e.g. 70% MeOH, unless trace amounts of cesium cations were added. 
This produced the X-DNA profile. The conclusion reached was that the extra 2- 
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amino group performed the same role as the Cs, that is, it dehydrates the minor 
groove and relieves its conformational variability. 
Poly(dD.dT) was then shown to form X-DNA under very mild conditions. 89  At 
low concentrations of the duplex, millimolar quantities of Mg 2+ caused the B-X 
transition. This further exemplifies the fact that X-DNA and A-DNA are not the 
same—A-DNA is destabilised by divalent cations in aqueous solution. 
The presence of alcohol, divalent cations, and the 2-amino group of dD are not the 
only factors which promote the transition to X-DNA. Substitution at the 5-position in 
pyrimidines enhances the transition to X-DNA. Indeed, recent work carried out by 
Vorlickova's group focused on the effect of the 5-methyl group in pyrimidines, 
namely in poly(dD.dT) duplexes. 50 The methyl group exerts a profound effect on the 
conformation of DNA, for example, poly(dA.dT) coexists in two conformers, 32  and 
poly(dA.dU) exists as a single conformation resembling RNA. 90  In addition, 
methylation of poly(rA.rU) to give poly(rA.rT) possesses some properties of DNA; 32 
and methylation of poly(dG.dC) promotes the B-Z transition, but inhibits the A-Z 
transition in poly(rG.rC). 9 ' 
The methyl group of dT, versus other small 5-position aliphatic groups, is the 
optimum for stabilisation of the B-type conformation of alternating purine-
pyrimidine DNAs. Vorlickova et a1 5° found that the putative A-form (previously X-
form89) of poly(dD.dT) was strongly stabilised by the thymine methyl group. They 
realised that neither poly(dD.dEtU) nor poly(dD.dU) isomerised into the putative A-
form in low salt aqueous solution with Mg 2 . 
The conformational isomerism (B-putative A) is strongly promoted by the 
combined effects of the 2-amino group of purines with the 5-methyl group of 
pyrimidines. Only poly(dG.dMeC), not poly(dI.dMeC) or poly(dG.dC), adopts the Z-
form relatively easy. The amino groups in the minor groove of the double helix 
cooperate with the methyl groups of the major groove, and with divalent cations, to 
stabilise the zigzag backbone of the form of poly(dD.dT). 
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In the poly(dD.dxU) family, the methyl group was found to destabilise the Z-form 
adopted by poly(dD.dT). The Z-form and putativative A-form are mutually 
exclusive 50 : 
Putative A-form (-Reluctant to form 	Z-form 
e.g. poly(dD-dT) 	 e.g. poly(dD-dEtU) 
1.5.3.4 B-Z Transitions 
As mentioned earlier, the transitions associated with poly(dD.dT) were thought to 
be B-Z, but the current body of evidence now points to a B-putative A-form. The 
ease of transition of poly(dD.dT) from its B-form to the putative A-form suggests 
that their base pair topologies are the same. 50 However, the putative A-form has a 
zigzag backbone which discriminates it from A-forms of poly(dA.dT), and other 
natural DNAs whose backbones are regular. 92  Poly(dD.dT) does adopt the Z-form, 
but only to a limited extent, as the putative A-form is the preferred conformation 
under conditions normally associated with B-Z transitions. What type of 
oligonucleotides undergo a B-Z transition? 
Most study regarding non-polymeric, mixed sequences containing dD, have been 
concerned with their use as probes and other applications. Here, the thermodynamic 
and hybridisation properties of the duplexes formed have been of concern, (see 
Sections 1.2 and 1.3), and actual structural studies on such duplexes formed, are 
relatively few in comparison. However, a few mixed sequences have been studied 
which adopt, at least in part, the Z-form. These include the self-complementary 
duplex: d(CDC GTG) 2, this adopts 25% Z-DNA in the high salt NMR study, and 
clearly shows the Z-form at low humidity by IR, although CD showed no evidence. 93 
The Z-form was found in two crystal structures by Coll and coworkers: d(CGT 
DCG)2, and the duplex studied by the group above: d(CDC GTG) 2 . 94 
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1.6 SYNTHESIS OF DIAMINOPURINE NUCLEOSIDES 
1.6.1 A REVIEW OF DIAMINOPURINE 2'-DEOXYNUCLEOSIDE 
SYNTHESIS 
Via an N'-Oxide 
Initial synthesis of 2,6-diaminopurine involved the reaction of cyanogen bromide 
with adenosine NI-oxide. 95  This yielded a cyclic N 1 -N6 product which with 
methanolic ammonia gave N 6-cyano-deoxyadenosine-N'-oxide. Methylation 
followed by alkaline treatment resulted in a rearrangement leading to 2-amino-N 6-
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Figure 1.20. The synthesis of diaminopurine from d4-N'-oxide. 
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Via N6-Triazolo Derivatives 
Another approach to synthesis of 2,6-diaminopurine 96 was provided by Sung who 
noticed that thymidine could be converted to 5-methyl-dC using relatively mild 
conditions. 97  The conversion of dT to 5-methyl-dC was achieved via an intermediate 
4-triazolopyrimidone. This was prepared from the reaction of protected dT with p- 
chlorophenyl phosphorodichloridate and 1 ,2,4-triazole in pyridine; after work-up, 
treatment with ammonia gave 5-methyl-dC. (It is interesting to note that this reaction 
is similar to a known side reaction in phosphoramidite chemistry that converts dG to 
M). 98 
This technique, based on post-synthesis treatment of the triazolo derivative of dG 
with ammonia, however, remained unsatisfactory, leaving a ratio of approximately 











concNH40Er HO 	N NNH2 
HO 
rti 
Figure 1.21. Conversion of 1V 6-triazolo dG to dD. 
PAO-TMG= pyridine aldoximate-tetramethyl guanidine. Ib= isobutyryl. 
Via 06 Suiphonation 
Guanine nucleosides are known to be reactive at the 06 position with a variety of 
acylating, sulphonating, and phosphorylating agents. 99 This susceptibility causes 
problems in oligonucleotide synthesis, 99  but provides access to many guanine 06, N, 
and S derivatives. 99,100 
Gaffney and coworkers exploited the reactivity of the 06 position of dG towards 
sulphonating agents and alkylating agents as a general synthetic route in obtaining 6-
substituted dG' ° ' or 06-protected dG 102 respectively. Sulphonation of the 06 
position of dG had been reported to proceed easily 103,104 to give a suiphonated 
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nucleoside which readily underwent displacement reactions with nitrogen 
nucleophiles to introduce an N 6 function. 
Gaffiiey and coworkers utilised the above findings to synthesise dD nucleosides. 69 
Tris-isobutyryl deoxyguanosine was sulphonated with tris-isopropylbenzene-
suiphonyl chloride (TPSC1) in triethylamine-containing dichioromethane solution, 
using dimethylaminopyridine as a catalyst. This derivative was then converted to the 
2,6-diaminopurine derivative by liquid ammonia displacement of an intermediate 
trimethylamino group,' °" °5 which is more readily displaced than the sulphonyl 
group. The N6 protecting group of choice was the benzoyl group. However, the use 











Figure 1.22. Amination via Suiphonation. 
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1.6.2 PROTECTION STRATEGY 
2,6-Diaminopurine is unique among the heterocyclic bases in that two amino 
functions must be furnished with protecting groups. 
NH 
</ 
RO 	 N  
RO 
Figure 1.23. The needfor two amino-prorecting.groups. 
Different strategies lie behind the choice for the protection of the N 2 and N6 
moieties—firstly, the problem of acid-catalysed depurination, which is more serious 
in dD than dA, will be addressed. 
1.6.2.1 Acid-Catalysed Depurination 
Synthesis of sequences containing dD is subject to a major side reaction: acid-
catalysed depurination of dD residues during TCA-induced detritylation of the 5'-
terminus. The rate of depurination is highly dependent on the choice of N 6 
protection, as noted for dA. 106 (The problem of depurination of dA during 
detritylation has been acknowledged for quite some time.' °7) Depurination is more 
severe when susceptible bases are situated towards the 3'-end of the sequence, and 
when the oligonucleotide is longer, since in both cases the purine residue is exposed 
to more acid detritylation steps. 
Early attempts to synthesise dD oligonucleotides were handicapped by the effects 
of depurination, 68 ' 69 even when zinc bromide was used for detritylation. This 
occurred because the N 6 protecting group employed was the benzoyl amide: the 
group of choice for dA. Following depurination, the oligonucleotide may be cleaved 
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at the apurmic site by the ammonia treatment at the end of synthesis. This cleavage 
of the 3'-OH side of the apurimc site is similar to that found in Maxarn-Gilbert 
sequencing. ' °8 The product obtained from the synthesis is therefore a combination of 
the desired oligonucleotide, apurinic material, and oligonucleotide fragments. 
There are three approaches that may be adopted to avoid the problem of 
depurination. These approaches involve changing either the: detritylation reagents; 
the 5'-OH protecting group; or the N 6 protection. Each of these alternatives will be 
considered in turn. 
(a)Detritylation Reagents 
The standard reagent used to remove the dimethoxytrityl group is a solution of 
TCA in dichioromethane. Other detritylating reagents which were used included 
benzenesulphonic acid in acetonitrile. 109 However, this also showed significant 
depurination. Attention then focused the use of aprotic reagents for detritylation. 
Saturated solutions of zinc bromide in nitromethane gave quantitative detritylation, 
and depurination did not occur as long as the nitromethane was scrupulously 
anhydrous. 110  Unfortunately, the 5'-OH group is unreactive to condensation reactions 
unless demetalated with mild alkaline hydrolysis. The deprotection stage then 
becomes a two step process: (1) a 30 minute treatment with sat. ZnBr 2/nitromethane, 
then (2) a 5 minute wash with n-butanol in THF/2,6-lutidine to regenerate the 5'-
OH." The complexity of the reagents required and the increase in cycle time make 
this an unattractive option compared to the use of TCA. 
(b) 5'-OH Protection 
Other groups used for 5'-OH protection include: tris(benzoyloxy)trityl, removed 
with NaOH;" 2 trityloxyacetyl, removed with dilute NH 40H;
113  t-butyldimethylsilyl, 
removed with F or AcOH;" 4 9-phenylxanthen-9-yl group (pixyl), removed by mild 
acid hydrolysis;' 5 and o-dibromomethylbenzoyl, which is removed with silver 
perchlorate." 6 Whilst these are only a few examples from a long list of 5'-OH 
protecting groups, changing the group would incur a new set of problems. Cleavages 
involving basic conditions are not acceptable as orthogonality of base and sugar 
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protection would be lost if base-labile sugar protection is adopted. Also, if acid-labile 
protection is used, such as the pixyl group, depurination will still remain a problem. 
Other problems would be introduced, for example phosphate cleavage by the fluoride 
ion. The 4,4'-dimethoxytrityl has its own inherent advantages around which the 
standard synthesis of oligonucleotides is based, and it is important to adhere to these 
protocols. 117 
(c)N6 Protecting Group 
Changing the N6 protection group is the most appropriate course of action, since 
there is no need to deviate from the well established protocols for phosphoramidite 
solid phase synthesis. 
Many different groups have been developed for the protection of the exocyclic 
amines, with several aimed at reducing the amount of acid-catalysed depurination of 
dA on detritylation. A modified form of the dimethoxytrityl group has been proposed 
for the N6 position. " 8 The resulting N6-4, 4' ,4"-tris(benzoyloxy)trityl-dA was found 
to offer up to four times the stability of N 6-benzoyl-dA in 2% DCAldichloromethane 
and eight times as stable in 80% AcOH. The phthaloyl group offered better 
depurination resistance in DCA and AcOH." 9 At the same time the phthaloyl group 
was found to be more base labile than the benzoyl group. N 6-Succinyl-dA was also 
made, and showed improvements over phthaloyl protection. 120  In an effort to change 
the site of protonation of N 6-benzoyl-dA, a different approach was proposed by 
Morin. ' 2 ' This involved N'-oxidation, which reduced the depurination during 
detritylation with benzene suiphonic acid. 
The breakthrough in N6 protecting group choice came with the application of 
amidine reagents to solid phase synthesis monomers. 122 
1.6.2.2 N6-Amidine Protecting Groups 
Amidine protection was originally used for ribonucleotides' 23 before being 
reintroduced for deoxyribonucleotides.' 24 The dimethylformamide (dmf) was easily 
placed on the N 6 of dA with dimethylformamide dimethylacetal in DMF to yield 
exclusively N6-protected material in 90% yield. However, when exposed to 
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oligonucleotide detritylation reagents (ZnBr 2 in nitromethane/methanol, or 3% TCA 
in dichioromethane) the amidine was rapidly hydrolysed. 125 This led McBride and 
Caruthers to propose N 6-(N-methyl-2-pyrrolidine amidine)-dA for use in 
oligonucleotide synthesis. 125 The half life of this compound in 1M TCA was three 
times that of the benzoyl protected dA (60 minutes versus 20 minutes). In order to 
extend the range of usable amidines, and help increase their hydrolysis resistance, a 
series of N6-dialkylformamides was prepared with increasing steric bulk in the 
dialkyl portion. 122 
N6-Diisopropylformamide-dA was resistant to depurination in 2% DCAI 
dichioromethane at 25°c with a half life of about 2 hours, but its deprotection with 
ammonia at 60°C took 12 hours. The group that emerged as most suitable was the 
N6-di-n-butylformamide-dA which remained stable to all oligonucleotide synthesis 
conditions, readily deprotected with concentrated ammonia in 3 hours at 60°C, and 
offering an approximate 20-fold suppression of depurination.' 22 
Formamide protection of the N 6 position of dA offers the following advantages. 
The protecting groups can be prepared from inexpensive starting materials. Unlike 
traditional (acyl) protection strategies, the nucleoside can be selectively N 6-protected 
without the inevitable transient protection of the 3'- and 5'-OH functions. ' 26 In 
addition, the formamide is easily removed under the standard deacylation conditions 
used, i.e. concentrated ammonia at 55°C. The most important property of the 
formamides is their ability to greatly increase the resistance of dA to acid-catalysed 
Cl '-N9 cleavage during the repetitive detritylation stage. 
1.6.2.3 The Effect of N 6 Protection on Depurination 
Observing the mechanism for acid-catalysed depurination does not make it 
obvious that the choice of N 6-protection will influence the rate of depurination. 
Depurination is known to proceed via an Al-type mechanism, involving the 
protonation of the purine in a pre-equilibrium step, followed by the rate determining 
step of C1'-N 9   glycosyl bond cleavage to form a cyclic glycosyl oxycarbenium 
ion. 121-129  This mechanism, shown below, is supported by a secondary deuterium 
isotope effect, and the influence of changes in the glycosyl moiety on the hydrolysis 
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rates as observed for the hydrolysis of ribosides versus deoxyribosides.' 29 
Deoxyadenosine has two reactive nitrogens as sites for protonation (N' and N 7), so 
the pre-equilibrium step may be the formation of either a mono- or di-cation. Both of 
these cases lead to Cl '-N 9 bond cleavage. The 1-methyl-adenosine cation depurinates 
at about the same rate as adenosine, suggesting that it is the 1 -protonated form of the 
latter that reacts with a second proton to result in a depurinating di-cation. 127 
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Figure 1.24. Acid-catalysed depurination, shown for diaminopurine. 
What is the effect of the N 6-protection on the depurination rate? By observing the 
changes in the N' and N 7 basicities, ' 5N nmr shifts in TFA the protonation sites can 
be determined. 130  2'-Deoxyadenosine showed a change in only the N' shift, 
indicating N'-protonation in agreement with the greater basicity of N', while N 6- 
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benzoyl-dA was protonated at N' and N 7 . In other words the relative basicity of the 
nitrogens is changed in the latter case, probably due to a reduction in electron density 
of the pyrimidine ring caused by the electron-withdrawing N 6-substituent. 
It has been proposed that N 7-protonation of dA leads to more rapid Cl '-N 9 
cleavage. The N 6-benzoyl-dA appears to depurinate more readily due to its 
preferential N 7-protonation. This may be due to N7-protonated adenine being a more 
stable leaving group than the N' tautomer.' 3 ' This change in protonation site had 
been observed previously in C8 hydrogen exchange experiments of N 6-substituted 
dA where protonation occurred at N 7 preferentially' 32  with the degree of change 
dpending on the acyl group present; benzoyl having a greater effect than the acetyl 
group. 132  Changes in nitrogen basicity influence depurination rates via the 
monocation route. The use of dialkylformamide N 6-protection for dA (and dD) such 
as the sterically hindered di-n-butylformamide group, would be expected to reduce 
the changes in protonation and N', N 7 relative basicity. 
1.6.2.4 N6 Protection for dD 
The features outlined above make the di-n-butylformamide group an attractive 
option for the protection of the N 6-position of dD. Preliminary studies were carried 
out by Booth. 133 
There were two target monomers. In the first monomer, the N 2-protection 
employed was the isobutyryl group (by analogy to dG' 26); in the second monomer 
the N2, N6-bis-di-n-butylformamide-dD monomer was synthesised. The reaction 
scheme is shown below, starting from the 2,3',5'-protected nucleoside. The 
conversion of the 06 function to an N 6-ainino function was carried out as outlined in 
Figure 1.25, (following Gaffhey 69). 
The first monomer showed resistance to depurination in TCA, however the N 2-
protection proved to be far too stable under standard deprotection conditions. The 
second monomer showed reduced coupling efficiency—this was probably caused by 
the large N2-di-n-butylformamido group sterically hindering the 5'-OH reaction site, 
when the base is in the syn conformation.' 33 
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Figure 1.25. Synthesis of the N 2-isobutyryl, I'/-di-n-butylformamidine monomer. 
R= isobuyryl. 
Stirring the 3',5'-OH, N 2-tris-isobutyryl-dD in dichioromethane with di-n-
butylformamidine dimethylacetal afforded the N 6-formamidine protected nucleoside. 
This was saponified using 2MNaOH, to allow standard tritylation, then 
phosphitylation. 
The free dD nucleoside was obtained by full deprotection of the isobutyryl 
protecting groups, by incubation in concentrated NH 40H solution at 60°C for five 
days. 133  Suspending the free dD in dimethylacetamide (DMA) with di-n-
butylformamide dimethylacetal for 18 hours gave the N 2, N6-bis-protected 
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nucleoside; which was then tritylated and phosphitylated, to give the bis-protected 
monomer 
In this project, the N 6-formamide strategy shall be adhered to, but the N 2-
protection must be developed, with regards to improving its lability under standard 
deprotection conditions (concentrated NH 4OH). 
1.6.2.5 N2 Protection for dD 
The standard choice of protecting the N 2-amino group (in dG) is the isobutyryl 
group. 134  As mentioned in Section 1.6.2.4, the isobutyryl group is unsuitable for N 2-
protection of dD due to the extremely long deprotection times in concentrated 
NH40H; and N2-di-n-butylfonnamide protection is unsuitable due to reduced 
coupling efficiency. 133 
Therefore a more base-labile protecting group must be found, which is not too 
sterically bulky. One aim of this project is to satisfy these criteria for N 2-protection 
of dD. The alternatives tested, and the results of these investigations will be 
discussed in Section 2. 
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1.7 DNA CONTAINING DIAMINOPURINE 
The duplex stabilising properties of diaminopurine were described in the main in 
Section 1.5. The incorporation of diaminopurine in DNA and its use in hybridisation 
with complementary oligonucleotides are a useful consequence. 
1.7.1 DNA PROBES 
Synthetic oligonucleotides have numerous applications in molecular biology, 
including their use as hybridisation probes. Only perfectly matched probe-target 
DNA duplexes are formed under controlled hybridisation conditions. 135 The 
introduction of additional stabilisation to DNA duplexes would allow the use of more 
stringent hybridisation conditions and therefore increase the probe specificity for its 
target. 
It has been shown that by incorporating base analogues, such as 2,6-
diaminopurine, into oligonucleotides, the hybridisation properties can be modified to 
enhance probe selectivity and binding strength. 
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1.7.1.1 Gene probing 
Voss and coworkers, ' 36 found that replacement of a single adenine residue with 2-
aminoadenine in a 20-mer oligonucleotide probe can be used to improve the 
identification and differentiation between the single base change associated with the 
sickle cell disease mutation. -The DNA immobilisèd contained inserts of the 
homozygous normal, and the sickle cell diseased genotypes of the -globin gene. The 
results indicated an increase in hybrid stability between the analogue-containing 
probe and the normal 3-globin gene sequence. 
Hence the use of this base analogue should not only facilitate the screening of 
other known base mutations for clinical genotyping, but should also enable the more 
stringent analysis of other gene sequences, such as those present in DNA libraries 
using oligonucleotide probes. 
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1.7.1.2 Ambiguity in probing 
In determining the sequence of the synthetic DNA probe complementary to a 
region of a gene, from the amino acid sequence, an ambiguity problem arises due to 
the redundancy of the genetic code. This is not a trivial problem: a single mismatch 
can lower the melting temperature by as much as 100C.74  Many methods have been 
introduced to solve this problem. 
An approach using probes carrying deoxyinosine (dl) at positions corresponding 
to ambiguous nucleotides was introduced to decrease the discriminative nature of the 
probes among ambiguous bases. 135 Other nucleotides which can make stable base 
pairs with ambiguous genomic nucleotides deserve study. 2,6-diaminopurine is a 
candidate as a base analogue to probe positions of sequence ambiguity. Cheong and 
coworkers74  measured the stabilities of a set of DNA oligomer duplexes containing 
each of the four normal DNA bases paired with dD. The contributions of these dD 
base pairs to duplex stability was calculated, and compared with those for dl, dA, dG, 
dC, and dl. 
The ideal analogue will not lower the melting temperature of a duplex (it is non-
destabilising), and it will bind equally well to all four natural bases (it is non-
discriminating). Cheong et al found that inosine was the best probe for the 
ambiguities of: A/C, C1G, C/I, A/C/G, A/C/T, C/Gil, and A/C/Gil; 2,6-
diaminopurine was best for: A/T, Gil, and A/G/T; and thymine for A/G. 74 
1.7.2 dD IN PCR PRIMERS AND DNA SEQUENCING 
Since its discovery in 1983 by Mullis, 
137 
 the applications for the polymerase chain 
reaction (PCR) have spread throughout the biological sciences. 
The oligonucleotide primers required for PCR are custom-synthesised and are 
usually 20 to 30 bases long. They hybridise to specific sequences on the target DNA 
segment. Diaminopurine-containing oligomers would be useful in primers which, by 
necessity, were too rich in adenine residues to hybridise with the template. 
50 
In sequencing technology, again the extra stability gained by replacing dA with 
dD, offers an attractive application for diaminopurine. This is particularly true in the 
recent developments in DNA arrays, where the maximisation of hybridisation, 
without sacrificing specificity, is crucial. 16 
1.7.3 ANTISENSE THERAPY 
On transcription, every gene gives rise to a relatively large number of messenger 
RNA, which is then translated into a large number of proteins. Therefore it would 
seem that inhibition of gene expression 138  would be more efficient than inhibition of 
the resulting protein (this is the approach followed by conventional drug design). It is 
possible to achieve sequence-specific recognition of nucleic acids using synthetic 
oligonucleotides that bind specifically to complementary nucleic acids. These 
compounds are called antisense oligonucleotides based on their binding to the target 
sequence (sense strand). Since the sequence of a 17-mer oligonucleotide occurs 
statistically only once in the human genome, extreme selectivity should be possible 
with antisense oligonucleotides of at least this length. 
Zamecnik and Stephenson were the first to propose the therapeutic use of 
synthetic antisense oligonucleotides. 139 They synthesised a 1 3-mer oligonucleotide 
complementary to the RNA of Rous sarcoma virus, and showed that this antisense 
strand inhibited the growth of the virus in a cell culture. 
There are many requirements that an oligonucleotide must fulfil in order to 
function as an antisense strand. Therefore it is necessary to chemically modify the 
oligonucleotides. An example of this is that the phosphate backbone must be 
modified to avoid enzyme digestion when the strand enters a cell. Typically the 
approach by which phosphorothioate-backbone analogues of the oligonucleotides are 
made, avoids enzymatic degradation. 39 
Indeed, antisense technology could exploit the extra stability and selectivity in 
duplex formation afforded by diaminopurine replacing adenine residues. So far, the 
only way of using antisense DNA with diaminopurine has been by enzymatic 
incorporation via the triphosphate in a reaction catalysed by Kienow polymerase. 73 ' 75 
I 
Thus a facile and high-yielding method incorporating a diaminopurine 
phosphoramidite in solid phase oligonucleotide synthesis would prove useful in 
diagnostic and therapeutic molecular biology, as well as for structural studies of this 
novel base analogue. 
1.7.4 MOLECULAR RECOGNITION OF dD 
The substitution of bases by analogues in DNA is often a useful approach to 
investigate DNA biochemistry. DNA containing base analogues (such as dD) have 
been shown to be modified in thermal stability, base pairing pattern, or double-
helical conformation. (See Sections 1.2-1.5). As a result, differences in hybridisation 
strength and selectivity, changes in protein recognition patterns, or mutational 
activity may occur. 
Recognition of a specific DNA sequence by an enzyme is achieved by the 
formation of hydrogen bonds between specific amino acid side chains of the protein 
and determinants in the major and minor grooves of DNA. Alteration of bases in a 
recognition site sequence may therefore disrupt or modify the hydrogen bonding 
pattern by electronic or steric effects. This usually results in a loss or decrease in 
enzyme activity. 
The ability of a protein to recognise a specific sequence of bases along a strand of 
double helical DNA lies at the heart of many fundamental biological processes, 
including the replication and expression of DNA. Other nucleic acid-protein 
interactions include: that of restriction endonucleases with double helical DNA, 
RNase H with DNA.RNA hybrids, and ligase enzymes with double- or single-
stranded nucleic acids. 
1.7.4.1 Probing restriction enzyme recognition sites 
Restriction endonucleases are often used as a paradigm for protein-DNA 
interactions because of their high specificity for DNA sequences and the simplicity 
of the DNA site recognised. 140 
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Chollet and Kawashima 75 used dD-substituted DNA to probe minor groove 
determinants, and demonstrated that substitution of adenine by dD in DNA has 
profound effects on the recognition and cleavage by some restriction endonucleases. 
All fragments obtained from cleavage of D-containing DNA were similar to the 
natural reference DNA. Cleavage of DNA by restriction endonucleases is 
accomplished in two steps: firstly the enzyme binds to the recognition site, and then 
the phosphodiester bond is cleaved. Whilst Chollet and Kawashima could not 
distinguish between these two steps, they were able to assess qualitatively the effect 
of the minor groove modification due to dD, and to demonstrate the complete 
inhibition of cleavage for several endonucleases 
1.7.4.2 Replication of DNA 
The faithful replication of DNA is dependent on the DNA polymerase enzyme 
recognising the primer-template region, and incorporating the correct substrate dNTP 
to complement the template. 
Primer-templates with poly(dD.dT) 
Sagi and coworkers 141  compared DNA polymerase reactions for poly(dA.dT) and 
poly(dD.dT) under conditions for the B-forms, and conditions known to induce the 
X-form of poly(dD.dT).*  This was carried out in order to assess whether this unusual 
conformation has any effect on DNA replication. Kinetic data presented in this study 
show that Kienow DNA polymerase is sensitive to the formation of this unusual type 
of double helix. Contrary to Z-DNA ' 42, X-DNA is copied by the Kienow enzyme, 
although with a reduced efficacy as compared to its B-form. This DNA polymerase 
differentiation is in vitro enzymatic evidence of an unusual DNA conformation. 
* The X-form (putative A-form) of poly(dD.dT), as discussed in Section 1.5.3.3, can 
be induced by millimolar concentrations of Mg 2 , when the monovalent cation 
concentration is low, and the pH is around 7. The DNA polymerase reactions were 
carried out in 60mM phosphate plus 6mM Mg 2+  (B forms) and in 10mM phosphate 
plus 6mM Mg 2+  {X-form of poly(dD.dT)}. 
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Diaminopurine and the fidelity of replication 
Certain analogues of the dNTP's, modified in the sugar or base, are accepted by 
polymerases for pairing with the DNA template and are incorporated into DNA, but 
subsequently block further chain growth or interfere with nucleic acid function. ' 43 
Chollet and Kawashima 75 prepared dDTP and showed that dDTP is a substrate for 
in vitro DNA polymerase I mediated enzymatic synthesis. Also, it was shown that 
DNA containing dD are good substrates for the DNA modifying enzymes: T4 DNA 
ligase, polynucleotide kinase, and E. coli methylase. Enzymatic synthesis using 
dDTP as the substrate proceeded at 20% of the rate when the substrate was dATP; 
this could be improved up to 90% of the control rate by increasing the concentration 
of dDTP. The induction of mutations through the formation of D.0 mispairs has been 
144 but the frequency of these mutations, while higher than spontaneous 
mutations, is insignificant. 145 
1.7.4.3 Transcription involving diaminopurine 
In their studies of amino analogues of adenine, Rackwitz and Scheit' 46 found that 
DTP, contrary to n 2c6ATP, behaved as a true analogue of ATP in the transcription of 
poly(dA.dT), poly(dT), and calf thymus DNA. This, along with their other findings, 
led them to conclude that the 6-NH 2 group of adenine is an essential steric feature in 
the recognition of A.0 base pairs during transcription. 
The effect of the minor groove: 2-NH 2 of dD has also been studied, with regard to 
its substitution of dA in T7 RNA polymerase promoter sites—dD and hypoxanthine, 
which have minor groove alterations, prevent utilisation of the promoter. These 
analogues do not affect transcription which starts outside of the modified region. 
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1.8 BASE-LABILE LINKERS AND AMINO PROTECTION 
1.8.1 THE SOLID SUPPORT AND COVALENT LINKER 
The advantages of solid-phase synthesis (Section 1.1) are obvious. Despite this, 
the development of satisfactory procedures for oligonucleotide synthesis required 
almost 20 years from the first introduction of this technique, This was primarily 
because of two obstacles that had to be overcome. The first was the need for rapid 
and highly efficient coupling reactions, and the second was the need for a suitable 
solid-support and the important covalent linkage that binds the oligonucleotide to 
it. 147 
The insoluble material used to anchor oligonucleotides during solid phase 
synthesis cannot be considered as simply an inert carrier, since both its physical and 
chemical properties can have an important influence on the success of the synthesis. 
Such important features include: uniform surface structure, uniform particle size, and 
length and type of spacer. In addition, the type of covalent linkage joining the first 
nucleoside to the support is important in determining both the strategy required for 
the final deprotection and cleavage reactions; and the terminal composition of the 
final product. 147 
1.8.1.1 The solid-support 
A large variety of materials have been tried as insoluble supports during the 
evolution of oligonucleotide synthesis. By far the most widely used support is 
controlled-pore glass (CPG) first used in 1972 by K6ster, 148 and reintroduced in the 
early 1980's when phosphorochloridite coupling chemistry was first applied to the 
solid-phase synthesis of DNA." 
The solid-support to succeed the aminopropylated CPG was long-chain 
alkylamine CPG (LCAA-CPG). This material contains a primary amino group on the 
end of a 17-atom-long linker arm. This linker arm, along with the large (500A) pore 
size of LCAA-CPG greatly improved coupling results up to oligonucleotides of 
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Figure 1.20. Comparing the aminopropylared CPG and LCAA-CPG. 
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Figure 1.21. The synthesis of succinyl-derivatised LCAA-CPG. 
DCC= 1 ,3-dicyclohexylcarbodiimide;DEC= 1 -(3 -dimethylaminopropyl)-3 -ethylcarbo-
diimide. 
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Much longer sequences can be prepared on similar 1 000A-2000A CPG supports 
(wide-pore). 147 
1.8.1.2 The covalent linker 
In almost all CPG supports, a nucleoside-3'-succinate is attached to the support via 
an amide bond. This succinate linkage is easily cleaved under basic conditions. This 
is usually desirable, because it allows cleavage from the support to be combined with 
the phosphate and base deprotections, which also require basic hydrolysis. 
Alternatives to the succinyl linkage have been developed for three main 
applications: the development of base-stable linkages; the development of more base-
labile linkages; and linkages which allow functionalisation of the 3'-terminus of 
oligonucleotides. The former two types of linker will be discussed below. 
1.8.2 BASE-RESISTANT LINKAGES 
The compatibility of the nucleoside linker with the persistent base-labile 
protecting groups precludes the synthesis of completely deprotected oligonucleotides 
on insoluble supports. This shortcoming has been overcome by several strategies that 
replace the nucleoside succinate attachment with more resistant linkages. These 
approaches allow easier purification of the final product, since fewer non-nucleotide 
impurities are present. They also allow the support-bound material to be used as a 
solid-phase affinity column. 
The first base-resistant linkage on CPG was introduced by Sproat and Brown, 
149 
who used tolylene-2,6-diisocyanate (TDIC) to link nucleosides onto LCAA-CPG via 
two urethane linkages. 
In another approach, by Brown et al, 150  LCAA-CPG was derivatised with a 
succinyl-sarcosyl linker which exhibited less than 5% cleavage after an overnight 
treatment with 10% DBU in dichloromethane. Under these conditions, the 
conventional succinate linkage was cleaved within 1 hour, presumably, as a result of 
the deprotonation of the amide function followed by intramolecular nucleophilic 
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Figure 1.22. Two base-resistant nucleoside linkages. 
comes from studies on the phthaloyl linker. When the solid-support was treated with 
10% DBU, liberation of the nucleoside was found to be extremely fast owing to the 
rigid conformation imposed by the aromatic ring, favouring the intramolecular 
reaction (50% cleavage in 3.5 minutes). 150  This observation led to the investigation 
of the phthaloyl group as a more base-labile linkage in this project. (See below, and 
Section 4). 
1.8.3 BASE-LABILE LINKERS 
In contrast to the above applications, several types of nucleoside linker have been 
prepared that use milder conditions to release the oligonucleotide. These more base-
labile supports are also supplemented by the introduction of either more labile 
protecting groups (see below), or coupling techniques that avoid base protection 
entirely, 151  so that overall more gentle conditions for deprotection can be employed. 
One possibility for an easily cleavable linkage is to use a 2-(2-nitrophenyl)ethyl 
linkage (NPE).' 52 Cleavage from the support was possible by treatment with DBU, 
therefore sequences made with the NPE-protected nucleoside 2-cyanoethyl 
phosphoramidites could be completely deprotected and cleaved from the support 
with a single DBU treatment. 
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An oxalyl linkage has also been used to attach nucleosides to LCAA-CPG.' 53 In 
this method, oxalyl chloride replaces succinic anhydride as the linker that joins the 
nucleoside to the support. The oxalyl linker was stable to dry pyridine or 
triethylamine for at least 15 hours at ambient temperature. Conversely, 5'-O-DMTr-T 
was cleaved from the oxalyl linker within 5 minutes upon treatment with either wet 
triethylainine, 40% trimethylamine in methanol, or 5% ammonium hydroxide in 
methanol. Under these conditions, less than 5% of 5'-O-DMTr-T was cleaved from 
the standard succinyl LCAA-CPG support. 153 
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Figure 1.23. Easy-cleavable nucleoside linkages. 
1.8.4 ULTRAFAST DNA SYNTHESIS 
Chemical synthesis of synthetic oligonucleotides has been completely automated 
during the last decade. However, deprotection, as well as purification, remains a 
manual and time-consuming process. At the same time the increasing demand for 
synthetic oligonucleotides in a variety of biological experiments has created much 
interest in their more rapid processing. 
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Commercial DNA synthesisers currently are capable of operating with fast cycles 
of 2 to 3 minutes. The synthesis of primers can, therefore, routinely be achieved in 
under an hour. However, a major bottleneck in processing the products is the 
cleavage and deprotection steps which can take anywhere from 1 to 7 hours. All this 
is before the isolation or purification strategies which take a minimum of 1 hour. 
Using the standard base protection scheme (Figure 1.4), deprotection can be 
speeded up by elevating temperature, 154  or combining elevated temperature (80°C) 
with the addition of triethylamine to the ammonium hydroxide. 155  In addition to the 
potential hazard of such a high temperature, in both cases the time for both cleavage 
and deprotection is still at least 1 hour. 
To speed up the rate of oligonucleotide deblocking, two approaches can be 
envisaged: firstly, utilise monomers which possess highly labile protecting groups' 56-
158 and linkers (see above), or, secondly, employ highly efficient deblocking reagents 
for the deprotection of classically-protected oligonucleotides.' 59 The most effective 
technique, clearly, would involve both approaches, without sacrificing fidelity of 
deprotection. 
1.8.4.1 Base-labile protecting groups 
The main plausible candidates for fast deprotection developed in recent years 
include: the phenoxyacetyl (pac) group, methoxyacetyl (mac), t-butyl phenoxyacetyl 
(bpac), isobutyryl (ib), dimethylformamidine (dmf), and acetyl (ac). These groups 
were namely used as: pac-dA, mac-dG, and ib-dC by Schulof et al; 157 dmf-dA, dmf-
dG, and ib-dC by Vu et al. 156  Sinha and co-workers developed bpac-dA, dG, and 
dC;' 6° whilst Reddy and coworkers developed ac-dC.' 58 These protecting groups are 
shown in Figure 1.24. 
Each protection system introduced to date has exhibited flaws. Pac protection is a 
reasonable alternative to the standard base protecting groups, but a deprotection time 
of 30-60 minutes does not include the linker cleavage step (normally at least 45 
minutes), and the pac-dG monomer is rather insoluble. 157  The use of dmf-protected 
nucleotides' 56  allows deprotection comparable with pac, but the stability of dmf-dA 
during synthesis remains a problem. The bpac-protected monomers 
160  (commercially 
60 
known as Expedite) offer faster deprotection (15 minutes at 55°C) but again the 
cleavage from the support is still 45 minutes. Also, these monomers require a change 
in capping reagent (t-butylphenoxyacetic anhydride rather than the normal acetic 
anhydride). These deprotection times are compared in Table 1.2 below. 
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Figure 1.24. Easily-cleaved protecting groups. 
1.8.4.2 More nucleophilic deprotection reagents 
The use of ethanolamine (EA) or particularly a mixture of ethanolamine/ 
hydrazine/methanol for deprotection of oligonucleotides was employed by Polushin 
and coworkers, in conjunction with oxalyl linkers and bpac-amino-protection. ' 6 ' 
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With EA, oligonucleotides were fully deprotected in 15-20 minutes at room 
temperature. Under the same conditions deprotection with the EA mixture required 
only 3-5 minutes. Potential drawback with this technique are the formation of a slight 
amount of modified C, as well as the volatility of EA. 161 
A commercial cleavage and deprotection system has been developed 
(U1traFAST),' 58 requiring the novel ac-dC protection. All other monomer protecting 
groups remain the same. This seemingly minor change in protecting leads to an 
oligonucleotide which can be cleaved and deprotected in 10 minutes using the 
reagent mixture AMA: ammonium hydroxide/aqueous methylamine (50:50). Table 
1.2, below compares this technique with other cleavage/deprotection strategies. 162 
Table 1.2. Comparison offast cleavage and deprotection techniques. 






Normal NH3  45min 800 60min 105mm 
Normal NH3/TEA 45min 800 30min 75mm 
Pac NH3  45min 700 30min 75mm 
Dmf NH3  45min 55 0 60min 105mm 
Bpac NH3  45min 55 0 15min 60mm 
Ac-dC AMA 5min 650 5min 10mm 
62 
RESULTS AND DISCUSSION 
63 
2.0 SYNTHESIS OF DIAMINOPURINE PHOSPHORA1'IIDITES 
As detailed in Section 1.6, two separate protecting groups are required for the 
exocyclic amino moieties. A successful protecting group for the N 6-position is the di-
N-butylformamidine group which helps suppress acid-catalysed depurination in 
adenine, and has been used for N 6-protection in dD.' 33 This group will be used 
throughout this study—one exception being monomer [12] which was synthesised in 
order to assess N6-dimethylformamide protection. 
The main aim of this study was to develop a dD monomer stable to standard 
oligonucleotide synthesis conditions, with routine coupling efficiency (>98%), and 
with satisfactory deprotection rates. (The previous generation of diaminopurine 
monomers, employing N 2-isobutyryl protection, had a half-life of approximately 35 
hours, for one diaminopurine residue, in concentrated ammonia at 55°C). 69 ' 73"33 This 
is clearly unsatisfactory—N 2-isobutyryl-deoxyguanosine is fully deprotected in less 
than 12 hours under the same conditions. In addition, it was hoped a more convenient 
synthesis of the phosphoramidite could be developed. 
2.1 N2-PHENYLACETYL PROTECTION OF DIAMINOPURINE 
The N2-phenylacetyl group was first employed for dG protection to help increase 
its solubility in organic solvents. 163  This group is more base-labile than the isobutyryl 
group, so it was hoped this group would make deprotection of oligonucleotides 
containing dD more facile. 
2.1.1 Synthesis of the N 2-phenylacetyl-dD nucleoside 151 (Figure 2.1) 
Reaction of 2'-deoxyguanosine with phenylacetic anhydride, with gentle reflux in 
pyridine, followed by work up and purification by silica gel chromatography gave 
compound [1] in 84% yield. This was dissolved in pyridine-methanol solution (3:1), 
cooled to 0°C, and treated with 2M NaOH solution. The reaction was quenched after 
10min with H form Dowex resin, filtered, and the solvent removed. This residue 
64 
was precipitated in dichioromethane-methanol (80:20), to give compound [21 in 88% 
yield. 
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(I) a:Phenylacetic anhydride in pyridine at 0°C. b:1 10°C. 
2M NaOH in pyridine/methanol at 0°C. 
Isobutyryl chloride in pyridine at 0°C. 
a:MSCI, TEA and DMAP in DCM. b:N-methyl pyrrolidine at 0°C. c:Liquid ammonia. 
2M NaOH in pyridine/methanol. 
Figure 2.1. Synthesis of N 2-phenylacetyl diaminopurine nucleoside [5]. 
HO 	 151 
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Reaction of [21 with isobutyryl chloride in pyridine gave compound [3] in 90% 
yield.This was dissolved in dichioromethane, with triethylamine (TEA) and DMAP, 
and reacted with: (i) mesitylene suiphonyl chloride, and (ii) N-methyl pyrrolidine. 
(iii) NH3 gas was then condensed into the reaction vessel (fitted with a dry-
ice/acetone cold finger). The resulting dark red-brown residue was worked up and 
purified to give [4] in 55% yield. This amination step is based on the method used by 
Gafffiey, 69 but the more reactive mesitylenesuiphonyl chloride replaces TPSC1, and 
the easier to handle N-methyl pyrrolidine (liquid) replaces trimethylamine (gas), (see 
Section 1.6). Compound [41 was saponified as for compound [2] to give dD 
nucleoside [5] in 83% yield. 
2.1.2 Synthesis of N2-phenylacetyl-dD monomer [7] (Figure 2.2) 
Diaminopurine nucleoside [5] was suspended in pyridine and reacted with di-N-
butylformamide dimethylacetal. After concentration to a pale yellow oil, the residue 
was dissolved in dichioromethane with triethylamine and DMAP, and 
dimethoxytrityl chloride was added. The reaction mixture was then worked up and 
purified to leave compound [61 in 92% yield. This nucleoside was then dissolved in 
THF with N,N-diisopropylethylamine (DIPEA) and reacted with 2-cyanoethyl N,N -
diisopropyl-chlorophosphoridate. After work up and purification, dD monomer [7] 
was obtained in 91% yield. 
2.1.3 Oligonucleotide synthesis using monomer [ 71 
dD monomer [7] was typically dissolved in anhydrous acetonitrile, and used as a 
0.1 2M solution during oligonucleotide synthesis 
Coupling efficiency of monomer [7] 
This monomer repeatedly gave coupling efficiencies of <95%, even after 
increasing coupling times, and increasing the monomer concentration to 0.15M. The 
exact reason for this poor coupling is not known. A possible explanation may lie with 
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a:Di-N-butylformamide dimethylacetal in pyridine. b:DMTrCI and DMAP in pyridine. 
2-Cyanoethyl-N,N-diisopropylchlorophosphoramidite and DIPEA in THE 
Figure 2.2. Synthesis of the phenylacetyl diaminopurine monomer [7]. 
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Poor coupling was also observed in a previous study when the N 2-di-N-
butylformamide group was employed. 133 
Deprotection of the N2-phenylacetyl group 
Although the coupling efficiency of monomer [7] was unsatisfactory, it was good 
enough to allow a study of the deprotection of the N 2-phac group. This group showed 
a vast improvement over the isobutyryl group previously used—the half-life of 
deprotection of an oligonucleotide containing 1 dD was 8 hours for phac, and 35 
hours for ib. FIPLC chromatograms showing deprotection of oligonucleotides 
containing one- and three-dD residues are shown in Figure 2.3. 
Although this group is not satisfactory, on the grounds of poor coupling, the 
deprotection times were much improved for single- or multiple-additions of dD 
residues. The search then had to focus on a less bulky group. 
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(a) TTT TTD U at 55°C for 20 hours (b) TTT lTD TT at 55°C for 40 hours. 
(c) TDD TDT T at 65°C for 20 hours (d) TDD TDT T at 65°C for 40 hours. 
Figure 2.3. The deprotection of N 2-phenylaceiyl test oligonucleotides in conc. NH 3 . 
In each case, (a)-(d), the protected oligonucleotide(s) are denoted (2), and the fully 
deprotected oligonucleotides are denoted as (1). (Note the use of higher temperature for the 
oligonucleotide containing three diam inopurine residues). 
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2.2 N2-ACETYL PROTECTION OF dD 
Attention then turned to the acetyl group for N 2-amino protection. It was hoped 
that the acetyl group would deprotect rapidly, as well as couple with high efficiency. 
2.2.1 Synthesis of the N 2-acetyl monomer [12] 
2'-Deoxyguanosine was refluxed with acetic anhydride and DMAP in pyridine to 
give a dark red-brown solution. This solution was treated with saturated aqueous 
NaHCO3 solution, and concentrated in vacuo. The resulting solid residue was 
recrystallised from water and methanol to give compound [8] in 76% yield as pale 
pink crystals. 
At this stage we decided to convert the lactam moiety to an amino group, via 
hydrogenation of an azide. It was hoped that this would increase the yield of the N 2-
protected diaminopurine nucleoside, since conversion via the amination of the lactam 
function as previously discussed, rarely exceeded 55% (see Figure 2.1). Compound 
[8] was reacted with mesitylenesulphonyl chloride then N-methyl pyrrolidine in the 
normal manner, then tetrabutylammonium azide (TBAZ) was added. The dark brown 
reaction mixture was then worked up and purified by wet-flash chromatography to 
give compound [9] as pale brown solid in 80% yield. Saponification of compound 
[9], followed by catalytic hydrogenation with palladium on activated charcoal at 
4atm gave a light-brown solid on in vacuo evaporation of the solvent. This residue 
was washed with a small amount of dichloromethane to leave compound [10] as a 
white powder in 84% yield. Reaction with di-N-butylformamide dimethylacetal, 
followed by tritylation in pyridine, gave compound [11] as a white solid foam in 78% 
yield. This tritylated nucleoside was phosphitylated in THF to give compound [12] as 
a white foam in near quantitative yields. 
2.2.2 Oligonucleotide synthesis using [12] 
dD monomer [12] was dissolved in anhydrous acetonitrile to a concentration of 
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a:Acetic anhydride and DMAP in pyridine at 0°C. b:Reflux at 110°C. 
a:MSCI, TEA, and DMAP in dichioromethane. b:N-methyl pyrrolidine at 0°C. c:TBAZ. 
a:2M NaOH in pyridine/methanol at 0°C. b.PdJC in ethanol at 4atm hydrogen. 
a:Di-N-butylformamide dimethylacetal in pyridine. b:DMTrCI and DMAP in pyridine. 
2-Cyanoethyt-N,N-diisopropylchlorophosphoramidite and DIPEA in THE 
Figure 2.4. Synthesis of the acetyl diaminopurine monomer [121 
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Coupling efficiency of monomer [121 
This monomer gave coupling efficiencies routinely >98% thus fulfilling the first 
expectation of the N2-acetyl protection group. 
Deprotection of the N 2-acetyl group 
The acetyl group offered a slight improvement over the isobutyryl group, but 
deprotected much more slowly than the phac group (half-life of 30 versus 8 hours). 
In addition, deprotection of the oligonucleotides synthesised could not be monitored 
by reverse phase HPLC—owing to the poor lipophilicity inherent with the acetyl 
group, the protected and deprotected oligonucleotides had exact same retention 
times, even when several ac-protected dD residues were present. This problem could 
not be resolved using capillary electrophoresis either, therefore the samples had to be 
desalted and subjected to enzyme digestion, then HPLC analysis in order to resolve 
the individual nucleosides. (Interestingly, the acetyl group was disregarded by 
Khorana for N2-protection of dO, because it was not lipophilic enough during the 
block coupling stage of the diester method of oligonucleotide synthesis). 164 
The HPLC chromatograms of the enzyme digests for the two test oligonucleotides 
are shown in Figure 2.5. 
The slow deprotection, along with the difficulties involved in resolving the 
protected and deprotected oligonucleotides, deemed the acetyl-protected dD 
monomer unsuitable for use in oligonucleotide synthesis. 
In the meantime, two other monomers were investigated in order to incorporate an 
N6-azide or an N6-dmf group, into oligonucleotides. 
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D 
(a) TTT TTD TT at 55°C for 40 hours. (b) TTT TTD TT at 55°C for 80 hours. 
0 0 
(c) TDD TDT T at 65°C for 60 hours. 	(d) TDD TDT T at 65°C for 80 hours. 
Figure 2.5. Enzyme digests showing the deprotection of the acetyl test 
oligonucleotides. 
These traces show the emergence of the dD nucleoside (C) at 16 mm, from N 2-acetyl-dD 
(B) at 15 mm. The dT peak (A) is shown at 12 mm. 
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2.2.3 Synthesis of N'-dmf-dD monomer [14] (Figure 2.6) 
Another novel nucleoside was synthesised—N 6-dimethylformamide (dm0 
protected dD. This was carried out in order to evaluate the suitability of the 
dimethylformamide group, as a replacement for di-N-butylformamide protection. 
Compound [10] was reacted with dimethylformamide dimethylacetal in pyridine 
to give the N6-protected nucleoside. This was coevaporated with, and redissolved in 
pyridine, and reacted with dimethoxytrityl chloride to give compound [13] in 61% 





a:Dimethylformamide dimethylacetal in pyridine. b:DMTrCI and DMAP in pyridine. 
2-Cyanoethyl-NN-diisopropylchlorophosphoramidite and DIPEA in THE 
Figure 2.6. Synthesis of the A' 6 -dimethylformamide monomer [141. 
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Oligonucleotide synthesis using monomer 1141 
The low yield of monomer [14] may have been a contributing factor of the failure 
of oligonucleotide synthesis—less than 200mg was available for synthesis. At these 
low levels, oxidation by-products can become a serious problem. Alternatively, the 
low coupling efficiency obtained may have been due to the use of the N 6-drnf group, 
as a previous study had raised questions about the stability of N 6-dmf-dA during 
oligonucleotide synthesis.' 65  The stability of the N6-dmf-dD nucleoside to TCA was 
investigated (see Section 2.5.3) to help explain the failure of oligonucleotide 
synthesis. 
2.2.4 Synthesis of N6-azido-dG monomer [16] (Figure 2.8) 
Many proteins that interact with DNA show a very high specificity for their 
particular target sequence. The use of reactive probes, where DNA containing 
modified bases which react with nucleophiles, is one method of studying the 
interaction of DNA with peptides and proteins. 166  This involves incorporating azido-, 
sulphur-, or halogen-modified nucleotides into the synthetic DNA of interest, and 
allowing the DNA-peptide interactions to take place. 167  Irradiation of the sample then 
crosslinks the two molecules together covalently. So far, the azido group has only 
been introduced into the sugar moiety of DNA, therefore the novel nucleoside [16] 
was the target of our attempts to synthesise a monomer containing an exocyclic azido 
group. 
Compound [9] was saponified, then coevaporated with pyridine, and tritylated in 
the usual manner to give compound [15] as a solid white foam in 77% yield. This 
was then phosphitylated using the standard procedure, but the reaction failed as the 
N6-a.zido group also reacted with the phosphitylating reagent. (This even occurred 
with the "milder" phosphitylating reagent: 2-cyanoethyl-bis-(N,N-diisopropyl) 
chiorophosphoramidite). In each case, on addition of the phosphitylating reagent a 
brown colour appeared, suggesting the degradation of the azido group. The reaction 
scheme is shown in Figure 2.7, and the likely product after phosphitylation is shown 

















a:2M NaOH in pyridine/methanol. b:DMTrC1 and DMAP in pyridine. 
2-Cyanoethyl-N,N-diisopropylchlorophosphoramidite and DIPEA in THF. 










(1) 2-Cyanoethyl'-N,N-diisopropylchlorophosphoramidite and DIPEA in THE 
Figure 2.8. The putative azido phosphitylation product. 
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A preliminary study into the introduction of the azido group after phosphitylation 
was attempted (results not shown) and seemed to offer a means to obtaining an N 6-
azido-dG monomer. 
2.3 N2-DMF-PROTECTION OF dD VIA 3',5'-BIS-ACETYL-PROTECTION 
As mentioned in Section 1.8.4.1, the dmf group has been used to successfully 
replace the isobutyiyl group in N 2-protection of deoxyguanosine in a fast-
deprotecting monomer. 156  Therefore this group was the next choice for protection of 
the N2-amino group of dD. This would be used in conjunction with the dbf group on 
the N6-amino function, since the dmf group was found to be unsuitable as an N 6-
amino protecting group. 
2.3.1 Synthesis of N 2-dmf-N6-azido-dD nucleoside 1211 (Figure 2.9) 
2'-Deoxyguanosine was suspended in pyridine and dimethylformamide and 
reacted with acetic anhydride. The resulting precipitate was filtered off, and ethanol 
was added to the supernatant, and this solution was concentrated in vacuo until 
precipitation commenced. Diethyl ether was added to encourage precipitation, and 
this white solid was recrystallised from ethanol and water to give compound [17] as a 
white crystalline solid in 92% yield. 
Compound [17] was then reacted with MSC1 in dichioromethane. However, the 
reaction mixture was seen to turn dark red. The dichioromethane was removed in 
vacuo, and the resulting dark residue was coevaporated with methanol. The solid 
obtained was washed with a solution of diethyl ether and methanol to leave 
compound [18] as a white powder in 58% yield. 
Compound [18] was then reacted with N-methyl pyrrolidine and TBAZ in 
dichioromethane to give compound [191 as an off-white foam in 89% yield. This 
nucleoside was in turn reacted with dimethylformamide dimethylacetal to introduce 
the dmf group and give compound 1201, as an off-white foam in 68% yield. 
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(1) Acetic anhydride in pyridinefDMF. 
Mesitylene suiphonyl chloride, TEA and DMAP in dichioromethane. 
a:N-methyl pyrrolidine in DCM. b:TBAZ. 
Dimethylformamide dimethylacetal in pyridine. 
2M NaOH in pyridine/methanol. 
Figure 2.9. Attempted synthesis of the N 2-dmf N 6-azido nucleoside [211 
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However, in the next step, the dmf group was removed from [20], along with the 
3',5'-acetyl-groups. This cleavage is shown below in Figure 2.10. Whilst this was a 
set-back in this synthetic route, it did give a hint toward the higher base-lability of 
the dmf group compared to any previous N 2-protection. For the next approach, a 








H 	N N NH, 
Figure 2.10. Cleavage of the dimethylformamide group during ribose saponification. 
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2.4 SYNTHESIS OF 3',5'-TIPS-NUCLEOSIDES 
The 1,1,3,3-tetraisopropyl-1,3-disiloxanediyl group, (TIPS), was introduced by 
Markiewicz to protect the 3'- and 5'-positions in RNA nucleoside chemistry. 168 As it 
is cleaved by fluoride ions, it allows orthogonality of deprotection between the 3',5'-
hydroxyl and the 2'-hydroxyl protection. TIPS should also be the ideal choice for 
selective deprotection of the 3',5'-O-protection in the presence of the N 2-dmf group in 
dD nucleosides, allowing non-basic deprotection of the sugar hydroxyl groups. 
2.4.1 Synthesis of 3',5'-TIPS-N 2-dmf-dD 1241 (Figure 2.11) 
2'-dG was suspended.in pyridine with DMAP and reacted with TIPSC1 2 . After the 
reaction was complete (shown by tic) dimethylformamide dimethylacetal was added 
to the cloudy-pale yellow reaction mixture. After completion, the solvents were 
removed in vacuo, the residue was then worked up and purified in the normal way, 
with the addition of 1% TEA added to the chromatography eluent to prevent 
degradation of the TIPS group. Compound [22] was obtained as an off-white solid in 
85% yield. 
The next stage involved the introduction of the azido function. Previous attempts 
at introducing the azido function in the presence of the basic N 2-dmf group gave very 
sluggish reactions. (Indeed, in Section 2.3.1, the N 6-azido group was introduced 
before the N2-dmf group was introduced). The mesitylene sulphonyl chloride would 
only react with nucleoside [22] if both pyridine and TEA were present in the reaction 
mixture. Presumably the pyridine and TEA act in a synergic manner, and help more 
facile removal of the N'-proton, allowing the MSC1 to react at the 06-position more 
readily. It is also possible the basic mixture drives the keto-enol equilibrium more in 
favour of the enol tautomer. 
Thus nucleoside [22] was suspended in pyridine along with DMAP and TEA. On 
addition of the MSC1, the reaction mixture was seen to turn purple briefly, then a 
dark red colour. After addition was complete, N-methylpyrrolidine and then TBAZ 
were added. The resulting dark-brown reaction mixture was filtered to remove 
precipitate, and the filtrate was removed in vacuo. The resulting residue was 
















a:TIPSCI and DMAP in pyridine. b:Dimethylformaniide dimethylacetal. 
a:MSCI, TEA, and DMAP in pyridine. b:N-methyl pyrrolidine at 0°C. c:TBAZ. 
Hydrogenation-see Table 2.1 for conditions. 
Figure 2.11. Synthesis of the TIPS-dimethylformamide nucleoside [241. 
The next stage of synthesis was the reduction of the azido group to leave the 
TIPS-N2-dimethylformamide-dD nucleoside [24]. However, under the normal 
reducing conditions employed to convert the azide to the amine (catalytic 
hydrogenation using Pd on activated charcoal—see Section 2.2.1), the N2-
dimethylformamide group was removed almost quantitatively. This is shown in 
Figure 2.12 below. 
As the dimethylformamide group was cleaved during catalytic hydrogenation, 
milder alternatives to the reduction of the azide were sought. Table 2.1 shows 














Figure 2.12. Major and minor products formed during hydrogenation. 
2.4.2 Synthesis of 3t,5TIPSN2tfadD  [27] (Figure 2.13) 
At this point, also, dD nucleosides were developed where the N 2-protection 
consisted of the trifluoroacetyl (tfa) group. This group was employed at an earlier 
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stage, but was rejected along with the dm1 group when both groups were found to be 
base labile during saponification of the acetyl esters (Section 2.3.1). 
2'-Deoxyguanosine was suspended in pyridine along with DMAP, and reacted 
with TIPSC12. After concentration of the solvents, the residue was treated with 
water/methanol to leave a white powder on washing with methanol. This gave 





,1)SiO 	1 71 
N3 
N 	NN CF3 CF3 X 	SiO 
0 	 H 
SiO 	[261 
TIPSCI and DMAP in pyridine. 
a:Trifluoroacetic anhydride in pyridine at 0°C. b:Sodium azide. 
Hydrogenation see Table 2.1 for conditions. 
Figure 2.13. Synthesis of the TIPS-trWuoroacetyl nucleoside [2 71. 
The next stage involved the introduction of the tfa group for N 2-protection, and 
the azido group on the 06-position in the one pot. This was deemed possible as 
reaction of the lactam function of 2'dG with trifluoroacetic anhydride in pyridine 
results in the introduction of a pyridinium intermediate, which can then be displaced 
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by nucleophiles. 99" 69 This novel method was applied, and a similar approach led to a 
new route to dD nucleosides (Section 2.5.1). Compound [25] was suspended in 
pyridine and trifluoroacetic anhydride was added to give a yellow solution. After the 
disappearance of the starting material to give a fluorescent spot on tic under UV, 
sodium azide was added to give a purple solution. Excess sodium azide was filtered 
off and the reaction mixture was worked up and purified by flash-column 
chromatography. Compound [26] was obtained as a purple foam in 66% yield. 
N3 	 NFL2 
JLL
hydrogenation 	 N_...'LN 
N ' jCF3 	 N 	2 
SiO 	1261 	 _>SiO 
Figure 2.14. Hydrogenation of the TIPS-truoroacetyl nucleoside. 
Compound [26] was subjected to reducing conditions as for the dmf analogue 
[23], but again, the N2-protecting group was cleaved, as shown in Figure 2.14. The 
extent of reduction was similar to that found for [231—see Table 2.1 below. 
Table 2.1. The lability of dmf or tfa N 2-protection to hydrogenation conditions. 
HYDROGENATION CONDITIONS 
Ni-PROTECTION Pd/C, H2 Raney Ni SnC12 Ph3P, H20 
dmfortfa xx xx x - 
xx = almost quantitative cleavage; x = intermediate cleavage; - = no reduction. 
An entirely different approach to synthesis of N 2-dmf-dD had to be made in order 
to avoid reduction of the N 2-protection. It was then decided that, initially the 
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synthesis of the free 2'-dD nucleoside would be carried out, followed by selective 
protection of the exocyclic amino groups. 
2.5 SYNTHESIS OF THE N2-DMF-N6-DBF-dD MONOMER [32] 
As the N2-dmf group was labile under conditions that reduced the N6-azido group, 
the next synthetic approach was to make the free-dD nucleoside, and enforce 
selectivity in protection of the N2- and N6-amino groups. This was necessary as bis-
protection using N 2-di-N-butylformamide was unsuitable for oligonucleotide 
synthesis; and N 6-protection using the dimethylformamide gave ambiguous results. 
There was not enough time to further investigate the use of N 6-dmf protection, 
therefore the tried and tested di-N-butylformamide group was employed. 
2.5.1 Synthesis of the free-diaminopurine nucleoside [281 (Figure 2.15) 
The fact that Raney Ni in ethanol at 60°C cleaves the tfa group whilst reducing the 
azido group, (see Figure 2.14) was exploited in the development of a novel route to 
the synthesis of 2'dD. 2'-Deoxyguanosine was suspended in pyridine and reacted with 
trifluoroacetic anhydride to give a red solution. Sodium azide was then added and 
when reaction was complete, leaving a brown-coloured solution, the excess NaN 3 
was filtered, and the filtrate was neutralised and worked up. The residue was then 
dissolved in ethanol and Raney Ni was added. This reaction was then gently refluxed 
at 60°C, then the catalyst was filtered off, and the filtrate was concentrated in vacuo, 
diethyl ether was added to the residue, and the mixture was left at 0°C to 
recrystallise. The resulting white crystals of compound [28] were obtained in 81% 
yield. 
2.5.2 Synthesis of dD monomer [32] (Figure 2.15) 
The next stage involved the selective protection of the N 6-amino group with dbf in 
the presence of the less nucleophilic N 2-amino group. This reaction proceeds to give 
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I321 
NC... ,P—N(iPr)2 
a:Trifluoroacetic anhydride in pyridine at 0°C. b:Sodium azide. c:Raney Ni in ethanol at 60°C. 
Di-N-butylformamide dimethylacetal in pyridine. 
Dimethylformamide dimethylacetal in pyridine at 50°C. 
DMTrC1 and DMAP in pyridine. 
2-Cyanoethyl-NN-diisopropylchlorophosphoramidite and DIPEA in THE 
Figure 2.15. Synthesis of the N 2-dmfAl 6-dbf-diaminopurine monomer f321. 
Compound [281 was suspended in pyridine, and di -N-butylformamide 
dimethylacetal was then added to give compound [29] as a light-yellow foam in 54% 
yield after flash-column purification. Compound [29] was then suspended in pyridine 
and dimethylformamide dimethylacetal was added, and the reaction mixture gently 
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heated at 50'C. Column chromatography gave compound [30] in 62% yield as a 
light-yellow foam. 
Compound [30] was tritylated then phosphitylated under normal conditions to 
give compounds: [31] in 66% yield, and [32] in 73% yield, respectively. 
2.5.3 Stability of nucleosides to TCA 
The ease at which protected dD nucleosides depurinate during the TCA-
detritylation stage of oligonucleotide synthesis has hampered the development of dD 
monomers. As discussed in Section 1.6.2, depurination is particularly detrimental in 
oligonucleotides containing N 6-acyl protected dD. In order to assess the effectiveness 
of N6-dbf protection, stability of this nucleoside was compared with several other 
related nucleosides in 3% TCAIDCM, and monitored with time. Decomposition of 
the nucleosides was followed by TLC, and the "native" nucleosides dA and dD were 
included as references. The results are shown below. 
Table 2.2. Stability of nucleosides to TCA. 




N ac,NndmfdD <20mm 0 
Nzdmf,NbfdD >1 .5hr 
... 	 n50 aKesult taken from Booth. 
bNondepurination degradation observed, along with depurination. 
As expected, 69  the N6-benzoyl protection has a severe effect on the susceptibility 
of the dD nucleoside to depurination. Comparing this with studies carried out on the 
depurination of dA, the benzoyl protection may alter the N' and N 7 basicities relative 
to one another to favour the N 7  -protonation. This species then acts as a good leaving 
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group according to the monocation depurination pathway. Such a low stability to 
TCA should preclude viable oligonucleotide synthesis. 
On the other hand, dbf protection offers a much increased half life. This agrees 
with the studies carried out on N 6-dmf-dA,' 22 where the formamide protection was 
found to be electron-donating, and did not to promote N 7-protonation to the same 
extent that acyl protection did. Here, the higher basicity of the N' position will favour 
protonation versus the less basic N 7 . 
The value of the half life for nucleoside [32] agrees well with a similar study 
carried out by Booth, where N 2-protection was isobutyryl or dbf, and N 6-protection 
was dbf.' 33 He concluded that the choice of N 2-protecting group had no influence on 
depurination. From this position, there is no resonance stabilisation of the N' 
monocation, which is stabilised by delocalisation of the formamide moiety in the 6-
position. Booth found similar half lives for the N 2-ib- and N2-dbf-protected 
nucleosides. 
It is interesting to note that the N 6-dmf group was not as stable to the TCA 
conditions as di-N-butylformamide. Degradation of the nucleoside occurred, but not 
only of the depurination variety—the N 6-dmf group appeared to be slightly labile in 
TCA. This may help explain the failure of monomer [14] during machine synthesis—
see Section 2.2.3. Again, similar behaviour to dA (N 6-dmf-dA gave ambiguous 
results during synthesis 165) is observed for dD nucleosides. However, it was not clear 
if this was the cause of synthesis failure, and further study must be carried out to 
clarify this ambiguity. 
2.5.4 Oligonucleotide synthesis using dD monomer [32] 
Monomer [32] was dissolved in anhydrous acetonitrile, and used as a 0.12M 
solution during oligonucleotide synthesis. 
Coupling efficiency of monomer [32] 
The coupling efficiency of oligonucleotide synthesis using monomer [32] was 
found to be routinely >98%. Therefore, this monomer fulfilled the initial criteron of 
use under standard synthesis conditions. 
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(a) Isobutyryl at 55°C for 40 hours. 	(b) Isobutyryl at 55°C for 90 hours. 
Chromatograms show (1) fully deprotected, and (2) isobutyryl protected oligonucleotides 
(c) Dmf at 55°C for 2 hours. 	 (d) Dmf at 55°C for 5 hours. 
Chromatograms show (3) fully deprotected, and (4) dmf protected oligonucleotides. 
Figure 2.16. Contrasting the deprotection of the isobulyryl and dmf groups. 
These deprotections are for the oligonucleotide: TTT TTD TT. 
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Deprotection of the N 2-dimethy1formamide group 
In addition to an acceptible coupling efficiency, the N 2-dmf-N6-dbf-dD monomer 
[32] deprotected faster than the previous N 2-protecting candidates, whilst allowing 
resolution of the deprotected and protected oligonucleotides. Figure 2.16 shows hplc 
traces for the deprotection of the test oligonucleotides containing 1 -dD residue, 
contrasting the dimethylformamide group with the isobutyiyl group. 
Again, the test sequence TDD TTD T was synthesised, and for monomer [32] the 
deprotection is shown below in Figure 2.17. 
0 0 
(a) TDD TDT T at 55°C for 5 hours. 	(b) TDD TDT T at 55°C for 30 hours. 
Figure 2.17. Deprotection of the dmf test oligonucleotide in conc. NH 3 . 
The asterisk marks the fully deprotected oligonucleotide in each case. 
It is interesting to note that the "next best" labile protecting group was the 
phenylacetyl group, which showed comparable deprotection after the same time, but 
at the elevated temperature of 65°C, (see Figure 2.3(b)). The dmf oligonucleotide 




Enzyme digestions of oligonucleotides containing monomer [321 
Enzyme digestions of oligonucleotides containing dD were carried out, as with 
previous monomers, in order to authenticate the incorporation of the modified base. 
Examples are given in Figure 2.19. 
2.5.5 Synthesis of dD-succinyl CPG [341 (Figure 2.18) 
As the N2-dmf protection was deemed suitable for incorporation of dD into routine 




(1) Succinic anhydride and DMAP in pyridine. 
(ii) a:4-Nitrophenol and DCC in DCM. b:Activated CPG in DMF. 
Figure 2.18. Synthesis of the diaminopurine-functionalised resin. 
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This was carried out in order to incorporate dD residues at the 3'-terminus of 
oligonucleotides. 
Compound [31] was dissolved in pyridine with DMAP, and reacted with succinic 
anhydride. The residue left after concentration was worked up with aqueous citric 
acid, and purified by column chromatography pre-equilibrated with TEA, and eluted 
with MeOHIDCM/TEA. Succinyl derivative 133] was obtained as a yellow-white 
foam in 77% yield. 
The attachment of nucleside [33] to the solid support was carried out as described 
by Sproat and Gait, 170  to give CPG [34] with a loading after capping, of 35.O.tmo1j
1 
. 
2.5.6 Oligonucleotide synthesis using LCAA-CPG [34] 
Appropriate amounts of the CPG were weighed out and packed in DNA synthesis 
columns, and used as for normal oligonucleotide synthesis. 
Coupling efficiency and deprotection of CPG [34] 
As with the dD monomer, oligonucleotides synthesised using dD-CPG [34] were 
found to exhibit the desirable coupling efficiency of >98%. The deprotection of the 
oligonucleotides was also similar to those synthesised in Section 2.5.3. 
Enzyme digestions of oligonucleotides containing [34] (Figure 2.19) 
As with monomer [32], the oligonucleotides containing the 3'-terminal-dD residue 
were authenticated using enzyme digestion, and the HPLC chromatograms for the 
digests compared with that of the genuine 2'-dD. Figure 2.19 shows examples of 




(a) CGT DDC GT 	 (b) GCA TTG AD 
Figure 2.19. Enzyme digests of diaminopurine-containing oligonucleotides. 
The order of elution of the nucleosides is shown. 
2.6 CONCLUSIONS AND FUTURE WORK 
After synthesising several dD monomers containing different N 2-protecting 
groups, the best candidate to emerge was the dimethylformamide group. This 
fulfilled the requirement of coupling >98% during oligonucleotide synthesis, as well 
as being stable to all reagents during nucleoside and oligonucleotide synthesis. In 
addition, the deprotection time of this group in conc. NH 3 was a vast improvement 
over the isobutyryl group previously used. A comparison of the "old" and "new" 
protection groups is given in Table 2.2. 
This monomer was ultimately synthesised via the free dD nucleoside, and a novel 
technique was devised for this approach, exploiting the simultaneous reduction of the 
N6-a.zido intermediate, and the labile N 2-trifluoroacetyl group. In addition, the 
difference in nucleophilicity/basicity of the N 6- and N2-amino moieties was taken 
advantage of during their selective protection with the dbf and dmf groups 
respectively. 
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Table 2.3. A comparison ofN 2 -protecting groups usedfor dD. 
Deprotection is compared in conc. ammonia at 55°C. 
MONOMER Coupling Efficiency approx. half-life 
isobutyryl [351 >98% 35 hours 
phenylacetyl [7] <95% 8 hours 
acetyl 112] >98% 30 hours 
dmf [321 >98% 2 hours 
Recent work carried out by Gryaznov and Schultz 78 employed synthesis of the bis-
protected nucleoside via the 5'-DMTr-dD. The protecting group of choice was the 
phenoxyacetyl group which, like the dmf group, is an established "fast-deprotecting" 
group (see Section 1.8.4.1). However, on the N 6-position this group will not have the 
same depurination suppression as the dbf group. Also, when this monomer was used 
in DNA synthesis, the diluent used was dichioromethane instead of the usual 
acetonitrile. This was compounded with the use of phenoxyacetic anhydride instead 
of acetic anhydride during the capping step. 
Future work could involve using TIPS-protected dG [25], instead of dG. This 
would enhance the solubility of the resulting dD nucleosides, and assist their 
subsequent purification. The N 6-dbf derivative of this would then provide an 
intermediate for the introduction of other candidates for the introduction of more 
base labile protection at the N 2-moiety. Such candidates would include the 
trifluoroacetyl group, and the phenoxyacetyl group. Owing to the inconclusive 
evidence, the bis-dimethylformamide-protected diaminopurine phosphoramidite 
should also be synthesised and evaluated. 
Another approach to speeding up the deprotection of diaminopurine residues 
would be to use of deprotecting reagents more nucleophilic than conc. NH 3 . 
Examples of these reagents were discussed in Section 1.8. 
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3.0 THE THERMODYNAMICS OF DNA CONTAINING dD 
The affinity of an oligonucleotide for its complement can be assessed using 
spectrophotometric techniques. Typically, an oligonucleotide and its complement are 
mixed at 1:1 stoichiometry in an appropriate hybridisation buffer, and the absorbance 
at 260nm is measured as a function of temperature. As the temperature is raised, the 
duplex converts to single strands with a concomitant increase in absorbance 
(hyperchromicity). 
The temperature at which half the molecules are duplex and half are single 
stranded is the TM, or melting temperature. Analysis of the shape of the melting curve 
can also yield thermodynamic parameters for the coil to helix transition, provided the 
transition is two-state. 172  The manipulation of the data derived from melting curves 
will be discussed in Section 3.2 below. 
3.1 THERMODYNAMIC COMPARISON OF d(TA) 4 AND d(TD)4 
Since duplexes containing the sequence: d(TD) have been studied in less detail 
than their d(TA) counterparts, melting curves were carried out comparing d(TA) 4 
and d(TD)4. These oligonucleotides were chosen as Booth had previously determined 
that the oligonucleotide d(TD) 3 readily formed a duplex, whereas the native hexamer 
d(TA)3 failed to show any temperature dependence in its UV absorbance, indicating 
that it was not present in the duplex form. 133 
3.1.1 UV melting curves of d(TA) 4 and d(TD)4 
The UV absorbance, Ab, at 260nm was recorded at a heating rate of 0.9°C per 
minute for an appropriate length of time for both oligonucleotides. Melting curves 
for both oligonucleotides were determined at a concentration, CT, of 40mM, using 
Eq. (1). 
Ab =CT.l.E.F 	 (1) 
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where 1 is the cell path length (1cm), E is the extinction coefficient of the 
oligonucleotides, calculated using the values for dA and dT given by Sproat and 
Gait; ' 73 and the determined value of E(dD) of 7.4xlo 3cm2j.tmor 1 . The 
hyperchromicity factor, F, was taken to be 0.8, from measurements of strand and 
nucleoside absorbance at 260nm, before, and after enzyme digestion. 
The first-order derivative of the UV absorbance measured as a function of time 
(temperature) gave the T m at the maximum. The melting curves for d(TA) 4 , DAP(3) 
and d(TD)4, DAP(4) along with T,,,'5 are given in Figure 3.1. 
ABS 
2.00 	12.00 	22.08 	32.88 	42.88 	52.80 	62.88 	72.00 
Temp./°C 
Figure 3.1. Melting curves for (1) d(TA) 4 and (2) d(TD) 4 in IM Na, 10mM 
phosphate buffer at pH 7. T m  d(TA)4 = 12°C and Tm  d(TD)4 = 37'C. 
96 
The dramatic difference in T m  (25°C) reflects the extra stability given by the D.T 
base pair, compared to the A.T base pair. Whilst this example serves to illustrate the 
difference in stability between A.T and D.T base pairs, this does not represent the full 
picture. As discussed in Section 1.5, poly d(DT) has a tendency to adopt the unusual 
putative A-form of DNA. This structure may offer extra stability for poly d(DT) over 
that Of the native B-form, which may be too conformationally flexible. Only more 
detailed thermodynamic and comparison will help explain these differences. 
Also, dD destabilises the DNA duplex when flanked by adenines, (disrupting the 
spine of hydration—see Section 1.5.2), and so the substitution of dD for dA clearly 
does not always increase the stability of the duplex. Again, obtaining full 
thermodynamic parameters for dD may allow prediction of the stability of duplexes 
containing dD. 
3.2 THERMODYNAMIC PARAMETERS OF DUPLEXES CONTAINING dD 
As outlined in Section 1.2.2, the stability of a DNA duplex depends on its base 
sequence. More specifically, the stability of a DNA duplex appears to depend 
primarily on the identity of the nearest-neighbour bases. The nearest-neighbours 
approach takes into account the "horizontal and "vertical" interactions, in addition to 
other sequence-specific effects. 
Ten different nearest-neighbour interactions are possible in any Watson-Crick 
DNA duplex structure. These pairwise interactions are: AA/TT; AT/TA; TA/AT; 
CA/GT; GT/CA; CT/GA; GA/CT; CG/GC; GC/CG; GG/CC. Results obtained, by 
Breslauer et al, on model systems, provided the thermodynamics of all ten nearest-
neighbour interactions. 174  This data now provides an empirical basis for predicting 
the stability (G°) and the temperature-dependent behaviour (iH°) of any DNA 
duplex region by inspection of its primary sequence. 
The aim of this Section was to compile a similar library of nearest-neighbour 
interactions for dD. This data could then be used in conjunction with that obtained by 
Breslauer et al, in order to predict the thermodynamic parameters of duplexes 
containing dD. 
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3.2.1 Calculating thermodynamic parameters from melting curves 
The formation or dissociation of complexes of molecularity greater than one will 
result in a concentration-dependent equilibrium. Such equilibria therefore can be 
characterised by determining the concentration dependence of the melting 
temperature. 175 
For a non-self complementary system at equilibrium 
TM = I-I°/{iS° + Rln(C1/4)} 	 (2) 
where H0 and S° are, respectively, the enthalpic and entropy of duplex formation, 
CT is the total oligonucleotide concentration, and R is the gas constant. 
Rearrangement of Eq. (2) gives 
1/TM  = RiLH° lfl(CT/4) + AS °/zH° 	 (3) 
Y 	m 	x 	c 
which, as indicated by the symbols in italics, corresponds to a straight line when the 
reciprocal of the melting temperature (1/T m) is plotted against the natural logarithm 
of the strand concentration divided by four (C T/4). The slope (m) of such a plot is 
equal to RhH°, and the intercept (c) is equal to S°/AH°. Figure 3.3 shows a typical 
1/TM  vs. ln(CT/4) plot. 
3.2.2 Obtaining the data 
As seen in Section 3. 1, absorbance vs. temperature profiles were measured for 
d(TA)4, and d(TD)4 and the Tm  was obtained from the first derivative of the curve at 
a given concentration. In order to obtain concentration-dependent data, the melting 
curves for duplexes formed for oligonucleotides DAP(5) to DAP(22), were obtained 
in triplicate for five concentrations covering a range of approximately 10-fold 
concentration. The other main difference in the following study was that none of the 
oligonucleotides were self-complementary—this avoided any possible intrastrand 
98 
D.T interactions as well as the added complication of having dD in both strands. 
(Incidentally, the latter event is unlikely in any application of dD in biology). 
The oligonucleotides: DAP(5) to DAP(22) were carefully chosen so as not to 
contain any obvious self-complementary regions, and the 8-mer size was convenient 
for melting curve determination in the conditions outlined in Breslauer et al. 174 
Adherence to these conditions was essential, since the values for the normal Watson-
Crick nearest neighbour interactions were to be employed in this study. As a means 
of checking this compatibility, concentration-dependent melting curves, and the 
resulting thermodynamic parameters were obtained for the non-self complementary 
duplex: Duplex 10, which contains only A.T and G.0 base pairs. 
The oligonucleotides studied in the concentration-dependent melting curves were 
as follows. 
DAP(5) CGT ADC UT 
DAP(10) CGT DAC GT 
DAP(7) CGT DDC GT 
DAP(6) COT CDC UT 
DAP(9) COT TDC UT 
DAP(8) COT GDC UT 
DAP(11) CGT DGC GT 
DAP(12) COT DTC UT 
DAP(14) DCD CDC DC 
DAP(15) CUT AAC UT 
DAP(13) DCG TTA CU 
DAP(16) ACG TTA CU (Duplex 1) 
DAP(16) ACU TTA CG (Duplex 2) 
DAP(16) ACG TTA CG (Duplex 3) 
DAP(17) ACG TGA CG (Duplex 4) 
DAP(19) ACG TAA CU (Duplex 5) 
DAP(18) ACG TCA CU (Duplex 6) 
DAP(20) ACU CTA CG (Duplex 7) 
DAP(21) ACG ATA CU (Duplex 8) 
DAP(22) UTU TOT UT (Duplex 9) 
DAP(16) ACG TTA CG (Duplex 10) 
DAP(15) CUT AAC UT (Duplex 11) 
An example of treatment of this data is given for duplex formed between DAP(5) 
and DAP(16), (Duplex 1). 
DAP(5) 5'- CUT AD CUT 
	
E=78.5x103  cm2  imo1 
DAP(16) 3'- UCA TT UCA 
	
E= 86.4x103 cm2 tmol' 
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Using Equation (1), and the average of the E values, we obtain the concentration, 
at a given temperature, which is the average of three readings. 
Figure 3.2 gives an example of one of the melting curves obtained for Duplex 1, 
and Table 3.1 shows the data obtained. 
ABS 
29Z. 00 	302.00 	312.00 	322.00 	332.00 	342.00 
Temp./°K 
Figure 3.2. The UV melting curve for Duplex 1 at 23.8pmol DNA concentration. 
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Table 3.1. Empirical data obtainedfrom melting curves of Duplex 1. 
CT/Lmo1' Tm(average)/°K ln(CT/4) 103/TM  
62.6 318.75 -9.61 3.137 
38.7 316.12 -10.10 3.163 
23.8 313.73 -10.58 3.187 
19.4 312.75 -10.79 3.197 
7.8 308.40 -11.70 3.243 
The concentration-dependence of the melting temperature is plotted as ln(CT/4) vs. 
i/Tm, (Figure 3.3). The errors for the thermodynamic parameters are estimated from 









-11.6 -11.4 -11.2 -11 -10.8 -10.6 -10.4 -10.2 -10 -9.8 -9.6 
ln(CT/4) 
Figure 3.3. The plot of ln(C714) vs. 1/Tm  for Duplex 1. 
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From a "least-squares" linear regression, the slope and intercept obtained for 
Duplex 1 were 
Slope = -0.0505 ±0.0005 x10 3 
Intercept = 2.5826 ± 0.0058 x10 3 
and from Eq.(3), 
= Rlslope = -164.6 ±1.7 kJmol' 
= th{°.intercept = -425.2 ±5.3 JK'mof' 
and from 
AGO = AHO - ThS° 	 (4) 
where T will be taken as 298.15K (25°C), we obtain 
= -37.8 ±4.3 kJmol' 
All values will be given rounded up to three significant figures, hence: 
= -165 ±2 kJmol', S° = -425 ±6 JK 1 mol 1 , and AG' = -37.8±4 kJmoF' 
The data obtained from the plots of ln(CT/4) vs. 1/Tm for the rest of the duplexes 
were treated likewise, and are listed below in Table 3.2. (The errors obtained for the 
AG' values were, on average, ±10% for all duplexes studied.) 
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Table 3.2. Thermodynamic parameters for Duplexes 1-10. 
(AGO calculated at 25°C). 
DUPLEX FI°/ kJmol4 AS°! JK'mof' AGO/ kJmol' 
1 CGT ADC GT 
GCA TTG CA -165 -425 -37.8 
2 CGT DAC GT 
GCATTGCA -193 -510 -40.6 
3 CGT DDC GT 
GCA TTG CA -190 -499 -41.0 
4 CGT CDC GT 
GCA GIG CA -205 -534 -46.4 
5 CGT TDC GT 
GCA AIG CA -201 -535 -41.0 
6 CGT GDC GT 
GCA CTG CA -208 -546 -46.0 
7 CGT DGC GT 
GCA TCG CA -242 -648 -48.5 
8 CGT DTC GT 
GCA TAG CA -205 -549 -41.0 
9 DCD CDC DC 
TGT TGT TG -237 -632 -48.6 
1OCGTAACGT 
GCA TIG CA -172 -453 -37.2 
Duplex 10 was included as a check on compatibility of the data obtained with that 
obtained by Breslauer et al for the 10 native nearest neighbour interactions. 174  The 
value for G°(redicted) for Duplex 10 agreed very closely with the experimentally 
obtained value. (See Appendix 1). 
Duplex 11 (containing one 5'-terminal diaminopurine) was excluded from 
treatment of data since the correlation coefficient was below 0.99—all other duplexes 
had a value of greater than 0.99. It was decided that Duplex 9 would be more 
"representative" of the DC/TG interaction, as the value obtained would be an average 
of four nearest neighbour values, not just relying on one 5'-terminal DC/TG 
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interaction, which may behave differently from internal DC/TG interactions. Ideally, 
thermodynamic parameters would have been determined for a Y-terminal 
diaminopurine residue to help obtain an average of values. However, shortly after the 
determination of the 5'-terminal diaminopurine, the Peltier block malfunctioned, 
preventing further study of any duplexes. 
3.2.3 Treatment of the data 
The compositions of Duplexes 1 to 10 for the nine possible nearest neighbour 
interactions for duplexes containing diaminopurine, as well as those for the ten native 
interactions, are given below in Table 3.3. 
Table 3.3. Nearest-neighbour frequencies. 
Nearest neighbours present in duplex 
Duplex AD DA DD CD DC GD DG TD DT AA TA CA GT GA CG GC 
777777 GT TG CT TC AT TA 77 AT GTCA CTGCCG 
1CGT ADC GT 1 0 0 0 1 0 0 0 0 0 1 0 2 0 2 0 
GCA TFG CA 
2CGTDACGT 0 1 0 0 0 0 0 1 0 0 0 0 3 0 2 0 
GCA TfG CA 
3CGTDDCGT 0 0 1 0 1 0 0 1 0 0 0 0 2 0 2 0 
GCA TFG CA 
4CGT CDC GT 0 0 0 1 1 0 0 0 0 0 0 0 2 1 2 0 
GCA GIG CA 
5CGTTDCGT 0 0 0 0 1 0 0 1 0 1 0 0 2 0 2 0 
GCA ATG CA 
6CGTGDCGT 0 0 0 0 1 1 0 0 0 0 0 1 2 0 2 0 
GCA CTG CA 
7CGTDGCGT 0 0 0 00 0 1 1 0 0 0 0 2 0 2 1 
GCA TCG CA 
8CGIDICGT 0 0 0 0 0 0 0 1 1 0 0 0 2 1 2 0 
GCA TAG CA 
9DCD CDC DC 0 0 0 3 4 0 0 0 0 0 0 0 0 0 0 0 
IGI TGT TG 
10CGTAACGT 0 0 0 0 0 0 0 0 0 1 1 0 3 0 2 0 
GCA TFG CA 
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From the tabulation of nearest neighbour interactions above, and from the known 
values for the normal Watson-Crick nearest neighbours, 174  the values of G'(25'C) 
for diaminopurine-containing duplexes was reduced to doublets. 
For example, from Duplex 4, we obtain 
= DC/TO + CD/GT + 2(GT/CA) + 2(CG/GC) +GAJCT -(-20.9)=-46.4kJmol' 
where -20.9kJmol' represents the helix initiation free energy, and using the values 
calculated for GT/CA and CG/GC, and GA/CT (-5.4, -15.1, and -6.7kJmoF') 174 this 
leaves the doublet: 
G°(DC/TG + CD/GT) = -19.6kJmoi' 
Values of the nearest neighbour doublets for all the diaminopurine containing 
duplexes were similarly obtained. 
The next step was to "close" the data to give a value for each nearest neighbour 
interaction. This was done by creating an inequality—the duplex chosen was Duplex 
9, which contains 4(DC/TG) and 3(CD/GT) nearest neighbours. The values were 
obtained as follows 
iG0totaI = 4(DC/TG) + 3(CD/GT) -(-20.9) = -48.6kJmol' 	(4) 
Inserting this equation into Eq.(4) we obtain 
zG°(DC/TG) = -10.7kJmof' and G°(CD/GT) = -8.9kJmol' 
These values were then plugged into the appropriate doublet values, for example with 
Duplex 1 
G°(AD/TT + DC/TG) = -13.90moi' 
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therefore iG°(AD/TF) = -3.2 kJmol'. 
This process was repeated for all remaining nearest neighbour doublets containing 
diaminopurine. These G° values are given in Table 3.4, along with the 
corresponding AG° values determined for the native nearest neighbour interactions. 174 
The CG/GC, GC/CG and GG/CC nearest neighbours are also included. 
Table 3.4. G° values for the 9 nearest neighbours containing diaminopurine, 
compared with the 10 native nearest neighbour interactions. 
Interaction G0IkJmoF' Interaction G0IkJmol4 
AD/TT -3.1 < AA/TT -7.9 
DA/TT -12.8 > AA/TT -7.9 
DD/TT -7.9 AA/TT -7.9 
CD/GT -8.9 > CA/GT -7.9 
DC/TG -10.7 > AC/TG -5.4 
GD/CT -6.9 GA/CT -6.7 
DGTFC -13.2 > AG/TC -6.7 
TD/AT -2.3 < TA/AT -3.8 




3.2.4 Interpretation of thermodynamic data for diaminopurine incorporation 
From Table 3.4, the most striking difference between nearest neighbour 
interactions with and without diaminopurine, are: the AD/TT interaction is much less 
stable than the corresponding AA/TT, whereas DA/TT is more stable than AA/TT. 
Also, the TD/AT interaction is less stable than TA/AT. 
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A previous study predicted that any duplex would be destabilised where 
diaminopurine is flanked by adenine, with respect to the duplex formed by adenines 
only.74 It was reasoned that the substitution of dD for dA would disrupt the spine of 
hydration formed in d(A).d(T) tracts, (see Section 1.5.2). As can be seen from Table 
3.4, the AD/TT nearest neighbour interaction is in agreement with this premise, 
however, the DA/TT interaction is actually more stable, by 4.9kJmol, than the 
AA/TT interaction. Therefore there must be additional forces stabilising this 
particular interaction, which more than compensate for the disruption to the spine of 
hydration. 
Also worthy of mention are the DT/TA and TD/AT interactions—the hierarchy of 
stability is analogous to that found for DA/TT and AD/TT, when compared to their 
respective native nearest neighbour interactions. Thus: 
DT/TA> AT/TA> TA/AT> TD/TA 
(-11.9) 	(-6.3) 	(-3.8) 	(-2.3) 	(kJmol') 
A pattern emerges relating the actual position of substitution of dD for dA, and the 
inherent stability—DX/TX is more stable than XD/XT, where X= any base and its 
complement. In general, when comparing duplexes containing diaminopurine with 
duplexes containing adenosine: 
DX/TX> XD/XT ~: AX/TX> XA/XT 	 (5) 
It is interesting to compare the DX/TX interaction with the AX/TX interaction—
in the AX/TX case, steric clashes occur between the thymine methyl group and the 
5'-neighbouring sugar.  37  This is the cause of the large negative propeller twist 
observed in A.T base pairs that blocks A-DNA conformations in AX/XT steps. It is 
possible that in DX/TX steps, since there already exists a tendency to adopt 
(putative)A-DNA conformation (see Section 1.5.3), there is enough flexibility to 
lessen the steric clash. 
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Since the DX/TX interactions offer substantial increases in stability compared to 
the AX/TX interactions, this usually compensates for the decrease in stability for the 
stability-decreasing TD/TA interaction. The exception being where the adenine 
substituted is 3' adjacent to a thymine, and is part of a terminal A-tract, thus 5'-
NTA-3' is more stable than 5'-N1'D-3' (by 1 .SkJmoi'). This "worst-case" example 
can be seen as negligible, as substitution of dD for dA in the N-region would, in most 
cases, compensate for the otherwise small decrease in stability when substituting dD 
for A in the 3'-A tail. 
3.3 CONCLUSIONS AND FUTURE WORK 
A thermodynamic library has been developed which may allow the prediction of 
stability of duplexes containing diaminopurine—this library is compatible with the 
data available for native nearest neighbour interactions. 
There is only one condition where local destabilisation of the duplex will occur 
when diaminopurine replaces all adenines. This is where a T residue is followed by a 
terminal oligo-dA at the 3'-end. Development of a computer program would allow 
prediction of the thermodynamics of duplexes containing diaminopurine, and would 
"recommend" any instance where dD substitution would be inappropriate. 
More oligonucleotides must be synthesised containing diaminopurine, and 
thermodynamics of the subsequent duplexes determined, in order to further test the 
data. Also, compiling a similar library of nearest neighbour interactions for 
DNA.RNA hybrids containing 2'-deoxydiaminopurine would prove useful. These 
hybrids, particularly relevant in antisense applications, have recently been shown to 
stabilise the resulting hybrid duplexes considerably more than the corresponding 
DNA.DNA duplex. 78  Normally DNA.RNA hybrids are less stable than the 
corresponding DNA.DNA duplex (see Section 1.5.3.1). The observation that 
diaminopurine-containing hybrids are very stable seems to agree with the observation 
that diaminopurine has a tendency to adopt the putative A-form—this form may well 
be compatible with the A-form which is adopted by DNA.RNA hybrids. This may 
also account for the increase in stability over the DNA.DNA duplex containing dD. 
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This study emphasises the importance of obtaining the thermodynamic parameters 
for oligonucleotides containing modified bases. This must be carried out before any 
predictions can be made about the effects this modification may have on duplex 
stability. Melting curves carried out for a selection of base pairs is insufficient—
determination of the nearest neighbour interactions is essential. When such libraries 
of modified bases are compiled, then the design of "super-stable" duplexes can be 
envisaged, containing a pre-determined combination of base analogues, for use in 
applications such as antisense therapy or sequencing. Such analogues would include 
diaminopurine, and other duplex-stabilising bases such as 5-methyl-cytidine. 
Study must also be carried out on the enzymatic recognition of diaminopurine 
where extension using a polymerase is carried out. This is of particular interest in 
primers containing 3'-diaminopurine residues for PCR and DNA sequencing 
reactions. 
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4.0 THE SYNTHESIS OF BASE-LABILE LINKERS- 
A PRELIMINARY STUDY 
As discussed in Section 1.8, there is room for improvement with regards to 
speeding up the cleavage of an oligonucleotide from its solid support. This can be 
achieved by using a more nucleophilic base instead of ammonia in the final 
deprotection stage, or replacing the succinyl linker with a more base-labile linker. 
The latter solution is the more attractive, as it means adhering to the well-
established solid phase phosphoramidite synthesis protocol. This is important as 
employing cleavage/deprotection reagents other than ammonia may require the use 
of non-standard or extra equipment, such as non-corroding seals for use with the 
AMA reagent described in Section 1.8. These reagents may also be more toxic and 
difficult to handle than ammonia. 
4.1 THE SYNTHESIS OF PHTHALOYL LINKERS 
There is evidence to suggest that base cleavage of an oligonucleotide from its 
linker occurs via deprotonation of the amide nitrogen followed by intramolecular 
nucleophilic displacement at the ester carbonyl group. This was shown by Brown et 
al—when the amide proton is replaced by the methyl group, the ester function was 
essentially unchanged under the same conditions that cleaved the unsubstituted 
amide. 150 
The potential of the phthaloyl group as a base-labile group was realised by Brown 
et al whilst investigating the stability of a variety of linkers to 10% solutions of the 
base DBU in dichloromethane.' 5° Under these conditions the phthaloyl linker was 
found to cleave much faster than the conventional succinyl linker, owing to the rigid 
conformation imposed by the aromatic ring. This conformation favours the 
intramolecular cleavage reaction, described above, and is illustrated by the phthaloyl 
group (see Figure 4.1). 
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Figure 4.1. The phthaloyl linker, showing the alignment for intermolecular cleavage 
by base. 
4.1.1 Synthesis of phthaloyl linker 1401 
Following the discovery that the phthaloyl linker was cleaved much faster than the 
succinyl linker in DBU, it was important to compare the two in conc. ammonia 
solution, the reagent commonly used to cleave and deprotect synthetic 
oligonucleotides. 
Firstly, thymidine was reacted with 4,4'-dimethoxytrityl chloride and DMAP in 
pyridine to give compound [361 as a solid white foam in 96% yield. 
This was then reacted with phthalic anhydride and DMAP in pyridine to give 
compound [371 as a yellow-white foam in 71% yield. The attachment of the 
phthaloyl linker to the solid support was carried out as for the succinyl linker, 
described by Sproat and Gait. 170  This involves activating the 3'-O-phthaloyl 
nucleoside with 4-nitrophenol in pyridine, then reacting this with DCC in 
dichloromethane. Dicyclohexylurea is seen to precipitate, and after the reaction had 
gone to completion (tic), the mixture was filtered, the filtrate concentrated, and 
suspended in DMF. Activated CPG was added to the suspension to give phthaloyl 
CPG [40] with a loading, after capping, of 7.5p.molg'. This synthetic scheme is 
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DMTrCI and DMAP in pyridine. 
Phthalic anhydride and DMAP in pyridine. 
a:4-Nitrophenol and DCC in DCM. b:Activated CPG in DMF. 
Figure 4.2. The synthesis ofphthaloyl CPG [401. 
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4.1.2 Synthesis of nitro-phthaloyl linkers [41] and [42] 
Nitro-phthaloyl CPG's [41] and [42] were also synthesised in order to determine 
the effect of the electron-withdrawing group on the cleavage rate of the linker. 
Compound 1361 was reacted with 3-nitro-phthalic anhydride and DMAP in 
pyridine, to give compound [38] as a yellow-white foam in 56% yield. This was then 
reacted as for the phthaloyl CPG to give nitro-phthaloyl CPG [41] with a loading, 
after capping, of 5.Opmolg 1 . This scheme is shown in Figure 4.3. 
To synthesise the other nitro-phthaloyl linker, compound [36] was reacted with 4-
nitro-phthalic anhydride and DMAP in pyridine to give two products (on tic). The 
higher running product, 1391 was isolated and obtained as a yellow-white foam, in 
47% yield. (It was assumed that the lower running spot was due to the impurity, ca. 
8%, of 3-nitrophthalic anhydride reacting with compound [36]. This impurity is 
present as a by-product in manufacture). Compound [39] was then reacted with 
activated CPG to give nitro-phthaloyl CPG 1421 with a loading of 2.5tmolg'. The 
synthetic scheme is shown in Figure 4.4. 
The loading of the nitro-phthaloyl resins [411 and 1421 were both found to be 
considerably lower than phthaloyl resin [40], which is already a "below-average" 
loading. Therefore there must be some intrinsic reason for such low loading in the 
phthaloyi series. This is likely due to steric bulk as compared to the succinyl linker 
where loadings of >30j.tmolj 1 may be obtained, if necessary. Another reason could 
be the low solubility of the phthaloyl nucleosides in DMF reducing reactivity 
towards the CPG. 
Low loadings are not necessarily a bad thing, since there is less steric hindrance 
for the growing oligonucleotide. The main problem involving nucleosides [38] and 





3-Nitrophthalic anhydride and DMAP in pyridine. 
a:4-Nitrophenol and DCC in DCM. b:Activated CPG in DMF. 
Figure 4.3. The synthesis of nitro-phthaloyl CPG [411. 











4-Nitrophthalic anhydride and DMAP in pyridine. 
a:4-Nitrophenol and DCC in DCM. b:Activated CPG in DMF. 
Figure 4.4. The synthesis of nitro-phthaloyl CPG [421. 
The nitro group may be at the 4- or the 5-position of the phenyl ring. 
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4.1.3 Comparing the cleavage of the phthaloyl linkers with the succinyl linker 
An initial study of the cleavage of oligonucleotides from succinyl CPG, and 
CPG's [40], [41] and [42], was carried out. These oligonucleotides were, 
respectively: SUC-1, PTH-1, PTH-2 and PTH-3, and the sequence synthesised for 
each resin was: 
5'-GAC TTG ACC TAT-3' 
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Figure 4.5. The cleavage of linkers: (a) succinyl; (b) phthaloyl[401; (c) nitro-
phthaloyl[411; and (d) nitro-phthaloyl[421. 
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This initial study was carried out by taking an aliquot from each stage of a 3x10 
min Endproc., and measuring the absorbance. The cleavage of the four linkers is 
shown in Figure 4.5. This experiment was not very accurate, as the machine-
delivered volumes of ammonia may vary, but this did give an idea of the cleavage 
times of the linkers. 
The order of the time of cleavageS,  with fastest first, was: 
phthaloyl[40] < NO2-phthaloyl [4 1 ] = succinyl < NO 2-phthaloyl [421 
that is, both the nitro-phthaloyl linkers did not cleave any faster than the phthaloyl 
linker. In fact, the nitro-phthaloyl linkers appeared to cleave more slowly than the 
unsubstituted phthaloyl linker. The nitro-phthaloyl carboxylic esters were expected to 
cleave more rapidly than the unsubstituted phthaloyl linker since the electron 
withdrawing nitro group would induce a partial positive charge distribution, 
particularly at the ortho and para positions of the benzene ring. It is possible that the 
reduction in cleavage times are due to the steric bulk introduced by the nitro group, 
along with the increase in lipophilicity. Both of these effects would be expected to 
slow down the cleavage of the phthaloyl group in aqueous ammonia. 
4.2 COMPARING THE PHTHALOYL AND SUCCINYL LINKERS 
From the qualitative results discussed above, attention then focused on comparing 
the phthaloyl CPG 1401, with the succinyl CPG. (The nitro-phthaloyl linkers, bearing 
in mind the very poor loading of resins 1411 and [42], and their apparent slow 
cleavage, compared to the phthaloyl linker, eliminated them from further 
investigation). 
In the following experiments, multiple tests were carried out, and more controlled 
conditions were employed—this gave a more accurate comparison of the two linkers. 
When the absorbance of the cleaved oligonucleotide had reached 90% of the final absorbance 
measured, this was taken as a working figure for comparing cleavage. This cut-off will be explained 
in Section 4.2.2. 
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4.2.1 The quality of oligonucleotide synthesis using phthaloyl or succinyl CPG 
The quality of the oligonucleotides synthesised will be considered first. The 
oligonucleotides synthesised were compared, with respect to their average coupling 
efficiency during oligonucleotide synthesis, and, after cleavage and full deprotection, 
were analysed by HPLC and CE, including co-injections for authenticity checks. 
Average coupling efficiency of oligonucleotide synthesis 
In the 12- and 20-mer test sequences shown below, the average coupling 
efficiencies for the phthaloyl linker were found to be much the same as those for the 
succinyl linker. The average coupling efficiency for each of the oligonucleotides 
SUC-2 and -3, and PTH-4 and -5 was found to be greater than 98.5%. Therefore the 
phthaloyl linker had no detrimental effect on oligonucleotide synthesis. 
SUC-2 ATG CAA CCG AGT 
SUC-3 ATA GCT TOG CAA GTA TGA CT 
PTH-4 ATG CAA CCG AGT 
PTH-5 ATA GCT TGG CAA GTA TGA CT 
using succinyl CPG 
using succinyl CPG 
using phthaloyl CPG [40] 
using phthaloyl CPG [40] 
HPLC analysis 
Next, the quality of the oligonucleotides synthesised was checked by HPLC. The 
chromatographs shown in Figure 4.6 are for the crude 20-mer test sequences. 
As can be seen, far from affecting the synthesis in a detrimental manner, PTH-5 
seems to have been a better synthesis than SUC-3, with less failure sequences, and a 
more pure product. This may be a consequence of the low loading on the CPG-




Figure 4.6 HPLC chromatograms of the crude, deprotected 20-mer obtained after 
synthesis on. (a) the succinyl linker, and (b) the phthaloyl linker [401. 
Capillary electrophoresis analysis 
The 20-mer phthaloyl test sequence, after HPLC purification and desalting, was 
compared with the "authentic" succinyl oligonucleotide by capillary electrophoresis. 
As can be seen, the coinjection of the two purified oligonucleotides shows they are in 
fact identical. This was carried out as CE can differentiate between slight changes in 
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coinjections of oligonucleotides; for example a 119-mer can be resolved from a 120-
mer. 176 
Figure 4.7. The CE chromatogram of a coinjection of pure, desalted SUC-3 and 
PTH-5. 
4.2.2 Comparing the cleavage of the phthaloyl and succinyl linkers 
In order to study the cleavage of the succinyl linkers in a more controlled manner, 
CPG was taken from the column after a 0.2jmol, no Endproc. oligonucleotide 
synthesis. This CPG was then added to 2.5 ml of concentrated ammonia solution in a 
1cm UV cuvette. The UV absorbance at 260nm was measured every 5 minutes, 
straight after the UV cell had been inverted to allow mixing of the cleaved 
oligonucleotide with the ammonia. The readings were taken until the absorbance 
started levelling off. 
This experiment was carried out three times for both of the linkers, to obtain an 
average value of cleavage time. An example of this absorbance at 260nm measured 
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Figure 4.8. Cleavage of the linkers as a function of time, for: (a) SUC-2 and (b) 
PTH-4. 
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This gives an average value of 9 minutes and 16 minutes for >90% cleavage from 
the solid support, for the phthaloyl and succinyl groups, respectively. 
It must be noted that the point where 100% cleavage is reached is actually the 
point where the absorbance measured is no longer increasing geometrically. 
However, the absorbance does not level off, but continues to increase linearly after 
"true" levelling off has taken place. This is why the reasonable "cut off' point for 
cleavage of an oligonucleotide is taken to 90% of the maximum—to exclude the 
misleading increase in absorbance from adding to measured cleavage time. 
It seems likely that after initial cleavage of the oligonucleotide from the linker, the 
resulting cyclic amide cleaving from the support adds to the absorbance measured, 
hence the linearity introduced into the graph. The size of this increase in absorbance 
was always proportionally greater for the phthaloyl group—this may reflect the 
higher absorbance at 260nm of this group over the cleavage of the succinimide group 
from the solid support. 
In summary, the gradient for the phthaloyl plot is very steep in the first one or two 
measurements, and then switches to a linear rise. In contrast, the succinyl plot shows 
a gentler decrease in the steepness of the gradient over time. This is down to the 
relative slowness in cleavage compared to the phthaloyl group, combined with the 
higher absorbance of the phthaloyl group. 
These observations would imply that scission of the phthaloyl linker was even 
faster than is shown in Figure 4.8(b). 
4.3 CONCLUSIONS AND FUTURE WORK 
From the finding that the succinyl linker is being given a cleavage time well in 
excess of that required, the Endproc. routinely used for the succinyl group is now 4x8 
minutes in Oswel DNA Service. This is a saving of 28 minutes for every synthesis, 
over the previously used 4x15 minutes Endproc. 
The results from the study of the phthaloyl linker suggest that an Endproc. of 
4x2.5 minutes would be more than adequate for obtaining >90% of the 
122 
oligonucleotide bound to the solid support. However, further study on the phthaloyl 
linker should include the measurement of cleavage at 1 or 2 minute intervals to give a 
more accurate determination of the cleavage time, coupled with detailed analysis of 
the cleavage products. Hence the cause of the "linearity" in later absorbance 
measurements, could be identified. If the absorbance was indeed not due to cleavage 
of oligonucleotides, then the phthaloyl linker would need less time than presumed. 
Again, this approach could be applied to the nitro-phthaloyl linkers in the event 
that the linearity problem was swamping the true measurement of cleavage. Further 
study on these groups would also determine the orientation of the nitro groups, in 
order that the actual charge distribution may be predicted. This, would help in the 
design of other substituted phthaloyl linkers. 
Phthaloyl linkers with electron withdrawing groups of less steric bulk, and lower 
lipophilicity should be synthesised, in order to test the hypothesis that the nitro 




5.1 SOLVENTS AND REAGENTS 
Solvents 
Solvents used for the extraction and chromatography of phosphoramidites, and for 
the preparation of anhydrous solvents, were of HPLC grade. Reverse-osmosis 
purified water was used during oligonucleotide synthesis, analysis and purification. 
All other solvents used were of laboratory grade. 
Anhydrous Solvents and Reagents 
Dichioromethane was distilled over CaH 2 ; benzene was dried with sodium wire; 
diethyl ether was distilled from sodiumlbenzophenone; N,N-dimethylformamide was 
fractionally distilled from 4A molecular sieves; pyridine was distilled from CaH 2 ; 
toluene was dried with sodium wire; triethylamine and NN-diisopropylethylamine 
were dried over CaH 2. Anhydrous acetonitrile was purchased from Applied 
Biosystems Limited (ABI). 
Other Reagents 
4,4'-Dimethoxytrityl chloride was purchased from Courtaulds, all other chemicals 
were supplied by Aldrich, Fluka or Sigma. 2-Cyanoethyl-N,N-diisopropylchloro-
phosphoramidite was synthesised by the procedure of Claesen et al.' 77 
5.2 ANALYTICAL TECHNIQUES 
Chromatography 
Flash column chromatography was carried out using 60 mesh silica gel (Merck), 
under slight argon pressure. 
Thin layer chromatography (TLC) was carried out on silica gel 60, F254, 0.2mm 
layer aluminium sheets (Merck) using the following solvent systems: 
Dichloromethane-methanol (9:1, v/v). 
Dichioromethane-methanol (95:5, v/v). 
Dichioromethane-methanol (8:2, v/v). 
Acetonitrile-ethyl acetate (50:50, v/v). 
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Dichloromethane-methanol (98:2, v/v). 
Ethyl acetate-acetonitrile (98:2, v/v). 
Dichioromethane. 
Ethyl acetate-diethyl ether (50:50, v/v). 
Ethyl acetate-methanol-ammonia (5:1:1, v/v/v). 
Dichioromethane-methanol-acetic acid (10:2:1, v/v/v). 
Products were visualised on TLC using the following techniques: 
UV absorption at 264nm for nucleosides. 
Spraying with a solution of 4-methoxybenzaldehyde: glacial acetic acid: conc. 
sulphuric acid: ethanol (5:1:1:50). Compounds with a protected or unprotected 
1 ,2-diol function gave a dark blue colour on strong heating. 
Exposure to conc. hydrochloric acid vapour produced a strong orange colour 
for compounds containing a dimethoxytrityl group. 
Purines containing an N6-azide gave a dark brown colour on strong heating. 
Purines containing an azide, nitrogen cation, or formamidine group fluoresced 
on absorption of UV at 264nm. 
TLC plates were pre-treated with triethylamine for compounds containing the 
dimethoxytrityl or TIPS groups. 
Combustion Analysis 
CHN analysis was carried out on a Perkin Elmer 2400 Elemental Analyzer. All 
samples were dried at 60°C over P 205 for at least 48 hours prior to analysis. 
NMR Spectra 
'H-NMR spectra were recorded on a Brucker WP-200 spectrometer (200.13MHz), 
a Brucker WP-250 spectrometer (250.13MHz) and a Brucker WP-360 spectrometer 
(360.14MHz). 
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13C-NMR spectra were recorded on a Brucker WP-200 spectrometer (50.32MHz), a 
Brucker WP-250 spectrometer (62.90MHz) and a Brucker WP-360 spectrometer 
(90.56MHz) 
31 P-NIvIR spectra were recorded on a JEOL FX90Q spectrometer (90MHz). 
Mass Spectra 
Positive ion Fast Atom Bombardment (FAB) mass spectra were recorded on a 
Kratos MS50 TC spectrometer using a thioglycerol/acetonitrile or a 3-nitrobenzyl 
alcohol matrix. 
UV Spectra 
UV spectra were recorded on a Perkin Elmer Lamda 15 ultraviolet-visible 
spectrometer over the range 190-320nm, using PECSS2 software. The solvent used 
in each scan was acetonitrile. 
IR Spectra 
IR spectra were recorded on a Bio Rad FTS-7 fourier transform spectrometer 
controlled by a Bio Rad SPC 3200 microcomputer using KBr plates, using a nujol 
mull or as a film from dichioromethane. 
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5.3 SYNTHESIS OF dD NUCLEOSIDES 
2-N, 3'-0, 5'-O-Tris-phenylacetyl-2'-deoxyguanosine [1]. 
[0] 
Ca 
2'-Deoxyguanosine monohydrate (6.3g, 22mmol) was coevaporated three times with 
anhydrous pyridine and suspended in anhydrous pyridine (250m1). The reaction 
vessel was cooled to 0°C, and phenylacetic anhydride (5eq, liOmmol, 28.0g) was 
added dropwise and then the reaction mixture was heated to 110°C with stirring. 
After 1.5 hours the pyridine was removed in vacuo, and the residue was dissolved in 
dichioromethane, washed with saturated aqueous NaHCO 3 (250ml), saturated 
aqueous KC1 (3x200m1) and dried with anhydrous Na 2SO4. The organic layer was 
evaporated in vacuo, and the residue purified by wet flash column chromatography, 
eluting with dichloromethane-methanol (99:1, v/v) to give a pale cream foam. Yield: 
11.5g, (84%). 
Rf 0.69 (solvent A), Rf 0.24 (solvent B). Found: C,65.26; H,5.02; N,10.83%. 
Requires: C,65.73; H,5.03; N,11.27%. 'H nmr (200.13MHz; CDCI 3): H: 2.30-2.41 
(1, ddd, J=2.OHz, J=6.3Hz, J=14.41-lz, 2'-H), 2.62-2.74 (1, ddd, J2.OHz, J=6.3Hz, 
J14.4Hz, 2"-CH), 3.58-3.60 (2, d, J=3.6Hz, 2-PhCH 2), 3.64 (4, s, 5'-PhCH2), 3.65 
(4, s, 3'-PhCH2), 4.34-4.45 (3, m, 4'-H, 5'-CH2), 5.27-5.31 (1, m, 3'-H), 6.05-6.12 (1, 
dd, J=6.2Hz, J8.1Hz, l'-H), 7.09-7.39 (15, m, aromatic-CH), 7.59 (1, s, 8-1-1), 9.41 
(1, s, 2-NH), 11.88 (1, s, 1-NH). ' 3C nmr (50.32MHz, CDC13) c: 36.25 (CH2), 40.80 
(2xCH2), 43.43 (CH2), 63.88 (CH2), 74.72 (CH), 82.11 (CH), 85.17 (CH), 121.92 
(C), 127.16-129.13 (16xCH), 132.70 (C), 132.97 (C), 133.04 (C), 137.89 (C), 147.07 
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(C), 155.34 (C), 170.65 (C), 172.00 (C), 172.93 (C). mlz (FAB) 622.23013, [(M+H) 
caic. for C 34H32N507 622.23015]. Xmax 200,253, 260, 286nm. 
2-N-Phenylacetyl-2'-deoxyguanosine [2]. 
2-N, 3'-0, 5'-O-Tris-phenylacetyl-2'-deoxyguanosine [1] (9.4g, 15.2mmol) was 
dissolved in a pyridine-methanol solution (400m1, 3:1, v/v) and cooled to 0 °C. To 
this mixture, 2M sodium hydroxide solution (3eq, 22.8m1) was added dropwise with 
stirring. After 10mm, the reaction was quenched with Dowex resin (H form). The 
Dowex resin was filtered off and washed with pyridine and methanol; the resulting 
filtrate was evaporated in vacuo. To the residue, dichioromethane-methanol (80:20 
v/v) was added, and the resulting precipitate was filtered off to leave a white powder. 
Yield: 5.15g, (88%). 
RI 0.16 (solvent A), RI 0.52 (solvent Q. Found: C,56.31; 11,530; N,18.13%. 
Requires: C,56.13; H,4.97; N,18.19%. 'H nmr (200.13MHz; d6-DMSO) H: 2.23-
2.35 (1, m, 2'-H), 2.49-2.65 (1, m, 2"-H), 3.56-3.66 (2, m, 5"-CH2), 3.81 (2, s, 2-
PhCH2), 3.83-3.89 (1, m, 4'-H), , 3.39-4.40 (1, m, 3'-H), 4.99 (1, s, 5-OH), 5.35 (1, s, 
3'-OH), 6.19-6.26 (1, m, 1'-H), 7.22-7.36 (5, m, aromatic-CH), 8.25 (1, s, 8-H) . 13C 
nnir (50.32MHz; d6-DMSO) c: 39.85 (CH2), 42.70 (CH2), 61.61 (CH2), 70.62 
(CH), 83.15 (CH), 87.89 (CH), 120.45 (C), 127.16 (CH), 128.60 (2xCH), 129.52 
(2xCH), 134.36 (C), 137.66 (CH), 147.96 (C), 154.96 (C), 174.20 (C). mlz (FAB) 





2-N-Phenylacetyl-2'-deoxyguanosine [2] (4.6g, 12mmol) was coevaporated three 
times with anhydrous pyridine and redissolved in anhydrous pyridine (250m1). The 
mixture was cooled to 0 °C, and isobutyryl chloride (3.2eq, 38.2mmol, 4.07g. 4m1) 
was then added dropwise with stirring. After 20min the pyridine was evaporated in 
vacuo, the residue redissolved in dichioromethane and washed with saturated 
aqueous NaHCO 3 (150ml), water (3x1 50m1), and saturated aqueous KC1 (lOOm!) and 
dried with anhydrous Na2SO4. The organic layer was then evaporated in vacuo to 
leave a stable foam. Yield: 5.8g, (90%). 
Rf 0.53 (solvent A), Rf 0.85 (solvent C). 'H nmr (200.13MHz; CDC1 3) H: 1.06-1.25 
(12, m, (CH3)3C), 2.40-3.04 (4, m, Me 2C-H, 2'-CH2), 3.85 (2, s, Ph-CH2), 4.23-4.36 
(2, m, 5'-CH2), 4.57-4.72 (1, m, 4'-H), 5.26-5.37 (1, m, 3'-H), 6.13-6.22 (1, m, l'-H), 
7.22-7.34 (5, m, aromatic-CH), 7.76 (1, s, 8-H), 9.98 (1, s, 2-NH), 12.00 (1, s, 1-NH). 
' 3C nmr (50.32MHz; CDC13) öc: 18.59 (2xCH 3), 18.73 (2xCH3), 33.58 (CH), 33.73 
(CH), 36.66 (CH2), 43.66 (CH2), 63.31 (CH), 74.02 (CH), 82.43 (CH), 85.26 (CH), 
121.99 (CH), 127.49 (CH), 128.28 (CH), 128.73 (2xCH), 129.16 (2xCH), 132.71 
(C), 137.82 (C), 147.22 (C), 155.30 (C), 172.93 (C), 176.11 (C), 177.39 (C). 





7 N IC'N 
2-N-Phenylacetyl-3'-0,5'-O-bis-isobutyiyl-2'-deoxyguanosine [3] (5 .5g, 1 0.5mmol) 
was coevaporated three times with, and redissolved in, anhydrous dichioromethane 
(100m!). To this, anhydrous triethylamine (4eq, 42mmol, 4.3g, 6.Oml), 
dimethylaminopyridine. (0.05eq, 0.5mmol, 100mg) and mesitylene suiphonyl 
chloride (2.5eq, 26.3mmol, 5.8g) were added and this mixture was stirred at room 
temperature for 1 hour. The reaction vessel was cooled to 0°C and N-methyl 
pyrrolidine (30eq, 0.32mol, 26.8g, 33.5ml) was added dropwise. After 15mm, 
anhydrous ammonia gas (Ca. 1 50m1) was condensed into the mixture and the reaction 
was allowed to reflux under a dry-ice cold-finger for 5 hours (under argon flow) 
before allowing the ammonia to evaporate overnight. The reaction mixture was then 
washed with water (3xlOOml), saturated KC1 (100m!), dried with anhydrous Na 2SO4 , 
and the organic layer was concentrated in vacuo to leave a dark red-brown residue. 
Wet flash column chromatography, eluting with dichloromethane-methanol (99.2:0.8 
v/v), gave the product as a light brown foam. Yield: 3.0g, (55%). 
Rf 0.48 (solvent A), Rf 0.81 (solvent Q. 'H nmr(200.13MHz; CDC13) oH: 1.11-1.26 
(12, m, Me2C), 2.46-2.86 (4, m, 2'-CH2, Me2CH), 4.28-4.38 (5, m, 5'-CH2 , 4'-H, Ph-
CH2), 5.26-5.33 (1, m, 3'-H), 6.25-6.32 (1, dd, J=6.OHz, J=7.9Hz, F-H), 6.81 (2, br s, 
6-NH2), 7.18-7.31 (5, m, aromatic-CH), 7.87 (1, s, 8-H), 10.18 (1, br s, 2-NH) . 13C 
nmr (50.32MHz; CDC1 3) Oc:  18.57 (2xCH3), 18.69 (2xCH3), 33.54 (CH), 33.65 
(CH), 37.58 (CH2), 43.38 (CH2), 63.39 (CH2), 73.87 (CH), 82.30 (CH), 83.96 (CH), 
116.70 (C), 126.63 (CH), 128.31 (2xCH), 129.30 (2xCH), 134.89 (C), 137.41 (CH), 
149.48 (C), 152.90 (C), 156.54 (C), 173.55 (C), 176.17 (C), 176.42 (C). mlz (FAB) 
525.24614 [(M+H) calc. for C 26H33N606 525.24615]. ?.max 199, 225, 272nm. 
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2-N-Phenylacetyl-2-amino-2'-deoxyadenosine [5]. 
2-N-Phenylacetyl-3'-O,5'-O-bis-isobutyryl-2-amino-2'-deoxyadenosine [4] (1-9g, 
3 .6mmol) was dissolved in a pyridine-methanol solution (1 60m1, 3:1, v/v) and cooled 
to 0°C. To this mixture, 2M sodium hydroxide solution (3eq, 15.4m1) was added 
dropwise with stirring. After 5mm, the reaction was quenched with Dowex resin (H 
form). The Dowex resin was filtered off and washed with pyridine and methanol; the 
resulting filtrate was evaporated in vacuo, and dichloromethane-methanol was added 
(8:2, v/v) to give a precipitate which was filtered and washed to leave a white 
powder. Yield: 1.6g, (83%). 
Rf 0.13 (solvent A), Rf 0.54 (solvent Q. Found: C,53.24; H,5.39; N, 20.37%. 
C18H20N604.(H 20) requires: C,53.71; H,5.51; N,20.89%. 'H nmr (200.13MHz; d6-
DMSO) H: 2.19-2.30 (1, m, 2'-H), 2.62-2.75 (1, m, 2"-H), 3.49-3.67 (2, m, 5'-CH2), 
3.82-3.86 (3, m, 4'-H, Ph-CH2), 4.41-4.42 (1, m, 3'-11), 4.93-4.98 (1, dd, J=3.8Hz, 5'-
OH), 5.31-5.33 (1, d, J=3.9Hz, 3'-OH), 6.24-6.31 (1, dd, J=7.3Hz, F-H), 7.19-7.33 
(7, m, Ph-CH, 6-NH2), 8.26 (1, s, 8-H), 10.14 (1, s, 2-NI-I). ' 3C nmr (91.75MHz; d6-
DMSO) c: 40.05 (CH2), 43.61 (CH2), 61.86 (CH2), 70.84 (CH), 83.10 (CH), 87.44 
(CH), 115.54 (C), 126.07 (CH), 127.76 (2xCH), 128.67 (2xCH), 135.02 (C), 138.18 
(CH), 149.06 (C), 151.61 (C), 154.87 (C), 168.54 (C). 





2-N-Phenylacetyl-2-amino-2'-deoxyadenosine [5] (0.95g, 2.5mmol) was suspended 
in pyridine and warmed to complete dissolution. Di-n-butylformamide 
dimethylacetal (1.3eq, 3.2mmol, 0.65g, 0.75m1) was added dropwise, and the 
solution was stirred for 2 hours at room temperature. The reaction mixture was then 
evaporated in vacuo, after coevaporation with toluene, to leave a pale yellow oil. 
This was dissolved in dry dichioromethane (25m1), with triethylamine (4eq, lOmmol, 
1 .4m1), and 4-dimethylaminopyridine (0.1 eq, 0.25mmol, 31mg). 4,4'-Dimethoxytrityl 
chloride (1.2eq, 2.2mmol, 740mg) was added portionwise with stirring. After 2 
hours, the reaction mixture was washed with water (2x50m1) and dried over Na2SO4 , 
then the solvent was evaporated in vacuo. Wet flash column chromatography on 
silica gel, eluting with dichloromethane-triethylamine (99:1) gave the product which 
was evaporated in vacuo to leave a white solid foam. Yield: 1.9g, (92%). 
Rf 0.58 (solvent D), Rf 0.49 (solvent E). Found: C,69.46; 1-1,6.97; N,11.42%. 
Requires: C,69.84; H,6.72; N,11.88%. 'H nmr (250.13MHz; CDCI 3) H: 0.90-0.98 
(6, t, formamide CH 3), 1.15-1.64 (8, m, formamide EtCH3 , CH3), 2.57-2.60 (2, m, 2'-
CH2), 3.28-3.43 (4, m, formamide PrCH 2), 3.58-3.68 (2, m, 5'-CH2), 3.71 (6, s, 
CH30), (3, m, 3'-OH, PhCH 3), 4.21-4.23 (1, m, 4'-H), 4.67-4.68 (1, m, 3'-H), 6.62-
6.69 (1, m, 1'-H), 6.71-6.77 (4, m, DMTr-H), 7.14-7.42 (H, m, DMTr-H), 7.97 (1, s, 
8-H), 8.11 (1, s, 2-NH), 9.03 (1, s, formamide C-H). ' 3C nmr(62.9OMHz; CDC1 3) öc: 
13.44 (CH3), 13.69 (CH3), 19.44 (CH2), 19.95 (CH2), 30.60 (CH2), 40.85 (CH2), 
44.25 (Cl2), 44.73 (CH2), 45.74 (CH), 51.63 (CH2), 54.90 (2xCH3), 64.00 (CH2), 
72.20 (CH), 83.68 (CH), 86.01 (C), 86.47 (CH), 112.86 (4xCH), 122.67 (C), 126.52 
(CH), 127.01 (CH), 127.58 (2xCH), 127.94 (2xCH), 128.60 (2xCH), 129.30 (2xCH), 
129.84 (4xCH), 134.08 (C), 135.65 (2xC), 139.40 (CH), 144.53 (C), 151.90 (C), 
133 
152.06 (C), 158.17 (3xC), 159.43 (CH), 160.21 (C). mlz (FAB) 826.42918 [(M+H) +  




2'-deoxyadenosine [61 (460mg, 0.56mmol) dissolved in anhydrous tetrahydrofuran 
(8m1) was added dry diisopropylethylamine (4eq, 2.24mmol, 0.40m1) and, dropwise, 
2-cyanoethyl N,N-diisopropyl-chlorophosphoridate 54 (1 .2eq, 0.67mmol, 0.16g, 
0.1 5m1). After stirring at room temperature for 30mm, the reaction was filtered under 
argon pressure, washed with 10% Na 2CO3 (2x50m1), dried over Na2SO4, and taken to 
an oil. The oil was purified by flash column chromatography eluting with argon-
purged ethyl acetate. (The column was pre-treated with triethylamine, and washed 
with ethyl acetate). The fractions were collected, and evaporated to give a white 
foam. Yield: 524mg, (91%). 
Rf 0.69 (solvent F), Rf 0.89 (solvent G) . 31P nmr (90MHz; CDC1 3) 	149.98 (s). 




Phenylacetic acid (60g, 0.44mo1) was refluxed for 1 hour with acetic anhydride 
(2.5eq, 1.lmol, 1 15g, 104ml). Excess acetic anhydride was removed in vacuo to 
leave an oil. On scratching the oil crystallised to leave crude phenylacetic anhydride. 
The crude crystals were then recrystallised from sodium-dried diethyl ether. Yield: 
47.8g, (86%). 
'H nmr (250.13MHz; CDCI 3) oH: 3.74 (4, s, CH2), 7.20-7.39 (10, m, Ph-H). ' 3C nmr 
(62.90M1 ­1z; CDC13) Oc: 41.85 (2xCH2), 127.17 (2xCH), 128.60 (4xCH), 129.22 
(4xCH), 131.80 (2xC), 166.78 (2xC). m/z (FAB) 255.10238 [(M+H) caic. for 
C 16H, 503 255.10211]. 




Di-N-butylamine (lOOml, 0.59mo1) and N,N-dimethylformamide dimethylacetal 
(1 .2eq. 0.7mol, 85g, 94ml) were guarded from moisture, and heated together for five 
days at 100°C to give a straw-coloured solution. Distillation at reduced pressure gave 
the desired product which was stored in the freezer under argon. Yield: 35.0g. (29%). 
Bp. 92-94°C lOmmHg. 'H nmr (250.13M}Iz; CDC1 3 ) OH: 0.79-0.88 (6, t, J7.2Hz, 
CH3CH2), 1.16-1.46 (8, m, EtCH 2, MeCH2), 2.46-2.55 (4, m, PrCH2), 3.23 (6, s, 
CHOCH3), 4.43 (1, s, CH). 13 nmr (62.90MHz; CDCI 3) Oc: 13.66 (2xCH 3), 20.19 
(2xCH2), 31.73 (2xCH2), 49.32 (2xCH2), 77.10 (CH). 




2'-Deoxyguanosine monohydrate (8.5g, 29.8mmol) was coevaporated three times 
with anhydrous pyridine (40ml), suspended in anhydrous pyridine (200m1), and 
cooled to 0°C. To this solution was added 4-dimethylaminopyridine (0.leq, 
3.Ommol, 370mg); and acetic anhydride (12eq, 358mmo1, 33.7m1) was added 
dropwise with stirring. After the addition was complete, the reaction vessel was 
allowed to warm to room temperature. The reaction mixture was then refluxed at 
110°C for 45mm, with stirring, which resulted in a dark red-brown solution. This 
solution was concentrated in vacuo, coevaporated with toluene, and to the resulting 
residue was added a solution of saturated NaHCO 3 until effervescence subsided. The 
resulting solid was filtered, washed with water, and recrystallised from H 20fMeOH 
(9:1) to give the product as pale pink-white crystals. Yield after 3 crops: 8.87g, 
(76%). 
Rf 0.51 (solvent A), RI 0.73 (solvent Q. Found: C,65.26; H,5.02; N,10.83%. 
Requires: C,65.73; H,5.03; N,1 1.27%. 'H nmr (200.13MHz; CDC1 3/d6-DMSO) 8H: 
1.87 (3, s, Cl-I3), 1.91 (3, s, CH3), 2.07 (3, s, amide.CH 3), 2.32-2.42 (1, m, 2'-H), 
2.67-2.81 (1, m, 2'-H), 4.07-4.24 (3, m, 5'-CH2, 4'-H), 5.16-5.19 (1, m, 3'-H), 6.02-
6.08 (1, t, 1'-H), 7.70 (1, br s,8-H), 10.96 (1, br s,2-NH, exch.), 11.99 (1, br s, 1-NH, 
exch.). 13C nmr (50.32MHz; CDC1 3/d6-DMSO) 6c: 20.22 (CH 3), 20.34 (CH3), 23.51 
(CH3), 36.41 (CH2), 63.12 (CH2), 73.85 (CH), 81.80 (CH), 83.86 (CH), 147.54 (CH), 
155.0 (C), 169.56 (2xC), 170.02 (C), 172.70 (3xC). m/z (FAB) 394.13617 [(M+H) 
calc. for C 16H20N507 394.13621]. ?max 206, 253, 259, 282nm. 
2-N, 3'-0, 5'-O-Tris-acetyl-6-N-azido-2'-deoxyguanosine [9]. 
N3 
N ::~Ao  N N"- - 1 H 
2-N, 3'-0, 5'-O-Tris-acetyl-2'-deoxyguanosine [8] (8g, 20.34mmol) was 
coevaporated three times with anhydrous dichioromethane (50m1), then dissolved in 
anhydrous dichioromethane (250m1). To this solution was added anhydrous 
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triethylamine (4eq, 81 .36mmol, 11 .3m1), 4-dimethylaminopyridine (0.1 eq, 
2.03mmol, 250mg), and mesitylene suiphonyl chloride (1 .5eq, 30.51 mmol, 6.67g) 
with stirring. After 2 hours the reaction vessel was cooled to 0°C and N-methyl 
pyrrolidine (lSeq, 305mmol, 31.7m1) was added dropwise. After 15mm, 
tetrabutylanimonium azide (2eq, 40.68mmol, 11.6g) was added. After 5 hours 
stirring, (with the exclusion of light), the reaction mixture was then washed with 
saturated aqueous NaHCO 3 , then saturated aqueous KC1, and the organic phase was 
dried over Na2SO4, filtered and concentrated in vacuo to leave a brown residue. This 
was purified by flash chromatography using methanol-dichioromethane (gradient 0-
4% v/v) to give the product as a pale brown solid. Yield 6.8g, (80%). 
Rf 0.68 (solvent A), Rf 0.17 (solvent H). Found: C,46.62; H,4.71; N,26.59%. 
Requires: C,45.93; H,4.34; N,26.79%. 'H nmr (250.13MHz; CDC1 3) 6H: 2.00 (3, s, 
CH3), 2.07 (3, s, CH3), 2.45 (3, s, amide.CH 3), 2.50-2.59 (1, m, 2'-H), 2.89-3.01 (1, 
m, 2"-H), 4.26-4.38 (3, m, 5'-CH 2, 4'-H), 5.36-5.41 (1, m, 3'-H), 6.28-6.33 (dd, 1, F-
H), 8.01 (1, s, 8-H), 8.57 (1, s, 2-NH, exch.). ' 3C nmr (62.90mhz; CDC1 3) c: 20.51 
(CH3), 20.67 (CH3), 25.02 (CH3), 36.86 (CH2), 63.41 (CH2), 74.02 (CH), 82.32 
(CH), 84.48 (CH), 120.81 (C), 141.34 (CH), 151.96 (C), 152.43 (C), 153.26 (C), 
170.05 (C), 170.25 (2xC). m/z (FAB) 419.14326 [(M+H) caic. for C 16H 19N306 




HO 	N ICN 
HO 
2-N, 3'-0, 5'-O-Tris-acetyl-6-N-azido-2'-deoxyguanosine [9] (3.0g, 7.2mmol) was 
dissolved in pyridine-methanol (320m1, 3:1, v/v), and cooled to 0°C. To this solution 
was added 2M aqueous sodium hydroxide (3eq, 30.8m1) with stirring. The reaction 
vessel was allowed to warm to room temperature over 5mm, after which time the 
reaction was quenched with Dowex resin (H form). The Dowex resin was filtered 
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off and washed with pyridine and methanol and the solution was evaporated in vacuo 
to give a light brown foam. Palladium on activated charcoal (ig) was slurried with 
ethanol (lOml) in a 500ml hydrogenation reaction vessel, and the saponified product 
dissolved in methanol (200ml), was added. The vessel was attached to the 
hydrogenation apparatus, and slowly evacuated, opened to hydrogen to a pressure of 
3 Atm, and this process was repeated two times. At the end of the third time, the 
hydrogen pressure was allowed to reach 4Atm. The reaction vessel was agitated for 4 
hours, alter which time the vessel was evacuated slowly, opened to air, and the 
reaction mix was filtered through Celite and the catalyst was washed with hot 
methanol. (Caution: the catalyst should never be allowed to dry out). The resulting 
filtrate was evaporated in vacuo to give a light brown solid. This was washed with a 
small amount of dichloromethane to leave a white powder. Yield: 1.97g, (84%). 
Rf 0.27 (solvent C), Rf 0.25 (solvent I). Found: C,46.26, H,5.38; N26.41%. Requires: 
C,46.75; H,5.23; N,27.26%. 'H nmr (200.13MHz; d6-DMSO) H: 2.20 (3, s, CH3), 
2.61-2.74 (1, m, 2'-H), 2.98-3.25 (1, m, 2"-H), 3.56-3.79 (2, m, 5'-CH2), 3.85-3.86 (1, 
m, 4'-H), 4.43 (1, br s, 3'-H), 4.96 (1, br s, 5'-OH, exch.), 5.29-5.31 (1, m, 3'-OH, 
exch.), 6.24-6.31 (1, t, 1'-H), 7.21 (2, br s, 6-NH 2), 8.22 (1, br s, 8-H). ' 3C nmr 
(90.56MHz; d6-DMSO) c: 24.68 (CH3), 39.82 (CH2), 61.91 (CH2), 70.97 (CH), 
83.50 (CH), 87.89 (CH), 116.28 (C), 138.83 (CH), 150.11 (C), 152.99 (C), 156.21 
(C), 169.78 (C). m/z (FAB) 309.13138 [(M+H) caic. for C 12H 17N604 309.13113]. 
?max 197, 224, 274nm. 
2-N-Acetyl-5'-O-4,4'-dimethoxytrityl-6-di-n-butylformamido-2-amino-2'-
deoxyadenosine 1111. 




2-N-acetyl-2-amino-2'-deoxyadenosine [10] (620mg, 2.Ommol) was coevaporated 
from (3xlOml), and suspended in anhydrous pyridine (20ml). Di-n-butylformamide 
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dimethylacetal (4eq, 8.Ommol, 1 .9m1) was added dropwise, and the reaction mixture 
was stirred for 4 hours at room temperature, then concentrated in vacuo to leave a 
foam. This was coevaporated three times with, and dissolved in anhydrous pyridine 
(20ml), with 4-dimethylaminopyridine (0.1 eq, 0.2mmol, 24mg). 4,4'-Dimethoxytrityl 
chloride (1 .2eq, 1 .44mmol, 484mg) was added portionwise, and the reaction mixture 
was left stirring for 10 hours. When complete, the reaction was quenched with 
methanol (lOmi) and concentrated in vacuo. The residue was dissolved in 
dichioromethane and washed three times with saturated aqueous KC1, the organic 
phase was dried with anhydrous Na2SO4 and concentrated in vacuo. The product was 
purified by flash-column chromatography (the column was pre-equilibrated with 
dichloromethane-triethylamine 99:1, v/v), eluting with methanol-dichloromethane 
(0.5:99.5, v/v) until all the dimethoxytrityl alcohol had passed, then with a gradient 
of methanol in dichioromethane (0.5-1.5%, v/v). The product was obtained as a solid 
white foam. Yield: 0.70g, (78%). 
Rf 0.86 (solvent A), Rf 0.53 (solvent D). Found: C,68.01; H,7.06; N,11.50%. 
Requires: C,67.27; H,6.86; N,13.08%. 'H nmr (200.13MHz; CDC1 3) 6H: 0.86-0.91 
(6, t, form.CH3), 1.25-1.40 (4, m, form.MeCH 2), 1.51-1.65 (4, m, form.EtCH2), 2.36 
(3, br s, amide.CH 3), 2.59-2.67 (2, m, 2'-CH2), 3.31-3.38 (4, m, form.PrCH2), 3.60-
3.68 (2, t, 5 1 -CH2), 3.72 (6, s, OCH3), 4.18-4.19 (1, m, 4'-H), 4.63 (1, br s, 3'-H), 
6.44-6.48 (1, m, 1'-H), 6.72-7.39 (13, m, DMTr-H), 7.94 (1, s, 8-H), 8.20 (1, br s, 2-
NH, exch.), 8.99 (1, s, form.CH). ' 3C nmr (50.32MHz; CDC13) 8c: 11.09 (CH 3), 
13.46 (CH3), 13.70 (Cl3), 19.49 (Cl2), 19.96 (Cl2), 28.98 (Cl2), 30.65 (CH2), 
40.38 (CH2), 44.98 (Cl2), 51.79 (Cl2), 54.96 (2xCH3), 63.86 (CH2), 71.86 (CH), 
83.85 (CH), 86.12 (CI, C), 112.89 (4xCH), 122.61 (C), 126.60 (CH), 127.61 
(2xCH), 127.88 (2xCH), 129.79 (4xCH), 135.53 (2xC), 139.24 (CI), 144.41 (C), 
151.72 (C), 152.10 (C), 158.20 (3xC), 158.86 (CH), 160.11 (C). m/z (FAB) 







adenosine [11] (3 80mg, 0.5 immol), was coevaporated from anhydrous 
tetrahydrofuran three times, and dissolved in anhydrous tetrahydrofuran (4m1). 
Anhydrous diisopropylethylamine (4eq, 2.04mmol, 0.34m1) was added, and the 
reaction flask was kept under argon. 2-Cyanoethyl-N,N-diisopropylchloro-
phosphoramidite' 77 (1 .2eq, 0.61 mmol, 0.1 3m1) was added dropwise, and after a few 
minutes, a white precipitate (salt) was seen to appear. After 45min the reaction was 
quenched with by the addition of ethyl acetate (argon purged), and the organic layer 
was washed with saturated aqueous KC1 before being quickly dried over anhydrous 
Na2SO4, filtered under argon, and evaporated in vacuo. The product was purified by 
flash-column chromatography (the column was pre-equilibrated with ethyl acetate-
triethylamine 99:1, v/v, then washed with ethyl acetate), eluting with ethyl acetate. 
The product was obtained as a white foam. Yield: 480mg, (99%). 
Rf 0.70 (solvent A), Rf 0.92 (solvent B) . 31 P nmr (90MHz; MeCN; (CD 3)2C0 lock) 
147.67 (s). mlz (FAB) 951.51432 [(M+H) calc. for C 51 H68N907P 951.51359]. 
2-N-Acetyl-5'-O-(4,4'-dimethoxytrityl)-6-N-dimethylformamido-2-amino-2'-
deoxyadenosine 1131. 
DMTIO-1 	 N 
HO 
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2-N-acetyl-2-amino-2'-deoxyadenosine [101 (740mg, 2.4mmol) was coevaporated 
from (3xlOml), and suspended in anhydrous pyridine (25m1). Dimethylformamide 
dimethylacetal (4eq, 9.6mmol, 0.77ml) was added dropwise, and the reaction mixture 
was stirred for 2 hours at room temperature, then concentrated in vacuo to leave a 
foam. This was coevaporated three times with, and dissolved in anhydrous pyridine 
(25m1), with 4-dimethylaminopyridine (0.leq, 0.24mmol, 30mg). 4,4'-
Dimethoxytrityl chloride (1 .2eq, 2.9mmol, 970mg) was added portionwise, and the 
reaction mixture was left stirring for 15 hours. When complete, the reaction was 
quenched with methanol (lOml) and concentrated in vacuo. The residue was 
dissolved in dichloromethane and washed three times with saturated aqueous KC1, 
the organic phase was dried with anhydrous Na2SO4 and concentrated in vacuo. The 
product was purified by flash-column chromatography (the column was pre-
equilibrated with dichioromethane-triethylamine 99:1, v/v), eluting with methanol-
dichloromethane (0.5:99.5, v/v) until all the dimethoxytrityl alcohol had passed, then 
with a gradient of methanol-dichloromethane (0.5-2.0%, v/v). The product was 
obtained as a solid white foam. Yield: 978mg, (61 %). 
RI 0.76 (solvent A), RI 0.25 (solvent D). 'H nmr (200.13MHz; CDC1 3) H: 2.33 (3, s, 
amide.CH3), 2.57-2.67 (2, m, 2'-CH2), 3.10 (3, s, form.CH 3), 3.14 (3, s, form.CH3), 
3.26-3.35 (2, m, 5'-CH2), 3.70 (6, s, OCH3), 4.21-4.22 (1, m, 4'-H), 4.65 (1, br s, 3'-
H), 6.47-6.50 (1, br t, 1'-H), 6.70-7.38 (13, m, DMTr-H), 7.94 (1, s, 8-H), 8.48 (1, br 
s, 2-NH, exch.), 8.92 (1, s, form.CH). ' 3C nmr (50.32MHz; CDCI 3) 6c: 24.70 (CH3), 
34.72 (CH3), 40.42 (CH2), 41.0 ,6 (CH3), 54.84 (2xCH3), 63.84 (CH2), 71.92 (CH), 
83.77 (CH), 85.97 (C), 86.22 (CH), 112.77 (4xCH), 122.48 (C), 126.48 (CH), 127.49 
(2xCH), 127.77 (2xCH), 129.68 (4xCH), 135.44 (2xC), 139.31 (CH), 144.29 (C), 
151.71 (C), 152.11 (C), 158.07 (3xC), 158.71 (CH), 159.55 (C). m/z (FAB) 









adenosine [14] (500mg, 0.75mmol) was coevaporated from anhydrous 
tetrahydrofuran three times, and dissolved in anhydrous tetrahydrofuran (7m1). 
Anhydrous diisopropylethylamine (4eq, 3.Ommol, 0.50m1) was added, and the 
reaction 	flask 	was 	kept 	under 	argon. 	2-Cyanoethyl-N,N- 
diisopropylchlorophosphoramidite (1 .2eq, 0.90mmol, 0.19m1) was added dropwise, 
and after a few minutes, a white precipitate (salt) was seen to appear. After 45min the 
reaction was quenched with by the addition of ethyl acetate (argon purged), and the 
organic layer was washed with saturated aqueous KC1 before being quickly dried 
over anhydrous Na2SO4, filtered under argon, and evaporated in vacuo. The product 
was purified by flash-column chromatography (the column was pre-equilibrated with 
ethyl acetate-triethylamine (99:1, v/v), then washed with ethyl acetate), eluting with 
ethyl acetate. The product was obtained as a glassy oil. Yield: 200mg, (31%). 
Rf 0.79 (solvent B), Rf 0.75 (solvent D). 865.403 15 [(M+H) calc. for C 45 1­157N907P 
865.40404]. 31 P nmr - all sample used for oligo. synthesis. 
2-N-Acetyl-5'-O-(4,4'-dimethoxytrityl)-6-N-azido-2'-deoxyguanosine [15]. 
D l NXLNJL% 
2-N, 3'-0, 5'-O-Tris-acetyl-6-N-azido-2'-deoxyguanosine [9] (380mg, 0.91mmol) 
was dissolved in pyridine-methanol (SOml, 3:1, v/v), and cooled to 0°C. To this 
solution was added 2M aqueous sodium hydroxide (3eq, 3.9m1) with stirring. The 
reaction vessel was allowed to warm to room temperature over 5mm, after which 
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time the reaction was quenched with Dowex resin (H form). The Dowex resin was 
filtered off and washed with pyridine and methanol and the solution was evaporated 
in vacuo to give a light brown foam. This was coevaporated three times with, and 
dissolved in anhydrous pyridine (1 OmI), with 4-dimethylaminopyridine (0.1 eq, 
0.1 mmol, 12mg). 4,4'-Dimethoxytrityl chloride (1 .2eq, 1.1 mmol, 332mg) was added 
portionwise, and the reaction mixture was left stirring for 10 hours. When complete, 
the reaction was quenched with methanol (lOmi) and concentrated in vacuo. The 
residue was dissolved in dichioromethane and washed three times with saturated 
aqueous KC1, the organic phase was dried with anhydrous Na 2SO4 and concentrated 
in vacuo. The product was purified by flash-column chromatography (the column 
was pre-equilibrated with dichloromethane-triethylamine 99:1, v/v), eluting with 
methanol-dichioromethane (0.5:99.5, v/v) until all the dimethoxytrityl alcohol had 
passed, then with a gradient of 0.5-4.0%, v/v methanol in dichioromethane. The 
product was obtained as a solid white foam. Yield: 446mg, (77%). 
Rf 0.72 (solvent A). 'H nmr (200.13MHz; CDC1 3) 6H: 2.46 (3, s, CH 3), 2.70-2.75 (2, 
m, 2'-CH2), 3.24-3.39 (2, m, 5'-CH2), 3.73 (3, s, OCH3), 3.80-4.05 (1, br s, 3'-OH, 
exch.), 4.17-4.18 (1, m, 4'-H), 4.60-4.63 (1, m, 3'-H), 6.39-6.46 (1, t, l'-H), 6.71-7.37 
(13, m, DMTr-H), 8.03 (1, s, 8-11), 8.20-8.60 (1, hr s, 2-NH, exch.). mlz (FAB) 
637.25241 [(M+H) caic. for C 33H33N806 637.25229]. ?max 196, 226, 236, 300nm. 
2-N-Acetyl-5'-O-(4,4'-dimethoxytrityl)-6-N-azido-2'-deoxyguanosine-3'-O-(2-






2-N-Acetyl-5 '-O-(4,4'-dimethoxytrityl)-6-N-azido-2'-deoxyguanosine [15] (320mg, 
0.5mmol), was coevaporated from anhydrous tetrahydrofuran three times, and 
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dissolved in anhydrous tetrahydrofuran (4m1). Anhydrous diisopropylethylamine 
(4eq, 2mmol, 0.34ml) was added, and the reaction flask was kept under argon. 2-
Cyanoethyl-N,N-diisopropylch1orophosphoramidite 54 (1 .2eq, 0.6mmol, 0.1 3ml) was 
added dropwise, and after a few minutes, a white precipitate (salt) was seen to 
appear. After 45min the reaction was quenched with by the addition of ethyl acetate 
(argon purged), and the organic layer was washed with saturated aqueous KC1 before 
being quickly dried over anhydrous Na 2SO4, filtered under argon, and evaporated in 
vacuo. The product was purified by flash-column chromatography (the column was 
pre-equilibrated with ethyl acetate-triethylamine 99:1, v/v, then washed with ethyl 
acetate), eluting with ethyl acetate. The product obtained consisted of a long streak of 
two spots on tic. (The N6-azide was phosphitylated in addition to the 3'-OH). 
Furthermore, attempted oligonucleotide synthesis using this monomer failed. 
Tetrabutylammonium azide 
N 	 N3 w w 
A solution of tetrabutyl ammonium hydrogen sulphate (6.8g, 0.02 mol) in water 
(10.0m]) was stirred and treated at room temperature with aqueous NaOH solution 
(5.Oml, 10% w/v), then with a solution of sodium azide (2.6g, 0.04mol) in water 
(5.Oml). The resulting cloudy mixture was stirred at room temperature for 1 Omin then 
extracted with dichloromethane (2x20m1) and the aqueous mother liquor discarded. 
The combined dichloromethane extracts were dried with anhydrous Na 2SO4 and 
concentrated in vacuo to give the crude product as a pale yellow oil. This was 
azeotroped with anhydrous benzene to give the product as a cream-coloured waxy 
solid which was stored frozen, and in the dark. Yield: 5.6g, (98%). 
'H nmr (250.13MHz; CDC1 3) H: 0.87-0.92 (12, t, CH3), 1.27-1.42 (8, m, MeCH 2), 
1.5 1-1.64 (8, m, EtCH2), 3.21-3.28 (8, m, PrCH 2). 13C nmr (62.90MHz; CDC13) 6: 
1127 (4xCH3), 19.35 (4xCH2), 23.46 (4xCH2), 58.11 (4xCH2). m/z (FAB) 




2'-Deoxyguanosine monohydrate (lOg, 35mmol) was coevaporated three times with 
anhydrous pyridine, then suspended in anhydrous pyridine (1 13m1) and anhydrous 
N,N-dimethylformamide (1 80m1). To this suspension was added acetic anhydride 
(12eq, 0.42mo1, 39.7m1). The reaction mixture was stirred with the exclusion of light 
at room temperature for 48 hours. The precipitate (salt) was filtered off, and ethanol 
(20m1) was added to the supernatant, and stirred for 1 0mm. This solution was 
concentrated in vacuo until crystallisation commenced. To this suspension was added 
diethyl ether (800m1) at 4°C to precipitate the product. The white solid was filtered 
off, and the product was recrystallised from ethanol-water (9:1, v/v) to give white 
crystals. Yield: 11.3g, (92%). 
Rf 0.20 (solvent A), Rf 0.57 (solvent C), Rf 0.59 (solvent J). Found: C,45.72; H,5.16; 
N,18.61%. C 1411 17N506.(H20) requires: C,45.51; H,5.19; N,18.97%. 'H nmr 
(250.13MHz; d6-DMSO) oH: 2.03 (3, s, CH3), 2.07 (3, s, CH3), 2.40-2.51 (1, m, 2'-
H), 2.85-2.97 (1, m, 2"-H), 4.14-4.28 (3, m, 4'-H, 5'-CH2), 5.27-5.30 (1, "d", 3'-H), 
6.10-6.16 (1, dd, P-H), 6.53 (2, s, 2-NH2, exch.), 7.92 (1, s, 8-H), 10.74 (1, s, 1-NH, 
exch.). ' 3C nmr (62.90MHz; CDC1 3) Oc: 20.73 (CH3), 20.97 (CH3), 35.64 (CH2), 
63.82 (CH2), 74.67 (CH), 81.67 (CH), 82.80 (CH), 116.94 (C), 135.42 (CH), 151.30 
(C), 153.94 (C), 156.96 (C), 170.22 (C), 170.40 (C). mlz (FAB) 352.12480 [(M+H) 
calc. for C 14H 18N506 352.12571]. ?max 197, 255nm. 
3'-0,5'-O-Bis-acetyl-6-0-mesitylene sulphonyl -2' -deoxyguanosine [181. 
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3'-0,5'-O-Bis-acetyl-2'-deoxyguanosine [17] (7.0g, 1 9.9mmol) was coevaporated 
three times with and then suspended in dichloromethane (1 60m1) with anhydrous 
triethylamine (4eq, 0.08mol, 11.1 ml) and 4-dimethylaminopyridine. Mesitylene 
suiphonyl chloride (3eq, 59.7mmol, 13.025g) was added with stirring, and the 
solution was seen to turn dark red in colour. After 1 hour the solvents were 
evaporated in vacuo, coevaporated with methanol, and a solution of methanol-diethyl 
ether (8:2, v/v) was added to the dark red residue. The resulting solid was filtered and 
washed with diethyl ether to leave a white powder. Yield: 6.21g, (58%). 
RI 0.65 (solvent A), RI 0.58 (solvent H). Found: C,52.20; H,5.48; N,13.16%. 
Requires: C, 51.58; H,5.46; N,13.08%. 'H nmr (250.13MHz; CDC13) 6F!:  2.23 (3, s, 
para-CH3), 2.43-2.52 (1, m, 2'-H), 2.66 (6, s, ortho-CH 3), 2.84-2.96 (1, m, 2"-H), 
4.26-4.40 (3, m, 5'-CH2 , 4'-H), 5.14 (2, s, 2-NH 2, exch.), 5.33-5.35 (1, m, 3'-1-1), 6.19-
6.24 (1, t, l'-H), 6.90 (2, s, Ar-H), 7.83 (1, s, 8-H). ' 3C miir (62.90MHz; CDCI3) öc: 
20.47 (CH3), 20.62 (CH3), 20.79 (CH3), 22.42 (2xCH3), 36.25 (CH2), 63.44 (CH2), 
74.18 (CH), 82.06 (CH), 84.23 (CH), 116.34 (C), 131.40 (2xCH), 131.82 (C), 139.78 
(CH), 139.97 (2xC), 143.75 (C), 154.73 (C), 155.12 (C), 158.32 (C), 170.06 (C), 
170.34 (C). m/z (FAB) 536.17871 [(M+3H) caic. for C 23 1430N508 S 536.18151]. 





3'-0,5'-O-Bisacetyl-6-0-mesitylene sulphonyl-2'-deoxyguanosine [18] (6.2g, 11.6 
mmol) was coevaporated three times with and then dissolved in dichioromethane 
(1 OOml). N-Methyl pyrrolidine (1 5eq, 1 74mmol, 18 .4m1) was added with stirring, 
and alter 20mm, tetrabutylammonium azide (2eq, 23.2mmol, 6.60g) was added. 
After 5 hours, the reaction mixture was washed with saturated aqueous NaHCO 3 
solution, then saturated aqueous KC1 solution. The organic phase was then dried with 
anhydrous Na2SO4 and evaporated in vacuo. The resulting residue was purified by 
flash-column chromatography eluting with a methanol-dichloromethane gradient 
(0.5-2.0%, v/v). The product was obtained as an off-white foam. Yield: 3.9g, (89%). 
Rf 0.58 (solvent A), Rf 0.81 (solvent C), Rf 0.37 (solvent H). Found: C,44.26; 
H,4.45; N,28.52%. Requires: C,44.68; H,4.29; N,29.78%. 'H nmr (250.13MHz; d6-
DMSO) H: 2.02(3,s, CH3), 2.09 (3, s, CH3), 2.55-2.64 (1, m, 2'-11), 3.00-3.11 (1, m, 
2"-H), 3.40 (1, s, 4'-H), 4.20-4.31 (2, m, 5'-CH2), 5.35-5.37 (1, "d", 3'-H), 6.33-6.39 
(1, dd, 1'-H), 8.37 (1, s, 8-H), 8.49 (2, s, 2-NH2, exch.). ' 3C nmr (62.90MHz; d6-
DMSO) c: 20.72 (CH3), 20.98 (CH3), 35.86 (CH2), 63.78 (CH2), 74.60 (CH), 81.97 
(CH), 83.56 (CH), 112.28 (C), 138.14 (CH), 144.05 (C), 144.63 (C), 146.16 (C), 
170.25 (C), 170.39 (C). m/z (FAB) 377.13426 [(M+H) 4 caic. for C 14H 17N805 




A O—i1 CN_ NI NMe2 
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3'-0,5'-O-Bis-acetyl-6-N-azido-2'-deoxyguanosine [19] (2.0g, 5 .3mmol) was 
coevaporated three times with anhydrous pyridine, then suspended in anhydrous 
pyridine (25m1). To this dimethylformamide dimethylacetal (Seq, 26.5mmol, 3.5m1) 
was added dropwise, and the reaction mixture was stirred for 1 hour at room 
temperature, then concentrated in vacuo, and coevaporated three times with toluene. 
The resulting residue was purified by flash-column chromatography eluting with a 
methanol-dichioromethane gradient (0.0-1.5%, v/v). The product was obtained as an 
off-white foam. Yield: 1 .56g, (68%). 
RI 0.45 (solvent A), RI 0.88 (solvent C), RI 0.15 (solvent H). 'H nmr (200.13MHz; 
CDC13) H:  2.09 (3, s, acetyl.CH 3), 2.13 (3, s, acetyl.CH 3), 2.61-2.70 (1, m, 2'-H), 
2.94-3.11 (1, m, 2"-H), 3.23 (3,s, form.CH 3), 3.30 (3, s, form.CH 3), 4.12-4.36 (3, m, 
5'-CI-12, 4'-H), 5.51-5.54 (1, m, 3'-H), 6.28-6.34 (1, dd, 1'-H), 7.94 (1, s, 8-H), 8.69 (1, 
s, form.CH). ' 3C nmr (50.32MHz; CDC1 3) 8c: 20.37 (CH3), 20.66 (CH3), 35.67 
(CH3), 36.71 (CH2), 41.47 (CH3), 63.28 (CH2), 73.62 (CH), 81.89 (CH), 84.49 (CH), 
115.83 (C), 138.88 (CH), 142.46 (C), 146.09 (C), 147.35 (C), 158.21 (CH), 170.19 
(C), 170.24 (C). m/z (FAB) 432.17482 [(M+H) caic. for C 17H22N905 432.17437]. 
2-N-Dimethylformamido-6-N-azido-2'-deoxyguanosine [211 .(Attempted depro-






3 '-O,5'-O-Bis-acetyl-2-N-dimethylformamido-6-N-azido-2'-deoxyguanosine 	[20] 
(1.lg, 2.6mmol) was dissolved in pyridine-methanol (hOrn!, 3:1, v/v), and cooled to 
0°C. To this solution was added 2M aqueous sodium hydroxide (3eq, 10.5m1) with 
stirring. The reaction vessel was allowed to warm to room temperature over 5mm, 
after which time the reaction was quenched with Dowex resin (H +  form). The Dowex 
resin was filtered off and washed with pyridine and methanol. 
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The N2-dimethylformamidine protecting group was found to be cleaved after less 
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2'-Deoxyguanosine monohydrate (6g, 21 .Ommol) was coevaporated three times with 
anhydrous pyridine, then suspended in anhydrous pyridine (21 Omi), along with 4-
dimethylaminopyridine (0.1 eq, 2.1 mmol, 250mg). 1,3 -Dichioro-tetraisopropyl-
disiloxane (1.2eq, 25.2mmol, 7.9m1) was added and the reaction mixture was stirred 
for 15 hours at room temperature, until the reaction reached completion (by tic). 
Dimethylformamide dimethylacetal (Seq, 105.Ommol, 14.Oml) was added dropwise 
with stirring, and after 2 hours at room temperature, H 20 (20m1) was added to the 
cloudy-yellow reaction mixture. The solvents were removed in vacuo, and the 
residue was covaporated with toluene. The residue was then dissolved in 
dichloromethane and washed three times with saturated aqueous KC1, the organic 
phase was dried with anhydrous Na2SO4 and concentrated in vacuo. The product was 
purified by flash-column chromatography (the column was pre-equilibrated with 
dichioromethane-triethylamine 99:1, v/v),eluting with a gradient of (0.0-2.0%, v/v) 
methanol in dichloromethane. The product was obtained as an off-white solid foam. 
Yield: 10.1g, (85%). 
Rf 0.68 (solvent A), RI 0.12 (solvent H). Found: C,51.71; H,8.61; N,13.52%. 
Requires: C,51.52; H,7.96; N,14.43%. 'H nmr (250.13MHz; CDC1 3) oH: 0.91-1.08 
(28, m, TIPS-CH3 , TIPS-CH), 2.46-2.54 (2, m, 2'-CH2), 3.02 (3, s, form.CH3), 3.11 
(3, s, fonn.CH3), 3.76-3.82 (1, m, 4'-H), 3.94-3.98 (2, m, 5'-CH2), 4.57-4.66 (1, dd, 
3'-H), 6.15-6.19 (1, m, 1'-H), 7.75 (1, s, 8-H), 8.49 (1, s, form.CH). ' 3C nmr 
149 
(62.90MHz; CDC13) 86  12.19 (CH), 12.65 (CH), 12.81 (CH), 13.11 (CH), 16.60 
(8xCH3), 34.92 (CH3), 41.08 (CH2), 41.17 (CH3), 61.49 (CH2), 69.60 (CH), 81.58 
(CH), 84.74 (CH), 119.98 (C), 135.28 (CH), 149.45 (C), 156.75 (C), 157.85 (CH'), 
158.32 (C). mlz (FAB) 565.30326 [(M+H) caic. for C 25H45N605 Si2 565.29900]. 





3 ',5'-O-( 1,1,3 ,3-Tetraisopropyl- 1 ,3-disiloxanediyl)-2-N-dimethylformamido-2'-
deoxyguanosine [22] (5.0g. 8.85mmol) was coevaporated three times with anhydrous 
pyridine, then suspended in anhydrous pyridine (90m1) along with 4-
dimethylaminopyridine (0.leq, 0.89mmol, 110mg) and anhydrous triethylamine 
(4eq, 35.4mmol, 4.9m1). To this was added mesitylene suiphonyl chloride (4eq, 
35.4mmol, 7.7g) and left for 3 hours, stirring at room temperature. (The reaction 
mixture went briefly purple, then turned dark red in colour). N-Methyl pyrrolidine 
(30eq, 266mmol, 28.1ml) and tetrabutylammonium a.zide (4eq, 35.4mmol, 10.1g) 
were then added portionwise, and the reaction mixture was stirred for 20 hours at 
room temperature with the exclusion of light. The dark-brown reaction mixture was 
then filtered to remove any precipitate, and the filtrate was evaporated in vacuo to 
remove the solvents. The resulting residue was washed with saturated aqueous 
NaHCO3 solution, then saturated aqueous KC1 solution, and the organic phase was 
then dried with anhydrous Na2SO4 and evaporated in vacuo. The residue was 
coevaporated with toluene, then ethanol (three times), and treated with ethanol 
(50m1) and left for 15 hours at 0°C. The resulting solid was filtered, washed with 
ethanol, and recrystallised from ethanol, to leave white crystals. Yield: 3.1g, (60%). 
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Rf 0.79 (solvent A). Rf 0.40 (solvent H). Found: C,50.48; H,7.69; N,21.21%. 
Requires: C,50.91; H,7.35; N,21.39%. 'H nmr (250.13MHz; CDC1 3) H: 0.89-1.07 
(28, m, TIPS-CH 3, TIPS-CH), 2.52-2.67 (2, m, 2'-CH 2), 3.20 (3, s, form.CH3), 3.27 
(3, s, form.CII3), 3.79-3.84 (1, m, 4'-H), 3.97-3.98 (2, d, 5'-CH2), 4.58-4.67 (1, m, 3'-
H), 6.22-6.26 (1, m, l'-II), 8.01 (1, s, 8-11). 13C nmr (62.90MHz; CDC1 3) 66 12.23 
(CH), 12.66 (CH), 12.80 (CH), 13.13 (CH), 16.62-17.23 (8xCH 3), 35.58 (CH3), 
40.10 (CH2), 41.63 (CH3), 6 1. 10 (CH2), 69.05 (CH), 82.41 (CH), 84.88 (CH), 115.52 
(C), 137.45 (CH), 142.21 (C), 146.19 (C), 147.21 (C), 158.00 (CH). mlz (FAB) 
590.30338 [(M+H) calc. for C 25HN9O4Si2 590.30548]. Amax 198, 206, 287nm. 
3',5'-O-(1 ,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2-N-dimethylformamido-6-
amino-2'-deoxyguanosine [241. (Attempted hydrogenation of N 6-azide). 
3' , 5 '-0-(1, 1,3,3 -Tetraisopropyl- 1,3 -disiloxanediyl)-2-N-dimethylformamido-6-N-
azido-2'-deoxyguanosine 1231 was dissolved in an appropriate solvent and subjected 
to a variety of hydrogenation conditions and reagents in order to reduce the azide, 
without a reaction occurring at the N 2-dimethylformamido protecting group. 
These conditions are outlined in Section 5.6. 






2'-Deoxyguanosine monohydrate (4.5g, 15.8nmiol) was coevaporated three times 
with anhydrous pyridine, then suspended in anhydrous pyridine (160m1), along with 
4-dimethylaminopyridine (0.1 eq, 1 .58mmol, 193mg). 1 ,3-Dichloro-tetraisopropyldi-
siloxane (1 .3eq, 20.5mmol, 6.5m1) was added and the reaction mixture was stirred for 
12 hours at room temperature. Methanol (20ml) was added, and the solvents were 
evaporated in vacuo. The resulting residue was coevaporated with toluene, then 
methanol, and treated with H 20-methanol (50:50, v/v) to give a white precipitate. 
This was filtered, and washed with methanol to leave a white powder. Yield: 7.16g, 
(89%). 
RI 0.28 (solvent A), RI 0.57 (solvent C). Found: C,51.58; H,8.01; N,15.43%. 
Requires: C,51.84; H,7.72; N,15.70%. 'H nmr (360.14MHz; d6-DMSO) 6H: 0.74-
0.90 (28, m, TIPS-CH3, TIPS-CH), 2.45-2.50 (1, m, T-CH), 2.58-2.60 (1, m, 2"-CH), 
3.91-3.92 (2, m, 5'-CH 2), 4.65-4.67 (1, dd, 4'-H), 5.61-5.62 (1, m, 3'-H), 6.04-6.07 (1, 
M, 1'-H), 6.43 (2, br s, 2-NH2, exch.), 7.75 (1, s, 8-H), 10.68 (1, s, 1-NH, exch.). 13C 
nmr (62.90MHz; d6-DMSO) c: 12.19 (CH), 12.39 (CH), 12.72 (CH), 12.88 (CH), 
13.07-17.41 (8xCH 3), 39.09 (CH2), 62.47 (CH2), 71.16 (CH), 81.13 (CH), 84.69 
(CH), 116.90 (C), 134.70 (CH), 150.77 (C), 153.92 (C), 156.82 (C). mlz (FAB) 
510.25718 [(M+H) caic. for C 22H40N505 Si2 510.25680]. ?max 198, 256nm. 
3',5'-O-(1,1 ,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2-N-trifluoroacetyl-6-N-
azido- 2'-deoxyguanosine [26]. 
N3 
N N 
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3',5'-O-( 1,1,3,3 -Tetraisopropyl- 1,3 -disiloxanediyl)-2'-deoxyguanosine [25] (3.5 g, 
6.87 mmol) was coevaporated three times with anhydrous pyridine, then suspended 
in anhydrous pyridine (70m1). The reaction flask was then cooled to 0°C, and 
trifluoroacetic anhydride (Seq, 33.5mmol, 4.8m1) was added with stirring to give a 
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yellow solution. After 20mm at room temperature, sodium azide (5eq, 33.5mmol, 
2.23g) was added portionwise to give a purple solution, and the reaction mixture was 
stirred at room temperature, with the exclusion of light, for another 5 hours. The 
remaining sodium azide was filtered, and the volume of the filtrate was reduced to 
Ca. 20m1. Saturated aqueous Na}{CO 3 solution (150ml) was added, and the mixture 
was extracted with dichloromethane (3x250m1). The organic phase was dried with 
anhydrous Na2SO4 and concentrated in vacuo. The product was purified by flash-
column chromatography (the column was pre-equilibrated with dichloromethane-
triethylamine 99:1, v/v), eluting with a gradient of (0.0-1.5%, v/v) methanol in 
dichioromethane. The product was obtained as a purple foam. Yield: 2.87g, (66%). 
Rf 0.37 (solvent A), Rf 0.72 (solvent Q. 'H nmr (250.13MHz; CDC1 3) 6H: 0.89-0.99 
(28, m, TIPS-CH3 , TIPS-CH), 2.05-2.06 (2, m, 2'-CH2), 3.77-3.80 (1, m, 4'-H), 3.97 
(2, m, 5'-CH2), 4.60-4.67 (1, dd, 3'-H), 6.35-6.39 (1, m, 1'-H), 8.10 (2, m, 2-NH, 
exch.; 8-H). ' 3C nmr (62.90MHz; CDCI 3) 56  12.14 (CH), 12.52 (CH), 12.70 (CH), 
13.01 (CH), 16.52-17.14 (8xCH3), 40.19 (CH2), 61.00 (CH2), 68.84 (CH), 82.93 
(CH), 84.90 (CH), 110.84-124.54 (quartet, J=287.6Hz, CF 3), 115.19 (C), 138.01 
(CH), 142.87 (C), 145.81 (C), 146.76 (C), 159.66-161.29 (quartet, J=34.lHz, 
OCF3). mlz (FAB) 63 1.24823 [(M+H) calc. for C 24H38N805 Si2F3 63 1.24558]. 
?.max 201, 31Onm. 
3',5'-O-(1,1 ,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2-N-trifluoroacetyl-6-amino-
2'-deoxyguanosine [27]. (Attempted hydrogenation of N6-azide). 
NH 
N 
SiO\ N CF3 
_?~ 
io 
3 ',5'-O-( 1,1,3 ,3-Tetraisopropyl- 1,3 -disiloxanediyl)-2-N-trifluoroacetyl-6-N-azido-2'-
deoxyguanosine [26] was dissolved in an appropriate solvent and subjected to a 
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variety of hydrogenation conditions and reagents in order to reduce the azide, without 
a reaction occurring at the N 2-trifluoroacetyl protecting group. 
These conditions are outlined in Section 5.6. 
2-Amino-2'-deoxyadenosine 1281. 
NH N :] _ 
HON N'NH2 
HO 
2'-Deoxyguanosine monohydrate (3.5g. 12.3mmol) was coevaporated three times 
with anhydrous pyridine, then suspended in anhydrous pyridine (120m1). The 
reaction flask was then cooled to 0°C, and trifluoroacetic anhydride (8eq, 98.4mmol, 
13.8m1) was added dropwise with stirring; and left at room temperature after addition 
was complete (reaction mixture turned from dark yellow to red). After 30mm, 
sodium azide (5eq, 61.5mmol, 2.8g) was added, and left for 1 hour at room 
temperature, with the exclusion of light, to leave a brown-coloured solution. The 
remaining sodium azide was filtered, and the volume of the filtrate was reduced to 
Ca. 40ml. Saturated aqueous NaHCO 3 solution (250m1) was added, and the mixture 
was extracted with dichioromethane (3x400m1). The organic phase was dried with 
anhydrous Na2SO4 and concentrated in vacuo. After coevaporation with ethanol, the 
residue was dissolved in ethanol (120ml), and Raney nickel (7ml) was added 
portionwise with stirring (this reaction is exothermic), and then gently refluxed at Ca. 
60°C for 2 hours with stirring. The Raney nickel was filtered off using Celite 
filtering agent, washed with hot ethanol (200ml) (caution: Raney nickel should never 
be allowed to dry), and the ethanol was removed in vacuo. Diethyl ether (lOOml) was 
added to the residue, and the mixture was left at 0°C for 10 hours (a little petrolium 
ether [40-60] was added to encourage crystallisation). The resulting white 
crystals/precipitate were filtered and washed with diethyl ether. Yield: 2.64g, (81%). 
Rf 0.10 (solvent A), Rf 0.34 (solvent C), Rf 0.67 (solvent I). Found: C,42.71; H,5.65; 
N,30.55%. C 10H 14N603 .(3/4H20) requires: C,42.92; H,5.59; N,30.05%. 'H nmr 
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(250.13MHz; d6-DMSO) H: 2.15-2.22 (1, m, 2'-H), 2.49-2.65 (1, m, 2"-H), 3.53-
3.62 (2, m, 5'-CH2), 3.85 (1, m, 4'-H), 4.36-4.37 (1, m, 3'-H), 5.36-5.37 (2, br "d", 5'-
OH exch., 3'-OH exch.), 5.86 (2, br s, 2-NH2, exch.), 6.15-6.20 (1, dd, 1'-H), 6.88 (2, 
br s, 6-NH2, exch.), 7.93 (1, s, 8-H). 13Cnmr (62.90MHz; d6-DMSO) 6c: 39.6 (CH 2), 
62.21 (CH2), 71.27 (CH), 83.41 (CH), 87.91 (CH), 113.62 (C), 136.16 (CH), 151.39 
(C), 156.40 (C), 160.27 (C). m/z (FAB) 267.12124 [(M+FI) calc.for C 10H, 5N603 
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2-Amino-2'-deoxyadenosine [28] (2.46g, 8.65mmol) was coevaporated three times 
with anhydrous pyridine, then suspended in anhydrous pyridine (90m1). Di-n-
butylformamide dimethyl acetal (Seq, 43.25mmol, 10.5m1) was added dropwise with 
stirring over 30mm. After 3 hours the reaction was quenched by the addition of water 
(20m1), and stirred for another 1 0mm. The solvents were then evaporated in vacuo, 
coevaporated with toluene, and the product was purified by flash-column 
chromatography, eluting with a gradient of (0.0-3.0%, v/v) methanol in 
dichloromethane. The product was obtained as a light yellow foam. Yield: 1.89g, 
(54%). 
Rf 0.67 (solvent C), Rf 0.37 (solvent I). 'H nmr (250.13MHz; d6-DMSO) H: 0.84-
0.93 (6, m, C113), 1.20-1.37 (4, m, MeCH2), 1.51-1.59 (4, m, EtCH2), 2.16-2.23 (1, 
m, 2'-H), 2.54-2.65 (1, m, 2'-H), 3.31-3.63 (6, m, 5'-CH2 , PrCH2), 3.85 (1, d, 4'-H), 
4.37 (1, br s, 3'-H), 5.19 (1, br s, 5'-OH, exch.), 5.33 (1, br s, 3'-OH, exch.), 6.00 (2, 
br s, 2-NH2, exch.), 6.20-6.26 (1, t, 1'-H), 8.04 (1, s, 8-H), 8.81 (1, s, form.CH). 13C 
nmr (62.90MHz; d6-DMSO) c: 13.69 (CH 3), 13.89 (CH3), 19.31 (CH2), 19.79 
(CH2), 28.81 (CH2), 30.69 (CH2), 39.58 (CH2), 44.36 (Cl-I2), 51.00 (CH2), 62.02 
(CH2), 71.07 (CH), 83.03 (CH), 87.75 (CH), 119.48 (C), 137.55 (CH), 153.23 (C), 
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157.84 (C), 160.02 (CH), 160.09 (C). mlz (FAB) 406.25880 [(M+H) caic. for 
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2-Amino-6-N-di-n-butylformamido-2'-deoxyadenosine [291 (1.23g, 3 .O3mmol) was 
coevaporated three times with anhydrous pyridine, then suspended in anhydrous 
pyridine (30m1). Dimethylformamide dimethyl acetal (lOeq, 30.3mmol, 4.Oml) was 
added dropwise and the reaction flask was heated to 50°C with stirring. After 12 
hours the reaction was quenched by the addition of water (1 Omi), and stirred for 
another 10mm. The solvents were then evaporated in vacuo, coevaporated with 
toluene, and the product was purified by flash-column chromatography, eluting with 
a gradient of (0.0-5.0%, v/v) methanol in dichloromethane. The product was obtained 
as a light yellow foam. Yield: 0.86g, (62%). 
RI 0.30 (solvent A), Rf 0.56 (solvent C), Rf 0.57 (solvent I). Found: C,54.82; H,8.62; 
N,22.25%, C22H36N803 .(H20) requires: C,55.20; H,8.01; N,23.42%. 'H nmr 
(250.13MHz; d6-DMSO) H: 0.83-0.93 (6, m, butylform.CH 3), 1.20-1.38 (4, m, 
MCCH2), 1.50-1.64 (4, m, EtCH 2), 2.20-2.29 (1, m, 2'-H), 2.63-2.74 (1, m, 2'-H), 
3.00 (3, s, dmf.CH 3), 3.11 (3, s, dmf.CH 3), 3.38-3.66 (6, m, PrCH 2, 5'-CH2), 3.87-
3.91 (1, dd, 4'-H), 4.41-4.43 (1, m, 3'-H), 5.42 (2, br d, 5'-OH exch.,3'-OH exch.), 
6.31-6.37 (1, dd, 1'-H), 8.24 (1, s, 8-H), 8.63 (1, s, dmf.CH), 8.93 (1, s, 
butylform.CH). 13C nmr (62.90MHz; d6-DMSO) c: 13.66 (CH3), 13.88 (CH3), 
19.25 (CH2), 19.78 (CH2), 28.81 (CH2), 30.58 (CH2), 34.59 (CH 3), 39.60 (CH2), 
40.49 (CH3), 44.38 (CH2), 50.93 (CH2), 62.06 (CH2), 71.13 (CH), 83.56 (CH), 88.00 
(CH), 122.22 (C), 139.74 (CH), 152.83 (C), 157.66 (CH), 158.10 (CH), 159.39 (C), 
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2-N-Dimethylformamido-6-N-di-n-butylformamido-2'-deoxyadenosine [301 (840mg, 
1 .8mmol) was coevaporated three times with, and dissolved in anhydrous pyridine 
(18m1), with 4-dimethylaminopyridine (0.leq, 0.18mmol, 22.5mg). 4,4'-
Dimethoxytrityl chloride (1.2eq, 2.16mmol, 740mg) was added portionwise, and the 
reaction mixture was left stirring for 5 hours. When complete, the reaction was 
quenched with methanol (10m!) and concentrated in vacuo. The residue was 
dissolved in dichioromethane and washed three times with saturated aqueous KC1, 
the organic phase was dried with anhydrous Na2SO4 and concentrated in vacuo. The 
product was purified by flash-column chromatography (the column was pre-
equilibrated with dichioromethane-triethylamine 99:1, v/v), eluting with methanol-
dichioromethane (0.5:99.5, v/v) until all the dimethoxytrityl alcohol had passed, then 
with a gradient of methanol-dichioromethane (0.5-5.0%, v/v). The product was 
obtained as a solid white foam. Yield: 905mg, (66%). 
Rf 0.85 (solvent A), Rf 0.28 (solvent H). Found: C,65.60; H,6.98; N,13.48%. 
C43H54N805 .(H20) requires: C,66.12; H,7.23; H,14.35%. 'H nmr (250.13MHz; 
CDC13) H: 0.87-0.95 (6, m, butylform.CH3), 1.24-1.40 (4, m, MeCH2), 1.55-1.64 (4, 
m, EtCH2), 1.90-2.10 (2, m, 2'-CH 2), 3.06 (3, s, dmf.CH 3), 3.14 (3, s, dmf.CH3), 
3.30-3.35 (2, t, 5'-CH2), 3.63-3.74 (10, m, PrCH 2, OCH3), 4.03 (1, m, 4'-H), 4.37-
4.39 (1, m, 3'-H), 6.61-6.68 (1, dd, 1'-H), 6.70-7.41 (13, m, DMTr-H), 7.81 (1, s, 8-
H), 8.69 (1, s, dmf.CH), 9.00 (1, s, butylform.CH). ' 3C nmr (62.90MHz; CDC1 3) öc: 
13.49 (CH3), 13.72 (CH3), 19.54 (CH2), 19.98 (CH2), 28.96 (CH2), 30.76 (CH2), 
34.80 (CH3), 40.65 (CH3), 44.57 (CH), 45.88 (CH 2), 51.34 (CH2), 54.91 (2xCH3), 
63.75 (CH2), 74.88 (CH), 82.96 (CH), 84.97 (CH), 86.0 1(CH), 112.85 (4xCH), 
122.24 (C), 126.49 (CH), 127.56 (2xCH), 127.84 (2xCH), 129.70 (4xCH), 135.46 
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(C), 135.54 (C), 136.04 (CH), 144.40 (C), 153.09 (C), 157.93 (CH), 158.12 (2xC), 
158.26 (CH), 160.03 (C), 162.48 (C). mlz (FAB) 763.42934 [(M+1-I) caic. for 





deoxyadenosine [311 (5 10mg, 0.67mmol) was coevaporated from anhydrous 
tetrahydrofuran three times, and suspended in anhydrous tetrahydrofuran (7m1). 
Anhydrous diisopropylethylamine (4eq, 2.7mmol, 0.47m1) was added, and the 
reaction flask was kept under argon. 2-Cyanoethyl-N,N-diisopropylchloro-
phosphoramidite (1.2eq, 0.80mmol, 0.18m1) was added dropwise, and after a few 
minutes, a white precipitate (salt) was seen to appear. After 2 hours the reaction was 
quenched with by the addition of ethyl acetate (argon purged), and the organic layer 
was washed with saturated aqueous KC1 before being quickly dried over anhydrous 
Na2SO4, filtered under argon, and evaporated in vacuo. The product was purified by 
flash-column chromatography (the column was pre-equilibrated with ethyl acetate-
triethylamine (99:1, v/v), then washed with ethyl acetate), eluting with ethyl acetate. 
The product was obtained as a glassy oil. Yield: 470mg, (73%). 
Rf 0.84 (solvent B), Rf 0.37/0.42 (solvent F), Rf 0.29 (solvent H) . 31 P nmr (80MHz; 
MeCN; (CD 3 )2C0 lock) 6: 147.94 (s). mlz (FAB) 964.54302 [(M+II) calc. for 








deoxyadenosine. [31] (240mg, 0.32mmol) was coevaporated three times with, and 
dissolved in anhydrous pyridine (3m!), with 4-dimethylaminopyridine (0. leq, 
0.03mmol, 39mg). Succinic anhydride (1.2eq, 0.38mmol, 38mg) was added 
portionwise with stirring, and the reaction mixture was left for 18 hours at room 
temperature. When complete, the reaction was quenched with methanol (lOmi) and 
concentrated in vacuo. The residue was dissolved in dichioromethane and quickly 
washed three times with aqueous citric acid solution (10%, w/v), then with water, the 
organic phase was dried with anhydrous Na 2SO4 and concentrated in vacuo. The 
product was purified by flash-column chromatography (the column was pre-
equilibrated with dichioromethane-triethylamine 99:1, v/v), eluting with methanol-
dichloromethane (0.0-3.0%, v/v; with 1% triethylamine) The product was obtained as 
a yellow-white foam. Yield: 2 10mg, (77%). 
Rf 0.28 (solvent A), Rf 0.59 (solvent Q. 'H nmr (250.13MHz; CDC1 3) oH: 0.83-0.95 
(6, m, butylform.CH 3), 1.31-1.38 (4, m, MeCH2), 1.55-1.75 (4, m, EtCH2), 2.54 (3, s, 
dmf.CH 3)?, 2.57 (3, s, dmf.CH 3)?, 2.80-2.90 (2, m, 2'-CH2), 3.17-3.20 (2, m, 5'-CH2), 
3.30-3.40(4, m, PrCH2)?, 3.45-3.70 (4, m, succ.CH2)?, 3.73 (6, s, OCH3), 4.25 (1, m, 
4'-H), 5.46 (1, m, 3'-H), 6.34 (1, dd, 1'-H), 6.72-7.36 (13, m, DMTr-H), 7.91 (1, s, 8-
H), 8.25 (1, br s, acidic.OH), 8.98 (1, s, dmf.CH), 9.44 (1, s, butylform.CH). ' 3C nmr 
(62.90MHz; CDC13) Oc: 13.47 (CH3), 13.72 (CH3), 19.49 (CH2), 19.97 (CH2), 29.00 
(CH2), 30.65 (CH2), 37.57 (CH), 44.85 (CH2), 44.98 (CH2), 51.76 (CH2), 52.54 
(CH2), 54.98 (2xCH3), 63.61 (CH2), 74.90 (CH), 83.70 (CH), 83.84 (CH), 86.29 (C), 
112.96 (4xCH), 123.22 (C), 126.69 (CH), 127.67 (2xCH), 127.86 (2xCH), 129.79 
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(4xCH), 135.31 (C), 135.33 (C), 138.81 (CH), 144.25 (C), 151.80 (C), 158.26 (2xC), 
158.97 (CH), 160.34 (C), 163.23 (CH), 172.69 (C), 177.06 (C). Xmax 202, 259nm. 
Derivatisation of Long-Chain Alkyl Amino Controlled Pore Glass (CPG) solid 





Activation of the CPG. 
CPG (0.5g, 150p.molg' loading) was dried in vacuo overnight over P 205 and washed 
with a solution of anhydrous N,N-diisopropylethylamine in N,N-dimethylformamide 
(4x5m1; 10% v/v), followed by N,N-dimethylformamide (5x5m1). 
Coupling the succinate onto the CPG. 
2-N-Dimethylformamido-5'-O-(4,4'-dimethoxytrityl)-6-N-di-n-butylformamido-3'-
succinyl-2'-deoxyadenosine [33] (leq, 0.2mmol, 170mg) was coevaporated three 
times with, and dissolved in anhydrous dichloromethane (lml). To this was added a 
solution of 4-nitrophenol (1 .2eq, 2.4mmol, 3 3mg) in anhydrous pyridine (0.1ml) 
followed by a solution of N,N'-dicyclohexylcarbodiimide in dichioromethane (2.5eq, 
0.5mmol; 103mg, 50% w/v). After a few minutes, dicyclohexylurea was seen to 
precipitate, and after the reaction had gone to completion (ca.4 hours) the 
dicyclohexylurea was removed by filtration. The filtrate was concentrated in vacuo, 
suspended in N,N-dimethylformamide (imi), and activated CPG (ca.0.leq, 150mg) 
was added to the suspension. The mixture was kept under argon and gently agitated 
for 9 hours, by which time the loading of the resin was 36.2moI/g (see below for 
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testing of CPG loading). The CPG was filtered off, and washed with anhydrous: 
N,N-dimethylformamide (5x5m1), THF (5x5m1) and diethyl ether (5x5m1). 
Capping the CPG. 
The functionalised resin was suspended in a solution of acetic anhydride-pyridine 
(4m1, 10% v/v) and gently agitated for 1 hour. The CPG was filtered off, washed 
successively with anhydrous: pyridine (5x5m1), THF (5x5m1), and diethyl ether 
(5x5m1); then dried in vacuo overnight over P 205 . 
Calculation of the loading of the CPG. 
A sample of the washed and dried resin (4-5mg) was weighed accurately, and placed 
in a 25ml volumetric flask. This was made up to the mark with a solution of 
trichloroacetic acid in anhydrous dichloromethane (3%, w/v). After 5min the 
absorbance of the solution at 504nm was measured to determine the concentration of 
dimethoxytrityl cations in solution and hence the loading of the resin. The final 
loading of CPG [34] was 35.Oj.tmolg'. [The value of 004=76m1cm'p.mol' for the 









5.4 OLIGONUCLEOTIDE SYNTHESIS 
Oligonucleotide syntheses were performed on an Applied Biosystems 394 DNA 
synthesiser. All DNA synthesis reagents and cyanoethyl-phosphoramidite monomers 
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were purchased from ABI. Monomers were prepared as 0.1M solutions using 
anhydrous acetonitrile. 
Coupling Efficiencies 
Coupling efficiencies of phosphorainidites were measured either manually (by 
comparison of the absorbance at 498nm of the dimethoxytrityl cations produced in 
the detritylation steps of successive synthesis cycles after dilution to 25m1 with 0.1 M 
toluene-4-sulphonic acid in acetonitrile); or in the case of the ABI Model 394, trityl 
monitoring was carried out on-line using the built-in conductivity detector. 171 
Oligonucleotide Deprotection 
After cleavage from the synthesis column, unmodified oligonucleotides were 
typically deprotected for 12 hours at 55°C and for 5 hours at 65°C. Oligonucleotides 
containing diaminopurine required longer deprotection times depending on the 
protecting groups employed, and on how many diaminopurine residues were present. 
Purification of Oligonucleotides 
Reversed-Phase HPLC analysis and purification were carried out on a Gilson 
model 306 HPLC system using ABI Brownlee Aquapore Octyl preparative-scale 
reverse phase columns. Following HPLC purification, oligonucleotides >12 bases 
long were passed through pre-equilibrated NAP-10 columns (Pharmacia, Sephadex 
G25) to desalt and remove small molecules. Shorter oligonucleotides were passed 
through a Sephadex G-10 column (16mm x 500mm). The pure, desalted 
oligonucleotides were then lyophilised to leave a white fluffy solid. 
Buffer A: 0.1M NH40Ac; Buffer B: 0.1M NH 40Ac/25% acetonitrile. 
Gradient 1 .Purification. 
Time/mm 	Flow/mlmin' 	%Buffer B 
0 	 3 	 0 
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3 3 0 
4 3 15 
16 3 75 
17 3 100 
19 3 100 
21 3 0 
22 3 0 
Gradient 2.Analvsis. 
Time/mm Flow/mimin' %Buffer B 
0 3 0 
3 0 
4 3 15 
24 3 70 
25 3 100 
27 3 100 
28 3 0 
30 3 0 
Oligonucleotide Storage 
Following desalting, oligonucleotides were stored at -20 °C as frozen solutions or 
lyophilised solids. 
Capillary Electrophoresis 
The purity of HPLC-purified oligonucleotides was checked by Capillary Zone 
Electrophoresis (CE) on an Applied Biosystems Model 270A Capillary 
Electrophoresis system with a Microgel capillary, using 75mM tris phosphate buffer 
at pH 7.6 with 10% methanol. 
163 
Enzyme digests 
The oligonucleotide to be digested (2 OD) was dissolved in 50 mM Tris buffer 
(0.3m1; 1M NaCl, pH=8.8). Phosphodiesterase I [type VII from Crotalus Atrox 
venom] (5j.il=0.05units), and alkaline phosphatase [type VII from bovine intestinal 
mucosa] (l.tl=0.15) were added. The digests were incubated for 10 hours at 37°C, 
and analysed by HPLC at 260nm using Gradient 1 with 20% MeCN in buffer B. 
Extinction coefficient for dD at 260nm 
2,6-Diaminopurine 1281 (approx. 0.26mg, 0.01mmol) was accurately weighed out 
and dissolved in distilled water (25m1) and the UV spectrum recorded over the range 
320-190nm (see Section 5.2). The absorbance at 260nm was used to calculate the 
extinction coefficient. The value was obtained in triplicate to give an average value 
Of CdD=  7.4x 10 
3  crn2gmol-1. 
Oligonucleotides synthesised for deprotection and coupling efficiency tests 
Oligonucleotides DAP(1) and DAP(2) were each synthesised on a 0.2.tmo1 scale 
for the following monomers: [7], [12], [14], [16], [321, and [35]. 
DAP(1) TVFTTDU 
DAP(2) TDD TDT I 
This was carried out to determine coupling efficiency of the given monomer, check 
the suitability of the monomer in oligonucleotide synthesis, and to monitor 
deprotection times of the particular N 2-protection. 
5.5 ULTRAVIOLET MELTING STUDIES 
For the determination of concentration-dependent thermodynamic parameters, the 
melting temperatures of the duplexes were measured in triplicate at 260nm for 5 
points over a 10-fold concentration range on a Perkin Elmer Lambda 15 ultraviolet 
spectrometer equipped with a Pettier Block and controlled by an IBM PS2 
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microcomputer. A heating rate of 0.9°C per minute was used throughout, with data 
collection at 10 second intervals and the crude data was collected and processed 
using a PECSS-2 software package. The absorbance versus time curves were stored 
and converted to absorbance versus temperature curves (degrees K). The T. value for 
each curve was obtained from the first derivative of the absorbance versus 
temperature curve 
The oligonucleotides were dissolved in aqueous buffer {sodium chloride (1 .OM), 
sodium dihydrogen orthophosphate (10mM), EDTA (1mM), and sodium cacodylate 
(10mM) which was adjusted to pH 7.0 by the addition of sodium hydroxide}. 
Oligonucleotides were heated to 80°C until the absorbance had stabilised to melt the 
duplexes, then allowed to anneal slowly to approx. 10°C. 
Extinction coefficients of oligonucleotides 
The extinction coefficient for each oligonucleotide was calculated using the 
following values at 260nm: 
T= 8.8; C= 7.3; G= 11.7; A= 	 173 and D= 7.4x103cm2j.mo1 1 . To allow for 
suppression of absorbance due to single strand base stacking etc., the sum of c values 
for each oligonucleotide were multiplied by 0.8 (hypochromicity factor, F). This 
value was determined from an average of F values, taken from measurements of the 
absorbance before, and after, an enzyme digest of the sample oligonucleotide was 
carried out. 
(FA[s ingIe strands]/'A[nuc leos ides]). 
Oligonucleotides synthesised for UV melting 
The following oligonucleotides were synthesised at 1 .0.tmol scale: 
DAP(3) TDT DTD TD 
DAP(4) TAT ATA TA 
DAP(5) CGT ADC UT and complement: DAP(16) ACG TTA CU 
DAP(6) CGT CDC GT 	 DAP(17) ACU TGA CU 
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DAP(7) CGT DDC GT DAP(16) ACG TTA CG 
DAP(8) COT GDC GT DAP(18) ACG TCA CG 
DAP(9) COT TDC GT DAP(19) ACG TAA CO 
DAP(10) CGT DAC GT DAP(16) ACG TTA CG 
DAP(11) CGT DGC GT DAP(20) ACG CTA CG 
DAP(12) COT DTC GT DAP(21) ACG ATA CG 
DAP(13) DCG TFA CG DAP(15) CGT AAC GT 
DAP(14) DCD CDC DC DAP(22) GTG TGT GT 
DAP(15) CGT AAC GT DAP(16) ACG TTA CG 
Testing dD CPG 
The following oligonucleotides were synthesised using CPG [341, at 0.2p.mol 
scale: 
DAP(23) GCA ITO AD 
DAP(24) ATG CAA CCG AGD 
along with the native sequences: 
DAP(25) GCA TTG AA 
DAP(26) ATG CAA CCG AGA 
The sequences were then compared on reverse phase HPLC (Gradient 2), and CE, 
(see Section 5.4). 
5.6 HYDROGENATION CONDITIONS 
Hydrogenation of nucleosides [23] and [26] to give [24] and [271 respectively, 
was unsuccessful employing catalytic hydrogenation with Pd on activated charcoal at 
4atm H2. The problem was due to reaction at the N 2-protection--dmf and tfa, for [23] 
and [26], respectively.' 78 
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In order to try to prevent reaction at the N 2-moiety, various alternative reagents 
were tried to reduce the N 6-azide under milder conditions. 
Ph3P. Nucleosides [231 and [26] were stirred in anhydrous pyridine, and triphenyl-
phosphine was added. 179  The azide reacted to give the iminophosphorane, but 
subsequent hydrolysis with H 20 did not occur. 
SnC12. Nucleosides [23] and [26] were suspended in EtOHIH 20 and gently heated 
(60°C) until dissolution was complete. SnC1 2 was then added sparingly until azide 
reduction was complete (by tic). These conditions also cleaved the N 2-protection to 
an extent. 180 
Raney Ni. Nucleosides [23] and [261 were suspended in a mixture of EtOHIH 20 
(9:1) and gently heated (60°C) until dissolution was complete. Raney nickel was then 
added sparingly until azide reduction was complete (by tic).' 8 ' These conditions also 
cleaved the N 2-protection to a large extent. 
None of the conditions above selectively reduced the azide moiety without 
cleaving the N2-dmf (or -tfa) group present. 
5.7 STABILITY OF dD-NUCLEOSIDES TO TCA 
A small amount of each nucleoside: dA, dD [28], 2-Ac-6-dmf-dD [13a], and 2-
dmf-6-dbf-dD [30], were dissolved in a 3% solution of trichioroacetic acid in 
dichloromethane (100tl). Samples were taken at time zero and at appropriate 
intervals thereafter, and examined by thin layer chromatography (solvent A for [13a], 
solvent C for dA and [30], and solvent I for dD) for signs of degradation against the 
starting material. Examination of the plates revealed loss of starting material, and 
build up of other products. From this, approximate half-lives for the stability of the 
nucleosides in TCAIDCM were obtained: dA: 45mm; dD: 35mm; [13a]: <20mm; 
and [30]: >1.5brs. 
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Thymidine (3.17g, 13.1minol) was coevaporated from (3x20m1), and suspended in 
anhydrous pyridine (30m1) with 4-dimethylaminopyridine (0.1 eq, 0.1 3mmol, 
160mg). 4,4'-Dimethoxytrityl chloride (1.1eq, 14.4nimol, 4.7g) was added 
portionwise, and the reaction mixture was left stirring for 10 hours. When complete, 
the reaction was quenched with methanol (20ml) and concentrated in vacuo. The 
residue was dissolved in dichloromethane and washed three times with saturated 
aqueous KC1, the organic phase was dried with anhydrous Na 2 SO4 and concentrated 
in vacuo. The product was purified by flash-column chromatography (the column 
was pre-equilibrated with dichloromethane-triethylamine 99:1, v/v), eluting with 
methanol-dichloromethane (0.5:99.5, v/v) until all the dimethoxytrityl alcohol had 
passed, then with a gradient of methanol in dichloromethane (0.5-1.5%, v/v). The 
product was obtained as a solid white foam. Yield: 6.7g. (96%). 
Rf 0.71 (solvent A), Rf 0.30 (solvent H). Found: C,68.44; H,6.25; N,5.16%. 
Requires: C,68.37; H,5.92; N,5.15%. 'H nmr (200.13MHz; CDC1 3 ) 8H: 1.42 (3, s, 5- 
C113), 2.26-2.47 (2, m, 2'-CH 2), 3.32-3.47 (2, dd, 5'-CH2), 3.75 (6, s, OCH3), 4.09-
4.10 (1, m, 4'-H), 4.57 (1, m, 3'-11), 6.22 (2, br s, 3'-OH, exch., 3-NH, exch.), 6.41-
6.48 (1, dd, 1 ,-H), 6.80-7.41 (13, m, DMTr-H), 7.63 (1, s, 6-H). 13C nmr (50.32MHz; 
CDC13) 86  11.0 (CH3), 40.76 (CH2), 45.47 (CH), 54.97 (2xCH3), 71.97 (CH), 84.61 
(CH), 86.18 (C), 86.58 (CH), 111.01 (C), 112.99 (4xCH), 126.84 (CH), 127.72 
(2xCH), 127.88 (2xCH), 129.84 (4xCH), 135.12 (C), 135.22 (CH), 135.61 (C), 
144.13 (C), 150.63 (C), 158.38 (2xC), 164.16 (C). m/z (FAB) 545.23081 [(M+H) 




5'-O-(4,4'-Dimethoxytrityl)-thymidine [36] (1.0g, 1 .8mmol) was coevaporated three 
times with, and dissolved in anhydrous pyridine (lOmi), with 4-
dimethylaminopyridine (0.leq, 0.18mmol, 22mg). Phthalic anhydride (2eq, 
3.60mmol, 533mg) was added portionwise with stirring, and the reaction mixture 
was left for 15 hours at room temperature. When complete, the reaction was 
quenched with methanol (lOml) and concentrated in vacuo. The residue was 
dissolved in dichioromethane and quickly washed three times with aqueous citric 
acid solution (10%, w/v), then with water, the organic phase was dried with 
anhydrous Na2SO4 and concentrated in vacuo. The product was purified by flash-
column chromatography (the column was pre-equilibrated with dichioromethane-
triethylamine 99:1, v/v), eluting with methanol-dichloromethane (0.0-5.0%, v/v; with 
1% triethylamine) The product was obtained as a yellow-white foam. Yield: 880mg, 
(71%). 
RI 0.40 (solvent A), RI 0.59 (solvent Q. Found: C,65.59; H,6.92; N,4.1 1%. 
C39H36N20 10.(H20) requires: C,65.89; H,5.39; N,3.94%. 'H nmr (250.13MHz; 
CDC13) H: 1.39 (3, s, 5-CH3), 1.78-1.94 (2, m, 2'-CH), 2.29-2.45 (2, m, 2"-CH), 
3.40-3.50 (2, m, 5'-CH2), 3.69-3.74 (6, s, OCH3), 4.52-4.58 (1, m, 4'-H), 5.83-5.92 (1, 
m, 3'-H), 6.39-6.49 (1, m, 1'-H), 6.67-6.82 (4, m, phthal.CH), 7.08-7.40 (13, m, 
DMTr-H), 7.50-7.60 (1, m, 3-NH), 7.78-7.88 (1, s, 6-14). 13C nmr (62.90MHz; 
CDC13) c: 11.44 (CH3), 37.09 (CH2), 54.99 (2xCH3), 63.78 (CH2), 77.84 (CH), 
82.68 (CH), 86.52 (C), 87.65 (CH), 110.60 (C), 113.04 (4xCH), 127.70-130.00 
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(9xDMTr-CH; 4xAr-CH), 133.60 (C), 133.89 (C), 134.72 (C), 134.93 (C), 135.14 
(CH), 144.12 (C), 150.60 (C), 158.40 (2xC), 162.73 (C), 171.44 (C), 172.43 (C). 





DMT fl LO 
5'-O-(4,4'-Dimethoxytrityl)-thymidine [36] (400mg, 0.75mmol) was coevaporated 
three times with, and dissolved in anhydrous pyridine (5m!), with 4-
dimethylaminopyridine (0.leq, 0.08mmol, 10mg). 3-Nitro-phthalic anhydride (4eq, 
3 .Ommol, 290mg) was added portionwise with stirring, and the reaction mixture was 
left for 20 hours at room temperature. When complete, the reaction was quenched 
with methanol (lOml) and concentrated in vacuo. The residue was dissolved in 
dichioromethane and quickly washed three times with aqueous citric acid solution 
(10%, w/v), then with water, the organic phase was dried with anhydrous Na 2SO4 
and concentrated in vacuo. The product was purified by flash-column 
chromatography (the column was pre-equilibrated with dichioromethane-
triethylamine 99:1, v/v), eluting with methanol-dichioromethane (0.0-4.0%, v/v; with 
1% triethylamine) The product was obtained as a yellow-white foam. Yield: 3 10mg, 
(56%). 
RI 0.41 (solvent A), RI 0.67 (solvent Q. 'H nmr (250.13MHz; CDCI 3) H: 1.30 (3, s, 
5-CH3), 2.40-2.55 (1, m, 2'-H), 2.70-2.85 (1, m, 2"-H), 3.45-3.65 (2, m, 5'-CH2), 
3.74 (6, s, OCH3), 4.60 (1, m, 4'-H), 5.75-5.77 (1, "d", 3'-H), 6.35-6.41 (1, m, F-H), 
6.80 (2, s, DMTr-H), 6.83 (2, s, DMTr-H), 7.10-7.42 (11, m, 9xDMTr-H; Ar-H; 3- 
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NH), 7.63 (1, s, 6-H), 8.11-8.39 (2, m, Ar-H). ' 3C nmr (62.90M14z; CDC1 3) 86  11.29 
(CH3), 37.12 (CH2), 54.97 (2xCH3), 63.64 (CH2), 76.40 (CH), 82.75 (CH), 84.19 
(CH), 86.82 (C), 111.18 (C), 113.02 (4xCH), 125.12 (CH), 126.89 (CH), 127.73 
(2xCH), 127.92 (2xCH), 128.73 (CH), 129.16 (CH), 129.86 (2xCH), 129.90 (2xCH), 
135.03 (C), 135.09 (C), 136.02 (CH), 138.72 (C), 144.12 (C), 145.55 (C), 147.46 
(C), 150.37 (C), 158.44 (2xC), 163.85 (C), 166.58 (C), 168.61 (C). 
m/z (FAB) 738.22942 [(M+H) caic. for C 39H36N30 12 738.22989]. 
3'-O-(Nitro-phthaloyl)-5'-O-(4,4'-dimethoxytrityl)-thymidine [391 
5'-O-(4,4'-Dimethoxytrityl)-thymidine [361 (400mg, 0.75mmol) was coevaporated 
three times with, and dissolved in anhydrous pyridine (5m!), with 4-
dimethylaminopyridine (0.1 eq, 0.08mmol, 10mg). 4-Nitro-phthalic anhydride (4eq, 
3.Ommol, 290mg) was added portionwise with stirring, and the reaction mixture was 
left for 20 hours at room temperature. When complete, the reaction was quenched 
with methanol (lOmi) and concentrated in vacuo. The residue was dissolved in 
dichioromethane and quickly washed three times with aqueous citric acid solution 
(10%, w/v), then with water, the organic phase was dried with anhydrous Na 2SO4 
and concentrated in vacuo. The product was purified by flash-column 
chromatography (the column was pre-equilibrated with dichioromethane-
triethylamine 99:1, v/v), eluting with methanol-dichloromethane (0.0-9.0%, v/v; with 
1% triethylamine) The product was obtained as a yellow-white foam. Yield: 260mg, 
(47%) [top spot]. 
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Rf 0.52 (solvent A), Rf 0.73 (solvent Q. 13C nmr (62.90MHz; CDC1 3) 56  11.28 
(CH3), 37.12 (CH2), 54.95 (2xCH3), 63.64 (CH2), 76.39 (CH), 76.90 (CH), 82.95 
(CH), 84.08 (CH), 86.81 (C), 111.37 (C), 112.99 (4xCH), 123.19 (CH), 124.27 (CH), 
126.91 (CH), 127.72 (2xCH), 127.88 (2xCH), 127.98 (CH), 129.85 (4xCH), 134.91 
(C), 134.99 (C), 135.22 (CH), 137.72 (C), 140.04 (C), 143.96 (C), 148.26 (C), 
150.42 (C), 158.44 (2xC), 163.81 (C), 168.09 (C), 169.26 (C). 
mlz (FAB) 738.22957 [(M+H) caic. for C 39H36N30 12 738.22989]. 
Derivatisation of Long-Chain Alkyl Amino Controlled Pore Glass (CPG) solid 
support with Compounds: 37, 38, and 39, to give: 1401, [411, and [42] 
[40] [41] [42] 
N( 
Activation of the CPG. 
CPG (1.5g, 1 50.tmo1g' loading) was dried in vacuo overnight over P 205 and washed 
with a solution of anhydrous NN-diisopropylethylamine in N,N-dimethylformamide 
(4x5m1; 10% v/v), followed by N,N-dimethylformamide (5xlOml). 
Coupling the 3 '-O-Phthalovl Nucleoside onto the CPG. 
The 3'-O-phthaloyl nucleoside (leq, 0.3mmol) was coevaporated three times with, 
and dissolved in anhydrous dichioromethane (lml). To this was added a solution of 
4-nitrophenol (1.2eq, 3.6mmol, 50mg) in anhydrous pyridine (0.lml) followed by a 
solution of NN'-dicyclohexylcarbodiimide in dichioromethane (2.5eq, 0.2m1; 20% 
w/v). After a few minutes, dicyclohexylurea was seen to precipitate, and after the 
reaction had gone to completion (ca. 5 hours) the dicyclohexylurea was removed by 
filtration. The filtrate was concentrated in vacuo, suspended in N,N- 
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dimethylformamide (imi), and activated CPG (0.1eq, 300mg) was added to the 
suspension. The mixture was kept under argon and gently agitated for ca. 20 hours. 
The CPG was filtered off, and washed with anhydrous: N,N-dimethylformamide 
(5x5ml), THF (5x5m1) and diethyl ether (5x5m1). 
Capping the CPG. 
The functionalised resin was suspended in a solution of acetic anhydride-pyridine 
(4m1, 10% v/v) and gently agitated for 1 hour. The CPG was filtered off, washed 
successively with anhydrous: pyridine (5x5m1), THF (5x5m1), and diethyl ether 
(5x5m1); then dried in vacuo overnight over P 205 . 
Calculation qf the loading of the CPG. 
A sample of the washed and dried resin (4-5mg) was weighed accurately, and placed 
in a 25m1 volumetric flask. This was made up to the mark with a solution of 
trichioroacetic acid in anhydrous dichioromethane (3%, w/v). After 5min the 
absorbance of the solution at 504nm was measured to determine the concentration of 
dimethoxytrityl cations in solution and hence the loading of the resin. 
The final loading of the CPG was found to be: 7.5molg' for [40], 5.0p.molj' for 
[41], and 2.54molg 1 for [421. 
[Using the value of 6504=76m1cm4mor' for the dimethoxytrityl cation].' 
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Linker cleavage studies 
The following oligonucleotides 
cleavage times from CPG, followin 
SUC-1 GAC TTG ACC TAT 
PTH-1 GAC iTO ACC TAT 
PTH-2 GAC TTG ACC TAT 
PTH-3 GAC TFG ACC TAT 
were synthesised, on a 0.2tmo1 scale to test 
machine synthesis: 
using succinyl CPG 
using phthaloyl CPG [401 
using NO2-phthaloyl CPG [41] 
using NO2-phthaloyl CPG [42] 
The end proc. consisted of 3x10 minute cycles. After each cycle of cleavage, the 
absorbance of the resulting aliquot was measured at 260nm, with the time noted. 
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The following oligonucleotides were synthesised: 
SUC-2 ATG CAA CCG AGT 	 using succinyl CPG 
SUC3 	ATA GCT TGG CAA GTA TGA CT using succinyl CPG 
PTH-4 ATG CAA CCG AGT 	 using phthaloyl CPG 1401 
PTH-5 ATA GCT TGG CAA GTA TGA CT using phthaloyl CPG [40] 
The oligonucleotides were synthesised (SUC-2, SUC-3, PTH-4, and PTH-5) on a 
0.2p.mol scale, without an End proc., to allow more detailed study of the cleavage 
times. Approximately 1/10 of the post-synthesis CPG was weighed out, and added to 
a "blanked" 1cm cuvette containing 2.5m1 of conc.NH40H. The cuvette was 
stoppered, and shaken once every 5 minutes—the absorbance reading (260nm) was 
taken once the CPG had settled. A plot of the time versus absorbance gave the t 1 12 
etc. 
Machine synthesis-compatibility of phthaloyl linkers 
Oligonucleotides SUC-2, SUC-3, PTH-4, and PTH-5 were also used to check the 
coupling efficiency, and the quality of synthesis of oligonucleotides containing a 3'-
phthaloyl linker. The resulting oligonucleotides from SUC-2 and SUC-3 were 
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Duplex 10, a native oligonucleotide of the type studied, was included in the 
thermodynamic study in order to check the compatibility of the data obtained with 
that obtained by Breslauer et al. 174  
COT AAC GT 
GCA TTG CA 	Duplex 10 
This duplex contains 1(AA/TT), 1(TA/AT), 3(GT/CA), and 2(CG/GC) nearest 
neighbours, and using the values from Table 3.4 (p106), with T=25°C: 
G°predicted = (-7.9) + (-3.8) + 3(-5.4) + 2(-15.1) + (229) = -37.2kJmor' 
The calculation assumes that the free energy of a duplex results from the sum of its 
nearest neighbour interactions. The underlined quantity corresponds to the helix 
initiation free energy. 174 
From a plot of ln(CT/4) versus 1/T,,,, as described in Section 3, the following 
results were obtained: 
AH°obsen,ed = -172.5kJmoF' 
L\S°obser,ed = 452 7JK4 of' 
and from Eq.(4), and using T=25°C, 
G°obsei.,ed = -37. 2kJmof' 




"Crystal and molecular structure of r(CGCGAAUUAGCG): an RNA duplex 
containing two G(anti).A(anti) base pairs." 
Structure 15 June 1994, 2: 483494. 
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Crystal and molecular structure of r(CGCGAAUUAGCG): 
an RNA duplex containing two G(anti)A(anti) base pairs 
Gordon A Leonard 1 , Katherine E McAuley-Hecht2, Susanne [bet2, 
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Background: Non-Watson--Crick base pair associa-
tions contribute significantly to the stabilization of RNA 
tertiary structure. The conforniation adopted by such 
pairs appears to be a function of both the sequence 
and the secondary structure of the RNA molecule. GA 
mispairs adopt G( anli)-A( anti) configurations in some 
circumstances, such as the ends of helical regions of 
rRNAs, but in other circumstances probably adopt an 
unusual configuration in which the inter-base hydrogen 
bonds involve functional groups from other bases. We 
investigated the structure of GA pairs in a synthetic RNA 
dodecamer. r(CGCGAAIJUAGCG), which forms a du-
plex containing two such mismatches. 
Results: The structure of the RNA duplex was de- 
termined by single crystal X-ray diffraction techniques 
to a resolution in the range 7.0-I8A, and found to 
be an A-type helical structure with 10 Watson-Crick 
pairs and two GA mispairs. The mispairs adopt the 
G( anti)'A( anti) conformation, held together by two ob-
vious hydrogen bonds. Unlike analogous base pairs seen 
in a DNA duplex, they do not exhibit a high propeller 
twist and may therefore he further stabilized by weak, 
reverse, three-center hydrogen bonds. 
Conclusions: G( anti)-A( will) mispairs are held to-
gether by two hydrogen bonds between the 06 and Ni 
of guanine and the N6 and N  of adenine. If the rnispairs 
do not exhibit high propeller twist they may be further 
stabilized by inter-base reverse three-centre hydrogen 
bonds. These interactions, and other hydrogen bonds 
seen in our study, may be important in modelling the 
structure of RNA molecules and their interactions with 
other molecules. 
Structure 15 June 1994, 2:483-494 
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Introduction 
Since the development of techniques to routinely syn-
thesize large quantities of DNA, the crystallography 
of short oligodeoxyrihonucleotides has become well 
established [1,2]. In addition, the detailed crystallo-
graphic analysis of tRNA represents a major success in 
structural biology [11.  The crystallography of synthetic 
RNA oligonucleotides has lagged behind because of the 
greater difficulties associated with synthesis and purifi-
cation. To date only two RNA duplex structures have 
been fully determined [3-5] and the structures of four 
chimaeric RNA-DNA hybrid structures have also been 
reported [6-8]. Recently, a preliminary X-ray analysis 
of the synthetic RNA oligonucleotide corresponding to 
domain A of ThermusJlaz'us 5S rRNA has been made 
[91 and structural detail should be available in the near 
future. NMR-derived structures are more common and 
this method has been applied in several cases [10]. 
In both the structure of DNA and that of RNA [2,11-151 
the GA mispair has been shown to be confomationally 
variable (Fig. 1). In DNA this conformational variability 
is both sequence and pH-dependent [11,13,16]. In RNA 
the structure of GA mismatches appears to depend on 
both the sequence and the secondary structure of the 
RNA molecule. NMR studies suggest that GA mispairs 
occurring at the ends of helical regions of rRNAs tend 
to adopt G(anti)A(anti) configurations as do those in 
Corresponding author.  
the sequence CGCAGGCG [15]. On the basis of NMR 
spectroscopic studies of GA base pairs in the sequence 
GGCGAGCC, at the loop end of the stem in extra-stable 
tetraloops and in ribozyme models it has been con-
cluded that these base pairs adopt an unusual configu-
ration in which the interhase hydrogen bonds involve 
functional groups on the major and minor groove sides 
of the purine bases (Fig. Id) [14,17-201. 
.As part of an ongoing project into the structure of 
oligonucleotides, in particular those containing non-
Watson-Crick base pairs, we have synthesized for crys-
tallographic study the dodecamer r( CGCGAAUUAGCG) 
which contains two GA mispairs. We describe the syn-
thesis, purification, crystallization and the single-crystal 
X-ray analysis of r( CGCGAAUUAGCG). We present a 
detailed structural analysis of the duplex, with an em-
phasis on the conformation of the mismatches, and 
make some comparisons with the only other RNA du-
plex crystal structure for which full details have been 
given [31. 
Results and discussion 
Structure solution and refinement 
The RNA dodecamer was synthesized, purified and 
crystallized as described in Materials and methods. 
© Current Biology Ltd ISSN 0%9-2126 	 483 
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Fig. 1. Four base-pairing arrangements for GA base pairs. (a) The G(anti)A(anti) conformation. (b) G(antd-A(syn). (c) The protonated 
G(.cyn)-AHiantO. (d) The C-A N7-amino, amino-N3 base pair. Possible hydrogen bonding interactions have been omitted. 
The space group is monoclrnic, P2 1 , with unit cell di-
mensions a = 41.69(1)A, b = 34-620A,  c 32.13(3)A, 
3= 127.6(1)0 after post-refinement (numbers in brack-
ets indicate standard errors). The asymmetric unit con-
sists of one RNA dodecamer duplex. The structure 
was solved using the multi - dimensional search pr( ,  
gram UITIMA [211 and refined using a comhinati in 
of rigid-body techniques [22], slow-cooling simulatc i 
annealing [23,24] and restrained least-squares mc' 
ods [25]. The final model consists of the RNA 
plex (510 atoms) and 97 water molecules (each trea, 
as an oxygen atom). Refinement converged at an 
factor of 19% for 3147 reflections with F ~!3c(F 
the resolution range 7.0-1.8A (R-factor Iro —F 
where F0 and Fc  are the observed and ca! 
lated structure factors respectively). The residues 
strand 1 are labelled Cl to G12 (5' to 3' directi 
and those on strand 2 are labelled C13 to G24 (5 
P. Water molecules are numbered from 1 to 97 
clusive with the label HOH. The geometry of the Ii; 
model is good with root mean square (rms) deviation 
from ideal bond lengths of 0,014 A for sugars/bases 
and 0.030 A for phosphate groups. For angle-associated 
distances the rms deviations from ideality are 0.016 A 
and 0.023 A respectively. The rms deviation from pla 
narity for the nucleotide bases is 0.013 A. For chiral 
volumes, which were not restrained, the rms deviation 
from ideality is 0.279A3 . Weak restraints were placed 
on the Watson—Crick hydrogen bonds in the structure 
but no such restraints were applied to the mispairs. An 
example of the fit of the model to the final calculated 
electron density is presented in Fig. 2. 
fig. 2. 1 
 
wire' fo r the G4-A2l base Par  in the r((_GCGAAUUAGC Gj duplex 
with the final refined model. The contour level is set at approxi-
mately one rms deviation from the mean value observed in the 
unit cell. The bases are depicted as sticks coloured as follows; 
carbon yellow, oxygen red and nitrogen blue, with key functional 
groups labelled. 
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The global structure of the RNA double helix and crystal 
packing 
The antiparallel RNA double helix consists of 10 
Watson-Crick base pairs and two GA mispairs (G4A21, 
G16A9) both of which adopt a G(anti)A( anti) confor-
mation. The duplex has a global helical rise of 2.62 A 
and global helical twist of 34.2 °(10.5 residues per full 
helical turn) which place it in the A-form family 11,21 
as do the values observed for the sugar-phosphate 
backbone torsion angles (Table 1: see below) and the 
geometrical parameters of the individual base pairs and 
base steps (Tables 2 and 3). The average value for the 
torsion angle ö is 78.5 and the standard deviation is 
8 indicating that the conformation of all the ribose 
moieties in the structure is close to C3'-endo. The mean 
distance between adjacent phosphorus atoms on the 
same strand is 5.8A and this is also fairly typical of 
the A-form nucleic acid duplex. The double helix has a 
very deep, narrow major groove and a rather shallow, 
though wide, minor groove (Fig. 3). Where they can be 
measured, the average widths of the major groove and 
minor grooves are 3.4A and 10.8A respectively. These 
are comparable to the values of 4.1 A and 11.3 A derived 
from a fibre model of poMA) pol)U) [261 and also 
to those values found in the structures of the acceptor 
stem and anticodon stems of tRNAP [271 and tRNAPhC 
128,291. The global values quoted above, whilst allow-
ing the overall cataloging of the duplex, do tend to 
mask structural variation at a local level. Such variation 
will be mentioned when the base-stacking interactions 
are described. 
As we had predicted when considering the solution of 
the structure (see Materials and methods) the duplexes 
are arranged in the crystal SO that they pack parallel to 
the c-axis of the unit cell and form a pseudo C-centred 
Table 1. Sugar-phosphate backbone and glycosyl torsion angles () 
for r(CGCGAAUUACCG). 
Residue X 01 0 ' 6 11 
Cl -162 30 83 -172 -62 
G2 -156 - 62 189 45 83 -168 -57 
C3 -162 -95 191 76 76 -116 -106 
G4 -165 -60 135 64 69 -155 -73 
AS -173 -74 177 76 71 -136 - 90 
A6 -151 -43 157 45 79 -139 - 83 
U7 -169 -71 158 72 83 -135 -95 
U8 -155 - 29 163 31 74 - 138 -76 
A9 -165 -91 157 73 72 -149 -71 
GlO -168 -71 169 71 81 -142 -84 
Cli -156 -52 165 47 80 -154 -78 
G12 -157 -49 172 40 77 
C13 -180 170 91 -114 -103 
G14 -163 -45 155 53 70 -129 -87 
C15 -150 - 9 182 - 2 91 -154 -30 
G16 -166 -106 171 75 82 -156 -76 
A17 -171 -54 171 54 82 -135 -98 
A18 -146 - 12 154 16 83 -169 -55 
U19 -158 -100 187 84 63 -137 -74 
U20 -159 -47 179 27 96 -136 -94 
A21 -161 -40 147 41 66 -156 -68 
G22 -157 -49 168 45 77 -161 -65 
C23 -166 -92 176 78 80 -142 - 81 
G24 -159 -45 164 46 76 
Main chain torsion angles are defined by 03'-P--05'-l3-05'-7 -C4' -6 - 
C3'-,-03' - r1 - P-05'. The glycosyl torison angle x is defined by 04'-Cl'- 
N1-C2 for pyrimidines and 04'-C1'-N9-C4 for purines. 
arrangement (Fig. 4). Each duplex interacts with six 
symmetry-related entities. Duplexes pack one on top 
of the other in a similar fashion to the structure of 
r(GGACUUCGGUCC) [4] to form a series of helical 
Fig. 3. A CPK representation in stereo of 
the RNA duplex. Base atoms are red, the 
sugar-phosphate atoms are black with 
the exception of the 02' hydroxyl which 
is coloured green. The selected view has 
the minor groove at the bottom of the 
diagram, the major groove at the top. 
(Figs 3, 5, 7, 8 and 9 were obtained using 
MOLSCRIPT 153]). 
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columns parallel to the c-axis. At the junctions of adja-
cent helices in these RNA columns there is a psuedo 
GpC step. The helical rotation for this psuedo step 
is only 8.9° while the helical rise is 2.86 A. In the du-
plex proper there are two real GpC steps which have 
helical rotations of 33.5 °and 35.6°and helical rises of 
2.45A and 2.55 A (Table 2, discussed below). The rise 
and rotation observed for the pseudo GpC step at the 
junction of two duplexes are therefore a consequence 
of the lack of chain connectivity rather than a true re-
flection of the rise and twist for GpC steps. The van 
der Waals interactions between the aromatic bases of 
the symmetry- related helices are supplemented by van 
der Waals interactions involving atoms of the attached 
rihofuranose rings. 
There are four helices positioned around the side of 
each duplex. The side-by-side array of helices is held 
together by numerous van der Waals contacts between 
symmetry-related duplexes all of which involve atoms 
on the sugar-phosphate backbone. Additionally, there 
are five inter-duplex hydrogen bonds associated with 
each RNA strand. These hydrogen bonds are all to func-
tional groups on a symmetry- related partner strand, so 
strand 1 only interacts with strand 2 of symmetry-re-
lated helices and vice versa. Hence, in total there are 10 
inter-duplex hydrogen bonds to stabilize the packing 
arrangement. These hydrogen bonds involve the 02' 
and 03' of 03) interacting with 02'A(21), 02'A(6) 
with 02'G(24), 02'A(9) with 02'C(15) and 02'G(12) 
with 02'A( 18). An example of the interduplex hydro- 
Fig. 4. The arrangement of r(CGCGAA-
LJLJAGCG) duplexes in the Unit cell. 
(a) The duplexes viewed approximately 
parallel to their helix axes to show the 
cross-section of the cell perpendicular 
to the c-axis. For clarity, only the sugar—
phosphate backbone atoms are shown. 
Note that the arrangement closely mim-
ics a C-centred motif and that the cen-
tral helix interacts with four others in 
this plane. (b) A stereoview illustrating 
how the helices are aligned along the c-
axis to form a continuous tube of RNA. 
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Table 2. Geometric parameters for the base steps in the 
r)CGCGAAUUAGCG) duple x .a 
Base step 	Twistr') Rise (A) Slide () Roll )) 
1 	 34.4 2.4 -1.9 1.6 
2 33.5 2.5 - 1.2 -4.7 
3 	 27.2 31 -1.1 - 0.1 
4 30.4 2.7 -1.4 3.4 
5 	 38.9 2.6 -0.6 -4.0 
6 32.8 2.4 -1.0 -3.3 
7 	 40.3 2.5 -1.1 -2.9 
8 28.3 2.7 -1.4 3.8 
9 	 28.0 3.0 -1.0 -1.4 
10 35.6 2.6 -1.2 -2.0 
11 	 39.6 2.5 - 1.5 13 
,'Parameters were calculated using the NEWHEL92 program distributed 
by RE Dickerson and available from the Brookhaven Protein Data Bank. 
Table 3. Geometric parameters for the base pairs in the 
r(CGCGAAUIJAGCG) duplex.a 
Base pair Propeller twist () C1'-C1' (A) 	Inclination () 
C1-G24 -12.5 10.4 17.9 
G2-C23 -20.1 10.6 17.7 
C3-G22 -9.1 10.6 19.4 
G4-A21 -9.6 12.4 18.9 
A5-U20 -12.4 10.6 19.0 
A6-V19 -27.0 10.1 21.1 
U7-A18 -23.1 10.4 20.3 
U8-A17 -17.8 10.9 18.4 
A9-G16 -10.4 12.9 18.7 
G10C15 -6.8 10.7 18.3 
C11-G14 -22.6 10.4 18.0 
G12-C13 -13.3 10.7 17.8 
aparamete rs were calculated using the NEWHEL92 program distributed 
by RE Dickerson and available from the Brookhaven Protein Data Bank. 
gen bonding is presented in Fig. 5. There are also sev-
eral solvent mediated contacts which principally link 
sugar-phosphate backbones. 
The crystal structure of U( CA )6A [3) also uses the 02' 
h-ydroxyl groups in the formation of the crystal lattice 
but in this case hydrogen bonds are formed to both the 
sugar-phosphate backbone and to the minor groove 
of the duplex. The importance of the 02' hydroxyl 
group in the rihozyme recognition of RNA has been 
brought to prominence by Pyle and Cecil [301. These 
crystal structures may nhinhic aspects of this recognition 
process. 
The conformation of the GA base pairs 
The GA base pairs in the structure of r(CGCGAAIJU-
AGCG ) adopt it G( (int/)A( a/ill) conformation  (Figs 
la and 2). This configuration is different from the 
G( anti)A( syn) GA mispairs in the analogous DNA 
structure d(CGCGAA1TAGCG) [311, but similar to 
the configuration of the GA base pairs observed in 
the structure of the synthetic 13-form DNA decarner 
d(CCAAGA1TGG) [12321. As in the d(CCAAGA-
TTGG) duplex, the Cl'-Cl'clistances for the G( anti)' 
A(anti) base pairs in the r(CGCGAAUUAGCG) double 
helix are increased by about 2A (Table 3) compared 
with the value of 10.5A associated with Watson-Crick 
base pairs. From an analysis of the sugar-phosphate 
torsion angles observed for the r(CGCGAAUUAGCG) 
double helix it would seem that the larger G( anti)' 
A(an ti) base pairs are incorporated into the duplex 
with very little change to the structure of the phos-
phodiester backbone (see below). An examination of 
phosphorus atom separations across the helix suggests 
that, as in the structure of d(CCAAGA'ITGG) [12], 
there is slight bulging of the duplex as a result of 
the G(anti)A(anti) conformation adopted by the mis-
pairs. This bulging of the backbone occurs only at 
points immediately adjacent to the mispairs and the rest 
of the duplex is apparently unaffected. 
Fig. 5. Stereoview to show one of the 
02' to 02' hydrogen bonds that help 
to stabilize the crystal lattice. In black 
is the trinucleotide r(UAG), residues 8, 
9 and 10 of the asymmetric unit. In 
red, r(GCG) residues 14, 15 and 16 of a 
symmetry related duplex 0 - x, 112 + v 
-z). The dashed green line indicates 
the hydrogen bond formed between 
02'A(9) and 02'015). 
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Although the global conforniations of the G( anti)A( anti) 
mispairs in r(CGCGAAUUAGCG) are similar to those 
observed in d( CCAAGATTGG) there are a number 
of significant differences in the fine structure of the 
base pairs. The most obvious is in the degree of pro-
peller twist that the base pairs exhibit. In the struc-
ture of r(CGCGAAUEJAGCG) the G4 -A,21 and G16 -A9 
base pairs have fairly low propeller twists of 9.1 ° 
and 10.4°. respectively (Table 3). In the structure of 
d(CCAAGATTGG) the GA mispairs have high pro-
peller twists of about 25 ° [12]. In the latter structure, 
the mispair guanines are involved in unusual minor 
groove cross-strand hydrogen bonding. The guanine 
N2 amino group hydrogen that is directed towards 
the adenine in the GA base pair forms a cross-strand 
hydrogen bond to the adjacent thvmine 02. This fea-
ture is quite definately sequence dependent. Since the 
other hydrogen atom on the amino group is free to 
form hydrogen bonds to solvent, this means that the 
hydrogen-bonding potential of the guanine N2 amino 
group can be completely fulfilled. In our RNA duplex, 
the sequence in which the G .A. mispairs are embed-
ded makes it impossible for similar hydrogen bonds to 
form. A consequence of this is that, at first sight, one 
of the guanine N2 amino group hydrogen atoms in the 
G-A base pairs in the structure of r( CGCGAAUUAGCG) 
(circled in Fig. 6) cannot form a hydrogen bond. Note 
that there is one amino group hydrogen that can inter-
act with solvent and this is indeed observed for G16, 
where HOl-142 is 3.4 A from N2. We have not, however, 
identified a well-ordered water hydrogen bonding to 
N2(G4). 
It was Crick, in 1966, who recognized that base pairs 
containing unfulfilled hydrogen bond donors or accep-
tors would be destabilized and that this effect might 
even prevent base pairing [33]. With this in mind we 
have studied the possible hydrogen bonding patterns 
in this mispair, paying particular attention to the gua-
nine N2 amino group. We remind readers that the e lec -
trostatic nature of the hydrogen bond means that the 
attractive force changes in very small decrements as 
the interatomic separation increases [34] and it is not 
necessary to restrict hydrogen-bonding distances to the 
sum of the van der Wails radii of the at(I)ms involved. 
A difficulty arises in nomenclature; what actually con-
stitutes a hydrogen bond? We concur with the Steiner 
and Saenger definition [351 that a hydrogen bond is .. any cohesive interaction X-HY. where I-I carries a 
positive and Y a negative (partial of full) charge and 
that the charge on X is more negative than on H'. We 
also believe that in a detailed analysis of such a cohesive 
interaction the dimensions and directionality of lone 
pairs as well as atomic positions should be considered. 
This latter point has not generally been applied in the 
characterization of hydrogen bonds. 
There are clearly two distances which are indicative 
of hydrogen bonds in the G( anti)A( anti) base pairs 
These involve N6(A) to 06(G) (296A for the 421 
7 
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Fig. 6. A representation of the reverse three-centre hydrogen 
bonding scheme that may help to stabilize the GA base pairs in 
the structure of r(CGCGAAtJUAGCG). (a) The G(anti)A(anti) bases. 
The lone pair on Ni of the adenine is depicted as a lobe, the 
guanine proton that could interact with this lone pair is circled. 
(b) The definitions of geometrical parameters tabulated in Table 2 
which are useful to analyze three-centre hydrogen bonding pos-
sibilities. Parameters rl and r2 are distances, oc , 01 and 02 are 
angles. 
pair and 2.66A for the 9-16 pair) and N1(G) to N1(A) 
(2.62 A and 2.96 A respectively). These are the primary 
determinants of the base alignments. We postulate that 
the inter-base hydrogen bonding scheme in the GA 
base pairs may also involve an unconventional reverse 
three-centre hydrogen bond we previously proposed 
for other base pairs. In this scheme both the guanine 
immo hydrogen and the N2 amino group hydrogen 
atom form hydrogen bonds to the adenine N  nitrogen 
atom (Fig. 6) and the hydrogen-bonding potential of 
the guanine N2 amino group can be fulfilled. To ascer-
tain whether such a hydrogen-bonding scheme could 
occur we calculated ideal i sitions for both hydro-
gen atoms and the adenine Ni nitrogen lone pair [361 
and analyzed the geometry of the potential hydrogen-
bonding scheme. A full description of our protocol has 
been published elsewhere 137].  Distances and angles, 
as defined in Fig. 6, are presented in Table 4. They 
are close to the values expected for three-centre hydro-
gen bond formation [3'-401 and suggest that the GA 
base pails in this RNA duplex could he stabilized by 
reverse three-centre hydrogen bonds. We caution how-
ever, that in energy and structural terms the presence 
of such a weak electrostatic interaction will he of minor 
importance compared with the two principal hydro-
gen bonds described above. An NMR study of the GA 
mispair in d( GCCACAAGCTC )d( GAGCTGGTGGC) by 
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Carhonnaux et al.. [411 revealed the bases were anti 
and an unusual chemical shift of an imino proton of the 
guanine suggested the formation of inter-base bifur-
cated hydrogen bonds. Our results are in accord with 
their swd 
Table 4. The geometrical parameters associated with the three-centre 
hydrogen bonds found in the structure of rlCGCGAAUUAGCCl.' 
r1 (A) r2 Al e1 i'i e2 	 x 
Reverse three-centre 
hydrogen bonds 
G4 - A21 	 1.7 	2.9 151 110 54 	315 
G16-A9 2.0 2.6 150 123 76 349 
Conventional three-centre 
hydrogen bonds 
A5U20:A6-U19 	 1.6 2.7 155 107 97 	359 
A17-U8: A18-U7 1.6 3.0 152 111 85 348 
aBoth conventional three-centre hydrogen bonds 1401 and reverse three-
centre hydrogen bonds 1361 are considered to he formed if r 1 < r 2 :5 3 A 
and 360° lie. 9 + 8, + 360°L 
Conformation of the phosphate-furanose backbone 
The torsion angles of the phosphate-furanose back-
bone and glycosvl bonds are presented in Table 1. In 
general the values observed correlate well with the ex-
pected range of values for an A-form duplex [1,2,26]. 
So ot and y assume gauche /gauche+ configurations 
with the exception of y for C13 which is Ira ns and sub-
ject to end effects. Values of 13 and are ira/is, while ç 
is gauthe. The glvcos-vl torsion angle, x ranges from 
- 146° to - 180°. There is no apparent difference in 
X values for purines or pyrimidines as has previously 
been observed for A-DNA structures [42]. As men-
tioned earlier the furanose conformations, as deduced 
from the 6 values, are all 0'-endo. In accord with 
this the intra-strand phosphorus-phosphorus distances 
range from 5.3A to 6.3Awith an average value of.8A. 
There is no gross distortion in the furanose-phosphate 
backbone conformation that can be attributed to the 
location of the mispair sites. 
Base pair stacking patterns and local geometry 
In addition to observing how the mispairs interact with 
the adjacent base pairs, we also see the detailed geom-
eny of some base pair steps involving Watson-Crick 
pairs that have not previously been observed in crystal 
structures of duplex RNA. In the r(CGCGAAUUAGCG) 
duplex there are 11 base pair steps, 7 of which involve 
only Watson-Crick base pairs and 4 of which involve 
the mispairs. Our numbering scheme assigns the dinu-
cleotide step 5 'C 1 pG2 3' (interacting with 5 'C23:G243 ') 
as step 1 which can be indicated as type CpG(CpG), 
5 'G2pC33' with G22:C233' as step 2, type GpC(GpC) 
etc. Geometrical parameters used to define local geom- 
etiy of base pair steps and of the base pairs themselves 
are presented in Table 2. 
The four steps which involve bases of the mispairs 
are steps 3 and 9 of type CpG(ApG) and steps 4 and 
8 of type GpA(UpA). There is consistency between 
these steps in that intra-strand purine-purine stacking 
interactions appear to dominate. In each case good 
stacking of the five-membered ring of a purine onto 
the six-membered ring of the adjacent purine is ob-
served. There is also a small degree of intra-strand 
pyrimidine-purine stacking and of cross-strand stack-
ing of purines. These tour steps have a reduced twist 
(average of 28.5 ° ) compared with the average value of 
36.4° for the remaining seven steps. Steps 3 and 9 also 
have the highest rise values. 
The remaining base pair steps can be grouped into 
the following categories. Steps I and 11 are type 
CpG(CpG). 2 and 10 are GpC(GpC). 5 and 7 are 
ApA(UpU). and step 6 is ApV(ApU). The stacking pat-
terns observed here are similiar to those observed in 
[U(UA )A] 7 [3] and fibre models 11.261 and are de-
terillilled by whether the bases involved are purities 
or pvnlllidifles. For the purpose of identifing a pat-
tern it does not appear important to consider which 
type of punne or pvnnlidine is involved. The patterns 
can be summarized as follows. The purine-pvrimidine 
steps, 2, 6 and 10, show pronounced intra-strand stack-
ing of the pyrimidine on the six-membered ring of 
the purine. No cross-strand interactions are observed. 
The pvrimidine-purine steps. 1 and 11, display good 
cross-strand stacking of purines on each other. The 
purine-purine steps, 5 and 7, are arranged SO that the 
five-membered ring on one purine stacks on the six-
membered ring of the -adjacent one. There is very lit-
tle interaction between the pyrilllidifles on the other 
strand. This is very similar to the pe of stacking ob-
served in GpG( =CpC) steps in A-form DNA [42]. All 
of the steps at which some degree of cross-strand 
purine-purine interaction is observed have higher slide 
values (average 1.55 A) than the other steps (average 
1.03 A). The lowest slide value is observed for step 
where there is the strong intra-strand stacking of the 
purines. 
A feature of the r(CGCGAAUUAGCG) duplex is the 
propeller twist of the A-V base pairs. Two of these 
base pairs (A6-U19 and A18-V7) have extremely iligil 
propeller twist (Table 3) with magnitudes of the same 
order as the AU base pairs found in the structure of 
U(UA)A [3] and the A-T base pairs in poiy(A)-polv(T) 
stretches of B-DNA [-+3]. Calculation of idealized posi-
tions for hydrogen atoms in the r(CGCGAAUUAGCG) 
duplex, as detailed previously, and an analysis of pos-
sible hydrogen-bonding geometry as defined by Fritsch 
and Westh )f [40] (Table 4) suggests that both of these 
base pairs may he involved in three-centre, cross-strand 
hydrogen bonding with the adjacent 5' A-U base pair 
(Fig. 7) similar in nature to that found in B-DNA [43]. 
To the best of our knowledge this is the first time such 
490 Structure 1994, Vol 2 No 6 
interactions have been proposed in duplex RNA and 
may be useful in molecular modelling of complex RNA 
structures. 
The base pairs with the next highest values for pro-
peller twist are at G2-C23 and C1FGI4 with values of 
- 20.1* and - 22.6* respectively. These positions are 
one base pair in from the end of the duplex. As dis-
cussed earlier, the crystal lattice is in part stabilized by 
a base-stacking type interaction involving the terminal 
base pairs. The base steps (1 and 10 have the largest 
values for slide and step 11 has the largest value for 
twist. The intermolecular interactions may influence the 
G-C pairs one position in from the end of the duplex 
to promote a high propeller twist and the base-stack-
ing pattern allows the pyrimidine room to flex away 
from the plane of the purine. The observation of high 
propeller twisted GC pairs is in direct contradiction to 
suggestions, based on DNA structures, that there are 
two requirements for a base pair to exhibit a large 
propeller twist 144]. These requriements are that the 
base pair must he AT and it has to be involved in 
major groove three-centre hydrogen bonding with an 
adjacent base pair. There are numerous examples of 
GC pairs in DNA dodecamers with high propeller twist 
values in excess of - 15 ° and this is further discussed 
by Leonard and Hunter [45]. The high values for two of 
the GC pairs in this RNA duplex are at the high end of 
the range observed in a survey of nucleic acid structural 
parameters [46], but there is precedent in A-form DNA. 
In the structure of d('CCGG) [47], a propeller twist of 
-21.4° is evident for a G-C pair and we also note that in 
the crystal structures of tRNA molecules high propeller 
twist values can be obtained for G-C pairings [29]. 
Hydration of the r(CGCGAAUUAGCG) duplex 
Two views of the RNA duplex wth associated solvent 
molecules are presented in Fig. 8. Of the 97 water 
molecules included in the final model, 65 (67 %) form 
direct hydrogen bonds to the RNA double helix and 
represent the first hydration shell. Of these first shell 
solvent molecules, 19 form hydrogen bonds to the ma-
jor groove of the RNA, 14 interact directly with atoms 
in the minor groove and 32 form hydrogen bonds to 
the sugar-phosphate backbone. Of the latter solvent 
molecules, 11 interact with 02' hvdroxyl groups on 
the ribose moieties. There are no striking patterns of 
hydration in the major groove of the RNA duplex. For 
the backbone, we observe only a couple of well de-
fined solvent molecules that bridge adjacent phosphate 
groups in a manner expected on the basis of Saenger 
and co-workers' study of hydration [48]. 
On the minor groove side of the duplex we observe a 
number of bridging solvent molecules, and examples 
are shown in Fig. 9. These involve 7 of the 14 solvents 
in this groove bridging atoms on the base edges and 
the 02' hydroxyl groups of the riboses. This is rem-
iniscent of the hydration pattern of the wide sections 
of the minor grooves of B-DNA duplexes [12] where 
solvent molecules also form bridges between the bases 
and the sugar-phosphate backbone and suggests that 
such a linking motif may he conserved in both DNA 
and RNA. 
The 02' hydroxyl group plays an important part in 
the stabilization of RNA secondary structure [1].  Mod-
elling has suggested that this group can take part in 
three types of interactions [49].  Firstly, a weak hydro-
gen bond may form to 04' of the neighbouring nu-
cleotide unit. Secondly, the positioning of 02' could 
promote the location of bridging solvent molecules 
linking up with 03' of the phosphate group, or, thirdly 
the group could link up with the minor groove of the 
bases as already discussed. There are four examples of 
waters bridging the hydroxyl group and the phosphate 
03'. We observe an additional interaction where, at 
two positions, a solvent link is formed with the 04' 
of the adjacent ribofuranose. In both tRNA and the 
r[U(UA)6A] structures the presence of similar bridging 
solvent molecules has been noted [3,29]. 
At numerous positions in the electron density maps 
there are indications of additional solvent molecules 
that could be included in the model. However, the qual-
ity of the peaks did not fit in with our selection criteria 
and we judged it best to leave them out. We feel that 
we have made a realistic interpretation of the solvent 
structure based on consideration of data quality. 
Fig. 7. A stereo ball-and-stick repre-
sentation of the r(AAUU) 2 middle sec-
tion of the RNA duplex. This view high-
lights the large propeller twist of the 
A6-U19 and A13-U7 base pairs and the 
major groove, cross-strand three-cen-
tre hydrogen bonds (green dashed lines) 
that could form as a result of this. 
Atoms are coloured as follows; phos-
phorous yellow, oxygen red, nitrogen 
blue, carbon white. 




.i. 	 .. 	I 
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Fig. 8. Two views of the duplex hall-and-stick model, red for base atoms, black for sugar-phosphate backbone atoms) with asodated 
solvent positions depicted as cyan spheres. (a) Side view perpendicular to the duplex axis. (b) View down the helix axis. 
Biological implications 
The structures of RNA molecules are likely to be 
important in processes as diverse as RNA trans-
port out of the nucleus, splicing, translation, RNA-
mediated catalysis, viral assembly, and target bind-
ing in RNA-based drug candidates. Many RNA se-
quences have been determined, yet there is only 
a limited amount of information on the struc-
tures of RNA molecules. Analysis by NMR, molec-
ular modelling [50] and X-ray crystallography (as 
in this study) is now beginning to give insight 
into the structure—function relationship of various 
RNAs, and should improve our understanding of 
the way that RNA interacts with other molecules, 
such as proteins. 
In many RNA molecules it is clear that non-
Watson—Crick base-pair associations are impor-
tant in determining the three-dimensional struc-
ture of the molecule. Of the many examples 
found in tRNA, GA mismatches appear most im-
portant, being commonly identified in sequence-
based modelling and NMR studies. Our study of 
a duplex containing two such mismatches has at-
towed us to determine in detail the conforma- 
tion that this mismatched pair adopts in a syn-
thetic RNA dodecamer, and to probe the reasons 
for its stability. We find that both GA pairs adopt 
the anti-anti conformation, and make two clear 
hydrogen bonds (N6 of adenine to 06 of guanine 
and NI of guanine to NI of adenine). We pro-
pose that the stability and lack of propeller twist 
seen in this structure may be partly due to weak, 
unconventional three-center hydrogen bonds to 
adjacent base pairs. 
The data from our study provide a glimpse of 
the hydration patterns, geometry, and hydrogen 
bonding involved in interactions between RNA 
molecules. This may aid molecular modelling 
studies of higher-order RNA structures in cases 
where experimentally-derived structural detail is 
lacking. 
Materials and methods 
RNA synthesis and crystallization 
The oligoribonucleotide was synthesized on a preparative 
scale using an ABI 320B automatic DNA synthesizer and 
phosphorarnidites with 1 -(2-fluorophenyl)-4-methox)piperidin 
4.yl (FPMP) protected 2'-hydroxyl functions. The crude product, 
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Fig. 9. Four specific examples of 02' 
hydroxyl hydration. The colour scheme 
is; phosphorous yellow, oxygen red, 
nitrogen blue, carbon white, solvent 
molecules cyan spheres. Hydrogen bonds 
are green dashed lines. (a) The link be-
tween 02'U(8) to the 02 mediated by 
H0H89. (b) 02'C(16) to N3 through 
HOH40. (c) The link from 02'011) 
through HOH52 to the 03'. (d) H0H35 
interacts with 02'A(21), N3A(21) and 
04'G(22). 
with the FPMP and 5'-trityl protecting groups still attached, was 
Purified by reversed- phase high pressure liquid chromatography 
(1ll'LC ) using a Brownlee aquapore octyl column (25 X  10 mm) 
and a gradient of 0 % to 50 % acetonitrile. ]'his step was carried 
out over a period of 30 minutes in it buffer of 0.1 M ammonium 
acetate at pFl7.5. The sample was subsequently desalted using 
a Sephadex G-10 column (30 x 2.5 cm). Protecting groups were 
removed with aqueous acetic acid at pH 2.0-2.5 and the oligonu-
cleotide was re-purified by anion-exchange, with a Partisil 10 
SAX column (25 x  8mm) using a gradient of 0.0-i--0.67M potas-
sium phosphate in the presence of 20% acetonitrile (pH 6.'4). 
The reversed-phase HPLC step (above) was repeated with a 
modified gradient of 0-20 % acetonitrile and the desalting stage 
was also repeated to produce the final sample. In our experi-
ence, sound laboratory practice has hecn sufficient to prevent  
nuclease degradation of this synthetic RNA txah at the synthetic 
stage and during crystallization. Glassware was autoclaved, MilIiQ 
purified (or doubly distilled) water, and high purity chemicals 
were used throughout. 
Crystals were grown from sitting drops containing 1 mM 
oligonucleotide, 12.5 niM sodium eacxMate (pH 6.5), 50-60mM 
magnesium chloride. 6.2% (v vi 2-methvl-2,41 - cntanediol (MP[)) 
and 0.9mM spemiine tetrahydrochioride equilibrated against 
an external reservoir of neat MPD. Single crystals appeared 
within 1-2 days and achieved final dimensions after 1-2 weeks. 
The largest crystals were grown at temperatures ranging from 
20-25°C. 
X-ray data collection and structure determination 
A needle of dimensions 1.2 X  0.2 x 0.1 mm was used for data 
collection on an R-AXIS If c image plate system mounted on a 
Rigaku Rt'20() rotating anode generator operating at 50 K and 
100 mA. Data were measured at 24 °C with graphite-monochro-
mated CuK radiation (k = 1.5-418 A, 0.5 mm focal spot). Unit 
cell determination was achieved by auto-indexing reflections on 
three still photographs taken at 45 ° intervals with 10 minute ex-
posure times. This resulted in a triclinic unit cell of dimensions 
a=32.1 A, b=27.IA, c=27.OA, =79.5 ° . 3=118.1°. y = 118.1 ° 
which transforms to a C-centred monoclinic cell with dimen-
sions a=41.69(1 )A, h3-i.62( I )A, c=32.13(3)A, 1= 127.6(1 )° 
after post-refinement. Initially the image plate was set at a (115-
tance of 84mm (corresponding to a data collection limit of 
1.8A) from the crystal and the data collected on 25 x 5 ° oscil-
lation frames with an exposure time of 20 minutes per frame. 
Some of the low to medium resolution data were saturating the 
detector with that length of exposure. A second data set was 
collected with the image plate at a distance of 138 mm, data 
collection limit 25A. These data were collected on 18 X  10° os 
cillatiun frames with exposure times of 10 minutes and enabled 
the most intense reflections to be measured. 
The length of the c-axis (32,13A) suggested that the duplexes 
pack parallel (or approximately so) to this axis. The cross-sec-
tion of the cell perpendicular to the c-axis is of dimensions 
34.6A by -asii43 = 33.0 A and is appropriate for the close-packing, 
in it Ccentred motif, of A-form nucleic acid duplexes with dia-
meter of about 20A. Close inspection of the data indicated that 
the unit cell is primitive although the majority of reflections with 
hi + k odd are very weak and the diffraction pattern is pseudo 
C-centred. The assumption of one duplex per unit cell leads to 
a calculated volume per base pair of 1527A 3 which is within the 
usual range for A-form duplexes [2]. We therefore anticipated 
a solution to the structure in which the RNA duplexes adopted 
a C-centred type packing as shown in Fig. 4. 
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For the first data set a total of 16956 reflections yielded 
3447 unique data with I ~ (7I) )11,, 1 =4.3 00. For the second 
set. 8535 reflections produced 15 -0 unique data with I ~! cr( 1) 
=5.3%). Scaling the two data sets together and merging 
resulted in a data set of 3863 reflections with Rmrge = 5.7% to 
a resolution of IRA. Auto indexing of the still photographs and 
data measurement and reduction from the oscillation frames 
were performed with the software package PROCESS 1511. Scal-
ing and merging together of the two individual data sets were 
carried out with the programs ANSC and AGROVATA from the 
CCP4 software package ISERC (UK) Collaborative Computer 
Project 4, l)areshur' Lahoratorc, UK, 1979]. 
Structure solution in the two possible primitive space groups 
1>2 and P2 1 was attempted using a canonical RNA duplex of se-
quence r( CGCGAAI 1 AGCG )-r( CGCI AAUUCGC(;) generated 
using the SYIWL software package (SYBYI. software, 'Iripos As-
sociates, St. Louis, MO, USA) as a search model. The ULTIMA 
program 1213 was used to find possible solutions based on 
a five-dimensional R-factor search using data in the resolution 
range 18.0-10.OA. In the space group P2, all possible solutions 
resulted in R-factors of greater than 60 % when refined as rigid 
bodies against the same data. These were not pursued. In the 
space group 1 1 2 1 however, several equivalent possible solutions 
resulted in residuals of less than 40%. One of these was exam-
ined on an Evans and Sutherland ESV30 graphics workstation 
and was found to have excellent crystal packing. The arrange-
ment of the RNA double helices closely mimics a C-centred pack-
ing motif and given that the X-ray data had revealed the unit cell 
to he pseudo C-centred we considered this solution to be viable 
for further refinement. 
Structure refinement 
Preliminary refinement of the model was carried out using rigid-
body techniques with a modified version of SFIELX [22). This 
was immediately follc )wed by a round of refinenient using the 
X-PLOR software package [23] which consisted of energy mini-
mization of the model, a simulated annealing protocol 1241 and 
120 cycles of Powell minimization using data with F > 2o(F) in 
the resolution range 8.0-2.6 A. The simulated annealing protocol 
consisted of a slow-cooling procedure in which the temperature 
of the system was reduced from 2000K to 300K in steps of 
25 K with a time.sep Of 0.2 is being employed for the molecular 
dvnaniics calculations. This resulted in an R-factor of 24.7% for 
1646 reflections. Electron density (2F 1 , - F. and difference 
density (F-F, c) maps were then calculated and examined 
on the graphics workstation [52]. These confirmed that the so-
lution was correct. 
Our initial model was a duplex consisting of 12 Watson -Crick 
base pairs and the electron density maps calculated at this stage 
were unequivocal in suggesting that it should be rebuilt Si) that 
it contained two G( anti)-A( anti) base pairs. This was coupled 
with alterations of the sugar-phosphate backbone in order that 
it made a better fit with the density. The refinement was then 
continued with a further round of simulated annealing refine-
ment with the data extended to 1.8 A. This resulted in R = 30.7% 
for the 3766 2(7(F) data. Further rounds of restrained least-
squares refinement incorporating individual restrained isotropic 
temperature factors and the conservative addition of solvent 
molecules were then used to complete the refinement. Initially 
the X-PLOR software was used but in the latter stages the re -
finement was performed with the program NUCLSQ 125.271 in 
order to improve the geometry of our model. The final model 
has a crystallographic residual of 19.0% for 3147 reflections 
with F~!3(F) in the resolution range 7.0 1 .8A. This repre-
sent,s 46.3% of the total theoretically available data within the 
resolution range stated. 37.9% in the range 2.06 A to 1.92 A, 
19.7% from 1.92 to 1.8A, These figures are a consequence of 
the pseudo C-centering (as those reflections with h± k odd are 
weak) but are also a reflection on the use of a thin crystal for data 
collection. When all processed data are included IF ~! 1Y(F)] in 
the structure factor calculations, the final residual is 21.2% for 
3717 reflections. When the data used have F ~!6(F) the final 
R-factor is 17% for 2244 reflections. We have been able to cam 
out a resolution test on station PX9.6 at the Synchrotron Radi-
ation Source at Dareshun. A crystal of approximate thickness 
0.07mm showed diffraction beyond 15 A resolution. It should 
therefore be possible to improve the accuracy of this structure 
at some later date by both improving the completeness of and 
the resolution limit of the data that is incorporated into the 
refinement. 
Structure factors and coordinates have been deposited with the 
Brookhaven ) a en Protei n  Data Bank. 
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